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ABSTRACT 
 
ANNA M. JOHNSON: Association between Exposure to Combat and Burden of Coronary 
Heart Disease, Ischemic Stroke and Subclinical Atherosclerosis in Aging Men: The 
Atherosclerosis Risk in Communities (ARIC) Study 
(Under the direction of Dr. Gerardo Heiss) 
 
Studies of the long-term cardiovascular consequences of combat stress are few and 
inconclusive.  We investigated the effect of combat on the incidence of coronary heart 
disease (CHD) and ischemic stroke (IS) and the burden of subclinical atherosclerosis—
measured by carotid intima-media thickness (CIMT) and carotid plaque—among 5,347 black 
and white men from the Atherosclerosis Risk in Communities (ARIC) cohort study. Combat 
veterans and non-combat veterans were compared separately with non-veteran “controls” and 
with one another. Veterans were older, white and of higher socioeconomic status than non-
veterans. Veterans were more likely to be current drinkers and heavy smokers but less likely 
to be current smokers and physically inactive. Combat veterans had the highest average 
systolic blood pressure and total cholesterol. Compared to non-veterans, combat veterans 
(Risk Ratio (RR): 1.19; 95% Confidence Interval (CI): 1.11, 1.28) and non-combat veterans 
(RR: 1.08; 95% CI: 1.01, 1.15) had higher risk of carotid plaque, and combat veterans (Risk 
Difference (RD): 28.6µm; 95% CI: 22.5, 34.6) and non-combat veterans (RD: 12.48µm; 95% 
CI: 2.64, 22.32) had higher average CIMT. Compared to non-combat veterans, combat 
veterans had higher risk of carotid plaque (RR: 1.11; 95% CI: 1.03, 1.19) and higher average 
CIMT (RD: 44.68µm; 95% CI: 32.47, 56.89). Differences remained when CIMT was 
dichotomized and when age was considered among men from the eras of World War II and 
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the Korean War but not the Vietnam Conflict. Combat veterans had higher CHD and IS 
incidence rates than non-combat veterans or non-veterans only among cohort members of the 
Korean War era. Incidence rate ratios (IRR) were statistically significant only in comparisons 
between combat and non-combat veterans for CHD (IRR=1.46; 95% CI=1.02, 2.07) and IS 
(IRR=1.81; 95% CI=1.01, 3.23). Results suggest that differences detectable at the subclinical 
level may not yet be manifest at the level of symptomatic disease. Interaction by era of 
service was noted in both analyses, with the most notable effects among men from the 
Korean War era. The findings in this study, if confirmed, have implications for our 
understanding of the lasting effects of traumatic stress on long-term cardiovascular health. 
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CHAPTER 1 
INTRODUCTION 
 
Stress is widely considered to have both psychological and physiological effects and 
is thought to influence the development of cardiovascular disease (CVD).1, 2, 3  A primary 
mechanism through which stress may increase the risk of CVD is through an inflammatory or 
atherosclerotic process, involving neurological, endocrine, and immunological 
components.4,5 Psychological, behavioral and other pathways have also been implicated. 6,7, 8  
The psychosocial stress experienced by veterans who have engaged in active combat is a 
uniquely traumatic stressor that can have positive as well as negative consequences9,10 and 
can have both short-term and long-term effects.11,12 The effects of military service in general 
and military combat in particular are so pervasive yet so little studied that they have been 
termed the “hidden variable” in the aging of older American men.13,14 Approximately 65% of 
American men over the age of 55 served in World War II or the Korean conflict. Further, 
about one quarter of all older American men were exposed to military combat at some time 
in their lives. 15,16 
The epidemiologic evidence supports a possible effect on increased cardiovascular 
risk from exposure to military combat, although the data are limited and to date have been 
inconclusive.17,18,19  Exposure to combat has been associated with higher rates of behavioral 
problems,20 psychological disorders, 21, 22 and self-reported health conditions 23, 24 Many 
studies have investigated the effects of military combat—typically depression or post-
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traumatic stress disorder (PTSD)—rather than exposure to combat itself. Further, most 
studies have focused on psychological and short-term health outcomes rather than long-term 
physiological outcomes. Of the studies that have investigated long-term consequences of 
combat exposure, mortality has been the primary outcome. Studies of the long-term impact 
of combat on the incidence of CVD are few, and to date, no studies have directly assessed the 
association between exposure to combat and the prevalence of subclinical atherosclerosis.  In 
this study, we took advantage of a unique opportunity to investigate the effect of combat on 
the incidence of coronary heart disease (CHD) and ischemic stroke (IS) and the burden of 
subclinical atherosclerosis in a large, community-based sample of men whose military 
service spanned World War II, the Korean War and the Vietnam Conflict. In the course of 
this study, the following two manuscripts were prepared: 
 
Manuscript 1: The association between remote exposure to combat and subclinical 
atherosclerosis was assessed among 5,347 men in the Atherosclerosis Risk in Communities 
(ARIC) cohort. Coronary artery plaque and carotid intima-media thickness (CIMT) were 
compared between non-veterans and veterans with and without one or more self-reported 
combat exposures. Cardiovascular measurements were taken an average of 36 years after 
entry into military service. Descriptive statistics were calculated for baseline distributions of 
sociodemographic characteristics, risk factors and military and combat exposures. Statistical 
evaluation of differences in the distribution of carotid plaque and CIMT compared combat 
veterans and non-combat veterans separately with non-combat “controls” and also contrasted 
the two veteran groups: combat veterans with non-combat veterans. Linear regression was 
used to estimate risk differences (RDs) and 95% confidence intervals (CIs) for continuous 
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CIMT, averaged over Visits 1 and 2, while modified Poisson regression was used to estimate 
risk ratios (RRs) and 95% CIs for binary CIMT and plaque variables.  Because age was not 
associated with the exposure in these data, it could not be treated as a typical confounder in 
statistical analyses. However, because it is strongly associated with the development of 
atherosclerosis, age at identification of subclinical atherosclerosis was accounted for by 
looking at age-specific values and ranges of each outcome. Results were stratified according 
to era of service (World War II, the Korean War or the Vietnam Conflict) and race (black or 
white) in order to assess potentially important heterogeneity in effects. This study addresses 
Aim 1 (see Section II).  
 
Manuscript 2: The association between remote exposure to military combat and the risk of 
coronary heart disease (CHD) and ischemic stroke (IS) was assessed among 4,620 men in the 
Atherosclerosis Risk in Communities study. Descriptive statistics were calculated for 
baseline distributions of sociodemographic characteristics, risk factors and military and 
combat exposures. Ten-year predicted risks of CHD and IS associated with exposure to 
military service with and without combat were calculated independently using linear 
regression using published sex and race-specific parameter estimates. Incidence rates (IR) 
were calculated by dividing the number of events by the total time experienced for the 
participants followed. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were 
calculated using Poisson regression. Combat veterans and non-combat veterans were 
compared separately with non-combat “controls,” and the two veteran groups—combat 
veterans and non-combat veterans—were also compared with one another.  Non-veterans 
were grouped into three age categories (<52, 52-59, 60+ years) that most closely mirrored the 
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age categories of veterans who served during the eras of World War II, the Korean War and 
the Vietnam Conflict, respectively. Results were stratified according to era of service (World 
War II, the Korean War or the Vietnam Conflict) in order to assess potentially important 
heterogeneity in effects. This study addresses Aim 2 (see Section II).  
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CHAPTER 2 
SPECIFIC AIMS 
 
In this study, we report on the long term association between exposure to military 
combat and the incidence of coronary heart disease (CHD) and ischemic stroke (IS) as well 
as the burden of subclinical atherosclerosis in a large, community-based sample of men 
whose military service spanned the eras of World War II, the Korean War and the Vietnam 
Conflict. Those with a history of military service who reported one or more combat-related 
stressors (combat veterans) were contrasted to those without a history of military service 
(non-veterans) as well as to those with a history of military service without combat (non-
combat veterans). Results were stratified by era of service (World War II, the Korean War 
and the Vietnam Conflict) to detect differences in effect among veterans of different birth 
and service cohorts. We also examined the extent to which differences by combat exposure 
status, if extant, vary by differences in sociodemographic and cardiovascular risk factor 
profiles. To this end, we evaluated the following specific aims:  
 
Specific Aim 1: To investigate the association between exposure to combat stress and the 
presence of subclinical atherosclerosis. 
Hypothesis 1.1:  Combat veterans have higher prevalence of subclinical carotid 
atherosclerosis (as measured by carotid intima media thickness (IMT) and the 
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presence of carotid artery plaque) than veterans without combat exposure or non-
veterans. 
Hypothesis 1.2:  Associations between combat stress and subclinical carotid 
atherosclerosis remain after age is taken into account, both when combat veterans are 
compared with non-combat veterans and when combat veterans are compared with 
non-veterans. 
Hypothesis 1.3:  Associations between combat stress and subclinical carotid 
atherosclerosis differ by era of service, with the strongest associations among men of 
the Vietnam Conflict and Korean War eras and the weakest among men of the World 
War II era.  
Hypothesis 1.4:  Associations between combat stress and subclinical carotid 
atherosclerosis differ by race, with stronger associations among black men than 
among white men. 
 
Specific Aim 2: To investigate the association between exposure to combat stress and the 
incidence of CHD and IS.  
Hypothesis 2.1:  Combat veterans have higher incidence of CHD and IS than veterans 
without combat exposure or non-veterans. 
Hypothesis 2.2:  Associations between combat stress and CHD and IS differ by era of 
service, with the strongest associations among men of the Vietnam Conflict and 
Korean War eras and the weakest among men of the World War II era.  
Hypothesis 2.3:  Associations between combat stress and CHD and IS differ by race, 
with stronger associations among black men than among white men. 
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CHAPTER 3 
BACKGROUND AND SIGNIFICANCE 
 
Cardiovascular disease (CVD) is the global term used to describe the major disorders 
of the heart and arteries supplying the heart, brain and peripheral tissues with blood.25 CVD 
comprises many diseases and conditions that vary widely in their symptoms and effect on 
circulatory functioning and overall health. It has been estimated that CVD is responsible for 
23% of all deaths the world, and 48% of deaths in industrialized countries.26 Further, CVD is 
responsible for considerable disability, lowered quality of life and social and economic costs 
even when non-fatal. The major category of CVD, based on its widespread impact on health, 
is the category of atherosclerotic and hypertensive diseases, a distinct but closely related 
conditions that include coronary heart disease (CHD), stroke, peripheral arterial disease 
(PAD), aortic aneurysm, congestive heart failure (CHF) among others.   
 
Atherosclerosis 
 Atherosclerosis refers to the lesions or plaques on the inner surface (lumen) and 
within the wall of large to medium-diameter arteries (macrovasculature) as well as to areas of 
the arterial wall that have been hardened (sclerosed) by lipid and calcium deposits, 
weakening the wall and intruding into the lumen, causing a partial or complete obstruction of 
blood flow. Atherosclerosis can occur in large or medium size arteries throughout the body, 
and thus it may affect blood flow differently based on the location of the lesions, including 
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flow to the heart, brain, lower extremities or abdominal aorta. Accordingly, atherosclerosis 
may contribute to a wide range of cardiovascular diseases, including hypertension, ischemic 
heart disease, pulmonary heart disease, cerebrovascular disease and diseases of arteries, 
arterioles and capillaries.27  
 The importance of blood cholesterol in the development of atherosclerosis has been 
recognized since the early 20th century when it was documented that even small changes in 
the amount of dietary cholesterol given to rabbits produced detectable changes in the 
likelihood of developing atherosclerosis. Further animal studies identified processes at the 
cellular level in which the arterial wall was affected by cholesterol-dense migrating cells. 
Human studies in the 1930s reinforced the cholesterol-atherosclerosis connection by finding 
that populations that consumed higher cholesterol diets were also those with higher rates of 
atherosclerosis.  The process by which blood lipid levels lead to atherosclerosis is a complex 
one, involving both cellular and extracellular components. At the beginning of this process, 
cholesterol is transported via lipoproteins through endothelial cells into the intima of the 
artery. To counteract this influx, HDL removes some of this cholesterol from the intima. At 
the same time, oxidation of LDL may occur, a molecular process that can damage endothelial 
cells and convert migrating macrophages into cholesterol-laden “foam” cells. These foam 
cells can act to further damage endothelial cell functioning, promoting the adhesion of blood 
platelets and leading to the formation of a clot or thrombosis, adding to the size of the 
growing atherosclerotic plaque or completely occluding the vessel leading to ischemia. It 
must be emphasized that blood lipid concentrations are not the only crucial factor in this 
process, such that other factors which can affect the probabilities of oxidation or other 
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molecular changes can play an important role in the lipid-atherosclerosis relationship and 
attendant processes. 28   
Another distinct though complementary mechanism that is thought to underlie the 
atherosclerotic process is the response-to-injury hypothesis. Through this process, 
atherogenesis can also be viewed as an inflammatory response, as the autonomic nervous 
system, which is engaged in a period of stress, interacts directly with the immune system. 
29,30, 31,32,33
  Prolonged elevation of cortisol levels, as can occur through the autonomic 
nervous system’s response to periods of stress, can inhibit proper functioning of the immune 
system, increase blood pressure and promote inflammatory vascular lesions. Such lesions can 
advance into a state of endothelial dysfunction, which is considered the first step in 
atherosclerosis, as described above.34 In response to a stressor or injury, levels of endogenous 
IL-6 and other pro-inflammatory cytokines are elevated.35, 36,37,38 The response-to-injury 
hypothesis of atherosclerosis is founded on the finding that an injury or stressor alters the 
homeostasis of the endothelium, leading to an increased adhesiveness of the endothelium to 
leukocytes and platelets, increased coagulation, increased migration and proliferation of 
smooth muscle cells at the area of inflammation, and increased permeability of the 
dysfunctional endothelial wall.39  These inflammatory mechanisms act in concert to thicken 
the arterial wall, leading to dilation and, eventually, remodeling of the artery and restriction 
of the arterial lumen.40  Specifically, the increased adhesion of platelets and leukocytes to the 
dysfunctional endothelium and to monocyte-derived macrophages that are assembled in 
response to injury accumulate on the arterial wall and further expand the lesion.41  Monocyte-
derived macrophages and T lymphocytes are key inflammatory cells and are key participants 
in the inflammatory response.  Activated platelets also release cytokines and growth factors 
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that further call upon the migration and proliferation of smooth muscle cells and monocyte-
derived macrophages.42,43  Smooth muscle cells, further activated in the presence of pro-
inflammatory cytokines,44 migrate and proliferate at the site of inflammation to create an 
intermediate lesion, while monocyte-derived macrophages and T-lympocytes from the blood 
multiply within the lesion.  These inflammatory cells, in turn, are activated to release 
cytokines, chemokines, and growth factors, which cause further damage that can lead to 
necrosis. At this point, the lesion has become advanced and may begin to narrow the lumen.  
Injury also acts to increase the permeability of the dysfunctional endothelial wall to LDL 
cholesterol.45,46 Macrophages recruited to the site of inflammation oxidize LDL cholesterol 
and internalize the oxidized cholesterol. This process leads to further stimulation of the 
replication and recruitment of monocytes which, in turn, create macrophages to continue the 
inflammatory process. The inflammatory response can continue indefinitely if the offending 
agents are not effectively deactivated.47  
 A third mechanism through which atherosclerosis can be initiated or promoted is 
through viral48 and bacterial49 infection. Though less well studied, this mechanism has been 
observed in both animals and humans, particularly with infections involving the herpes 
viruses as well as bacterial infections with Chlamydia pneumoniae and Helicobacter pylori 
and the development of CHD. Additional mechanisms, including hormonal changes and 
other processes, leading to or furthering the atherosclerotic process are being studied.  
 
Subclinical atherosclerosis 
Even before clinical manifestations of atherosclerosis are observed, subclinical 
atherosclerosis may be present. The Cardiovascular Health Study (CHS) investigated a 
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composite index of subclinical atherosclerosis in a population of adults aged 65 years and 
older, finding that while one quarter to one third of participants had clinical disease, more a 
third of participants had symptoms of atherosclerosis (via ultrasound, echocardiography 
(ECG) or self-reported impairment of coronary or lower extremity blood flow).50  The 
prevalence of subclinical atherosclerosis in this study was approximately the same for men 
(39%) and women (36%), and the risk factors for subclinical disease were found to be similar 
to those for clinical disease—LDL and HDL cholesterol, SBP, blood glucose, smoking—
though at younger ages. Individuals with subclinical disease are at very high risk for 
developing clinical atherosclerosis, particularly at older ages. Atherosclerotic changes, 
including cholesterol deposits known as fatty streaks, have been identified as early as 
childhood, suggesting atherosclerosis can have its origins early in life.2   
 
Atherosclerotic Plaque 
 Plaque is a hallmark of either subclinical or clinical atherosclerosis. Atherosclerotic 
plaque refers to lesions on the lumen and within the wall of large to medium-diameter 
arteries where cholesterol deposits have become covered by a fibromuscular cap. Through 
the mechanisms outlined above, progression of atherosclerosis begins with the development 
of a fatty streak, becomes a transitional then advanced fibrolipid plaque and can become a 
complicated plaque. (Figure 1) Such advanced plaques can disrupt blood flow through the 
artery or, if ruptured, can cause occlusive thrombosis and, depending on the location of the 
plaque, lead to sudden cardiac death (SCD), myocardial infarction (MI), ischemic stroke (IS) 
or peripheral arterial disease (PAD). Advanced atherosclerotic plaques are known as 
atheromas, and due to chronic inflammation, may undergo changes that soften the material 
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within the fibrous cap, predisposing it to rupturing and potential formation of blood clots that 
can further enlarge the plaque and restrict or obstruct blood flow.  
 
Figure 1. Atherosclerotic Progression. 
 
Source: Adapted from the Mayo Clinic, 2006. 51  
 
Although plaque can develop in large and medium sized arteries throughout the body, 
the carotid artery bifurcation, the location where the external and internal carotid arteries 
branch off from the common carotid artery, is the most common location of the development 
of atherosclerotic plaques in humans (Figure 2) The six carotid arteries (common carotid, 
internal carotid and external carotid on the left and right sides of the body) provide the main 
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blood supply to the brain and face. The common carotid artery is the blood vessel that 
supplies the head and neck with oxygenated blood, dividing in the neck to form the external 
carotid artery, which brings blood to the face and internal carotid artery, which brings blood 
to the brain. Blockage of blood flow to the carotid arteries can lead to a cerebral embolism or 
stroke. Specifically, carotid atherosclerosis is usually most severe within two centimeters of 
the bifurcation and most often involves the posterior wall of the artery.  
 
Figure 2. Atherosclerotic Plaque and the Carotid Arteries. 
 
Source: Adapted from Nott, 2007. 52  
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Epidemiology of Atherosclerosis 
 Atherosclerosis has been recognized as a human disease since the 19th century. In the 
past 50 years, however, a great deal more about the pathology and epidemiology of 
atherosclerosis has been learned. Holman’s autopsy studies in the 1950’s of young persons 
(ages 1-40 years) discovered that fatty streaks appear commonly within the first ten years of 
life, and that these can progress into fibrous plaques and more advanced plaques with age. 
Holman also noted that progression of disease can occur at different rates in different 
population groups, and that progression occurs particularly quickly during puberty, 
suggesting hormonal involvement in the progression of the disease.53 Further supporting the 
finding that considerable development of atherosclerosis occurs within the first twenty years 
of life, a series of autopsy studies of US military casualties reported visible lesions in the 
coronary arteries of 77% of the 300 Korean War casualties investigated54 and the presence of 
coronary atherosclerosis in 45% of the 105 Vietnam Conflict casualties investigated by 
coronary angiography.55  
The large-scale International Atherosclerosis Project (IAP), which investigated over 
23,000 sets of coronary arteries in 14 countries in the 1960s, developed the standard of using 
the percentage of intimal arterial surface area that is covered by fibrous plaques and calcified 
lesions to measure the extent of atherosclerosis and discovered notable sex and race 
differences in the amount and location of atherosclerotic plaque development.56 IAP 
investigators studied the arteries of decedents between the ages of 25 to 64 of different race 
groups and found that in a New Orleans population, white men had more than twice the 
surface area involvement (20%) of white women, while in a Durban, South Africa population 
the rates for black men and women were considerably lower (8%). Further, while the amount 
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of atherosclerosis in the aorta differed little between men and women, it was a considerably 
greater among men in the coronary arteries.  
The notable progression of atherosclerosis by age was also highlighted in a World 
Health Organization (WHO) Study that looked at the presence and progression of 
atherosclerotic plaques in five European cities in the 1980s.57 This WHO study noted an 
increase in the frequency of the population with atherosclerotic plaques by age, from less 
than 15% at age 20 to 100% for those ages 50 years and older. Another key study of changes 
in atherosclerosis with increasing age is the Bogalusa Heart Study.58 Thirty years ago, 
investigators began following over 3,500 black and white, male and female school-age 
children to describe age trends and risk factors—including blood pressure, smoking, 
cholesterol, diet, anthropometric measurements—for the development and progression of 
atherosclerosis. Investigators noted the importance of controlling risk factors as early as 
childhood, as key risk factors such as blood lipids and blood pressure contribute prominently 
in the development of atherosclerosis early in life. These findings were supported in the 
Muscatine Study, a long-term prospective cohort study of Iowa children followed into their 
early 30s.59 
The importance of blood lipid concentrations and smoking as risk factors for 
atherosclerosis were again highlighted in the US-based Pathobiological Determinants of 
Atherosclerosis (PDAY) Study, a post-mortem study of men ages 15 to 34 years. PDAY 
investigators reported considerably more atherosclerotic surface area involvement among 
smokers with unfavorable blood lipid profiles than among non-smokers with favorable blood 
lipids (30% versus 10% at age 15 and 50% versus 25% at age 34).60 The PDAY study also 
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drew attention to sex differences in the location and extent of atherosclerosis, even as early as 
the teenage years, even after controlling for differences in smoking and blood lipid levels.   
Marked differences in the rates of atherosclerosis among people from different 
industrialized countries have also been reported. Notably, a study comparing men ages 24 to 
44 years from Tokyo, Japan with black and white men from New Orleans found little 
difference in the amount or location of fatty streaks but in the amount of surface area with 
raised lesions in the aorta and coronary arteries.61 Further, this study brought to light the 
different importance of particular risk factors on the development of atherosclerosis in 
different anatomic locations. Specifically, while age, cholesterol and blood pressure were key 
risk factors for the degree of atherosclerosis in coronary arteries, blood pressure was most 
strongly related to the extent of disease in the cerebral arteries.   Additional detail about the 
contribution of specific risk factors in the development of atherosclerosis, CHD and stroke 
are provided in section E below.  
 
Coronary Heart Disease 
A major disease of the heart, CHD is currently the leading cause of death in the 
United States62 and accounts for 12.6% of deaths worldwide.63  CHD, also known as 
ischemic heart disease, refers to atherosclerosis of the arteries supplying the myocardium or 
heart muscle. Because continuous supply of oxygen and nutrients is critical for the proper 
functioning of myocardial cells, insufficient blood supply to the myocardium (ischemia) can 
lead to injury and death in a matter of minutes.64 The biological and clinical progression of 
CHD generally begins with a prolonged process of atherosclerosis, which leads to the 
development of advanced atherosclerotic plaques within the coronary arteries. Disruption or 
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enlargement of an advanced plaque can lead to acute symptoms (unstable angina), 
myocardial infarction (MI) or sudden death or to more chronic symptoms such as residual 
cardiac dysfunction or later onset of an event. Six major conditions are currently classified 
within CHD, according to the Tenth Version of the International Classification of Diseases 
(ICD-10), as shown in Figure 3 below. 
 
Figure 3. Categories of Coronary Heart Disease. 
ICD-10 Code  Diagnosis         
I20   Angina pectoris 
I21    Acute myocardial infarction 
I22   Subsequent myocardial infarction 
I23    Certain current complications following acute myocardial infarction 
I24   Other acute ischemic heart disease 
I25   Chronic ischemic heart disease 
 
Source: Adapted from World Health Organization, 1992.65  
 
The first of these conditions, angina pectoris, commonly known as angina, is defined 
as chest pain due to a transitory (15 seconds to 15 minutes) lack of blood flow (ischemia) of 
the myocardium due to obstruction or spasm of one or more of the coronary arteries and that 
fails to cause cellular death. Coronary artery disease (CAD), or atherosclerosis of the cardiac 
arteries, is the primary cause of angina.  
Acute myocardial infarction (AMI or MI), commonly known as a heart attack, is the 
leading cause of death for both men and women throughout the world.66 MI is caused by 
interruption of the blood supply to the myocardium resulting in necrosis of heart tissue.  
CAD is also the primary cause of MI, with the most common triggering event being the 
disruption of an atherosclerotic plaque in a coronary artery.  
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Sudden cardiac death (SCD) also falls under the general category of CHD and is 
defined by death resulting from sudden loss of heart function that occurs within one hour of 
the onset of acute symptoms. The majority of out-of-hospital cardiac-related deaths are due 
to SCD. The most common underlying cause of SCD is atherosclerosis; in 90% of adults 
with SCD, two ore more major coronary arteries are obstructed.  The sudden cardiac arrest 
most commonly occurs when the electrical signals in the diseased myocardium become 
irregular (i.e., when there is an arrhythmia). This can occur when the impulses become too 
rapid, as occurs in ventricular tachycardia, too slow, in the case of bradycardia or irregular, 
as occurs in ventricular fibrillation. This arrhythmia can cause the heart to suddenly stop 
beating.67  
 
Epidemiology of Coronary Heart Disease 
Although CHD was recognized in clinical observation as early as ancient Greek and 
Egyptian times, it was not until the 19th century that progress was made toward a more 
advanced understanding of its pathology and epidemiology.68  In the early 1900’s the 
important link between acute occlusion of a coronary artery and the onset of MI was made,69 
as well as the recognition of CHD as a distinct, clinical entity and the development of key 
diagnostic procedures such as electrocardiography (ECG). Geographic variations in the 
prevalence of and mortality from CHD were noted early on with the Europe-based Seven 
Countries Study,70 the Ni-Hon-San Study of Japanese men in Japan, Hawaii and San 
Francisco,71 the Framingham Study of American men,72 and other community-based studies.  
These studies were revolutionary in their design, providing for many years of follow-up, 
ancillary studies of both experimental and observational design, large-scale prevention 
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interventions and a wealth of information about the differences in risks among populations as 
well as the differences in risks within populations.  
In the 1950s and 1960s, advancements were made in the standardization of 
definitions and classification systems; the interview methods for taking health histories (the 
London School of Hygiene or Rose questionnaire); and procedures for coding ECG findings 
(the Minnesota code), all of which were critical for comparison of data across studies.73,74  As 
new diagnostic tools became available, such as troponin and other biomarkers for damaged 
cardiac cells, standardized definitions and classification systems have been updated 
accordingly.  The algorithm for diagnosis and classification of acute CHD was initially 
developed by American Heart Association (AHA) investigators in the mid-1980s and, since 
its adoption by the WHO MONICA (Monitoring Trends and Determinants in Cardiovascular 
Disease) Project, the largest cardiovascular epidemiology study to date, this algorithm has 
become standard operating procedure in population studies. According to this diagnostic and 
classification system, fatal and nonfatal CHD events in population studies are classified 
according to the clinician’s confidence in its occurrence (definite versus possible infarction), 
whether resuscitation from cardiac arrest was achieved, and, in the case of fatal events, 
whether sufficient information was available for classification as definite or possible 
infarction. Diagnosis of events is based on a composite picture including ECG findings, 
myocardial enzymes, history of chest pain and evidence of necropsy.75  
Historically, population studies of CHD have measured its occurrence based on 
mortality (CHD deaths per 100,000 population per year), incidence (new fatal or non-fatal 
CHD cases per 1,000-100,000 population per year), case-fatality (the proportion of all CHD 
cases in the population that are fatal within 28 days of the onset of symptoms) and prevalence 
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(the proportion of the population living with identified CHD at any given time, reported as 
CHD cases per 1,000-100,000 population). Since the late-1950s, when standardized CHD 
mortality rates peaked in the US, rates have declined considerably.76 Reasons for this decline 
are unclear, although it is thought that improvements in medical care, particularly in coronary 
intensive care units, as well as improved prevention efforts have reduced the incidence of 
CHD events.77 Although mortality rates have declined over time for both men and women 
and for both black and white persons, race and sex-specific levels have consistently differed 
from one another over time. According to most recent estimates by the AHA, in 2004, CHD 
mortality rates per 100,000 population (using the year 2000 standard population for age 
adjustment) varied considerably, from 194.4 for white males, to 222.2 for black males, to 
115.4 for white females and to 148.6 for black females.78 International data on mortality from 
CHD comes primarily from the WHO MONICA Project, which found considerable variation 
in CHD mortality in the 21 countries studied, from nearly 500 CHD deaths per 100,000 men 
in Finland to 50 CHD deaths per 100,000 men in China and from 110 per 100,000 women in 
the United Kingdom to 11 per 100,000 women in Spain.79  
Because of the many requirements needed for ascertainment of a CHD event, 
incidence, case-fatality and prevalence data are less available than mortality data. However, 
the WHO MONICA Project has been a fundamental source in providing this information 
internationally. According to data from this project, like CHD mortality rates, incidence rates 
vary widely among nations, from 915 per 100,000 men in East Finland to 76 per 100,000 
men in China and from 256 per 100,000 women in the United Kingdom to 30 per 100,000 
women in Spain. Incidence rates were consistently four to five times greater among men than 
women.  
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Differences in case definitions for case-fatality rates also complicate comparisons 
among studies and different populations. Regardless of the definition, case-fatality rates 
differed widely among nations studied, both for men—from 37% in Iceland to 81% in 
Poland—and women— from 31% in Canada to 69% in China—according to the definition 
that includes definite fatal events, possible fatal events, unclassifiable fatal events and 
definite nonfatal events. In the US, the Minnesota Heart Study has been a valuable source of 
information on CHD case-fatality rates and identified a 25% decrease in CHD mortality 
between 1985 and 1990 among both men and women and among both in-hospital and out-of-
hospital cases, suggesting a combination of decreased incidence and decreased case-fatality 
rates.80 Improvements in prevention and treatment have been credited for these reductions.  
Persons included in the numerator of prevalence estimates include those who have 
survived past 28 days of the onset of a CHD event, those who have had a silent MI detected 
through screening, and those with a history of angina pectoris. In 1996, the prevalence of 
CHD in the US was estimated to be 5.23%, or about 13 million Americans.81 Prevalence 
estimates are collected primarily through field surveys, and in developing countries with 
fewer resources estimates often do not follow standardized diagnostic criteria and methods.   
In addition to studies designed to focus primarily on differences among cohorts of 
people, a number of large-scale community and employment studies have provided a wealth 
of information about factors that help explain differences in risk among persons within 
cohorts. In 1978 the AHA, in collaboration with the Heart Disease Control Program and the 
National Heart Institute, produced a Final Report of the pooled results of five such studies—
the Albany civil Servants Study, the Chicago Gas Company Study, the Chicago Western 
Electric Company Study, the Framingham Study and the Tecumseh Study—and included a 
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total of 72,011 person-years and 658 incident CHD events before the age of 65 among a 
group of predominantly white men in the US.82 This study determined that when persons are 
placed into quintiles of risk—defined by profiles of diastolic blood pressure (DBP), serum 
cholesterol concentration, smoking status and age—substantial CHD risk exists even well 
below the highest risk group. Another large-scale study of middle-aged American men, the 
Multiple Risk Factor Intervention Trial (MRFIT) prospectively followed 342,815 men free of 
disease at baseline and assessed the contribution of age, blood pressure, serum cholesterol 
concentration and cigarette smoking in the development of CHD. 83  This study found that 
persons in the highest risk levels for smoking, blood pressure and cholesterol were more than 
20 times more likely to die of CHD than those in the lowest risk stratum for each of these 
risk factors. Additional detail about the contribution of specific risk factors in the 
development of atherosclerosis, CHD and stroke are provided in section E below. 
 
Stroke 
Cerebrovascular accident (CVA), commonly known as “brain attack” or stroke, is the 
third leading causes of death in the United States.84 While CHD is the major class of 
atherosclerotic and hypertensive disease caused by a disorder in circulation to the heart, 
stroke is the major class of atherosclerotic and hypertensive disease caused by a disorder in 
circulation to the brain. Stroke generally begins with a sudden onset of symptoms, such as 
loss of consciousness or in function on one side of the body. Strokes are caused by a 
hemorrhage, or obstruction of a major artery by thrombosis (a clot near the brain) or 
embolism (a clot that formed elsewhere and traveled to the brain). While the onset of stroke 
symptoms is generally acute, the atherosclerotic or hypertensive condition preceding the 
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stroke is often a long-term process. Symptoms of stroke and its effects may disappear within 
minutes or houses or may persist ending in permanent disability or death. 
Strokes are classified by whether symptoms resolved, the time in which symptoms 
resolved and whether the stroke was caused by a hemorrhage, thrombosis or embolism. 
Episodes that resolve within one hour are known as transient ischemic attacks (TIA). 
Previously, TIAs were defined as resolving within 24 hours, but this definition has recently 
been changed. TIAs that last more than one hour but less than 24 hours are known as 
reversible ischemic neurological deficit (RIND). Approximately 60% of persons who suffer a 
TIA or RIND have evidence of brain infarction.  Strokes with symptoms that persist longer 
than 24 hours are referred to as completed strokes, and those that are followed by a death 
within 28 days are termed fatal strokes.  
Strokes are commonly classified into ischemic or hemorrhagic strokes. Ischemic 
strokes account for 85% of all strokes and are caused by an interruption in cerebral 
circulation by occlusion of an artery near the brain. Ischemic strokes include TIAs, RINDs, 
thrombotic strokes (those in which an acute clot occludes an artery near the brain) and 
embolic strokes (those in which an acute clot that forms proximally separates from its source 
and travels to an artery near the brain). A ruptured plaque is the primary mechanism of most 
thrombotic and embolic strokes. Hemorrhagic strokes account for the remaining 15% of 
strokes and occur when a cerebral artery ruptures into the surrounding tissue. Brain cells can 
suffer direct trauma from the hemorrhage. Secondary damage also commonly occurs if the 
rupture leads to increased intracranial pressure, releases damaging mediators or causes 
decreased blood supply to the brain tissue downstream from the ruptured artery. 
Hemorrhagic strokes are further classified into intracerebral hemorrhagic strokes (ICH; when 
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blood ruptures directly into the brain parenchyma, most commonly from small intracerebral 
arterioles damaged by chronic hypertension)85 and subarachnoid hemorrhagic strokes (SAH; 
when blood seeps into the subarachnoid space). SAHs are most commonly caused by 
aneurysms and can cause sudden and painful symptoms.86   Proper classification of a stroke 
as a hemorrhagic or ischemic stroke is critical for treatment, as reperfusion therapy and 
fibrinolytic agents used to treat ischemic stroke can be fatal if given to a patient with a 
hemorrhagic stroke.  
 
Epidemiology of Stroke 
 In the US, stroke morality and prevalence are approximately one quarter to one-third 
those of CHD. While stroke mortality rates vary widely among different populations, over 
the past few decades they have been decreasing in most of the countries in which trends have 
been described.87 Between 1900 and 1960, stroke mortality in the US decreased 
continuously—from more than 125 to 75 or fewer deaths per 100,000 population88—and 
continued to decrease into the 1980s. However, this decline in mortality rates appears to be 
tapering off or ending.  
Similar to CHD, case definitions for stroke for use in epidemiologic research were 
developed by the AHA in association with WHO and published through the WHO MONICA 
Project. According to this diagnostic system, stroke is defined as definite stroke, not stroke, 
definite stroke associated with definite MI or insufficient data to make a diagnosis. 
Classification is based on necropsy in fatal cases or computed tomography (CT) findings in 
nonfatal cases and include SAH, ICH, brain infarction due to occlusion of precerebral 
arteries, brain infraction due to cerebral thrombosis, or embolic brain infarction.89 Ten major 
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conditions are currently classified within stroke, according to the Tenth Version of the 
International Classification of Diseases (ICD-10), as shown in Figure 4 below (Note that 
TIAs are not included in this list.) In order to ensure standardization, stroke type is based on 
CT findings in nonfatal cases and on postmortem examination in fatal cases.   
 
Figure 4. Categories of Cerebrovascular Disease. 
ICD-10 Code Diagnosis         
I60 Subarachnoid hemorrhage 
I61  Intracerebral hemorrhage 
I62 Other nontraumatic intracranial hemorrhage    
I63  Cerebral infarction 
I64 Stroke, not specified as hemorrhage or infarction 
I65 Occlusion and stenosis of precerebal arteries, not resulting in cerebral 
infarction 
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral 
infarction 
I67 Other cerebrovascular diseases   
I68 Cerebrovascular disorders in diseases classified elsewhere 
I69 Sequelae of cerebrovascular disease 
 
Source: Adapted from World Health Organization, 1992.90  
 
It was not until the middle of the 20th century that stroke mortality rates were 
compared in different geographic locations.91 Methodological challenges for epidemiologic 
study of stroke included difficulty in systematically distinguishing between different stroke 
types in death certificates and low event rates in young populations.92 Despite these 
challenges, comparisons were made among a number of countries through death certificate 
studies, with mortality rates ranging from more than 150 to less than 40 cases per 100,000 
population per year, and with the highest rates in Finland and Japan. Of special note was a 
study of men of Japanese descent by Gordon, in which he reported decreasing stroke 
mortality rates of men from Japan to Hawaii to California, a trend in distinct opposition to 
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the trend for CHD mortality rates.93 Also of note was a study by Stallones that found no 
relation between the distributions of mortality from stroke and ischemic heart disease in US 
states, suggesting different mechanisms and disease processes. This study noted that 
Southeastern states had the highest stroke mortality rates, causing this region to be known as 
the “stroke belt.”  Although the prevalence of stroke has been declining in most developed 
nations, declines have been least marked in Russia and eastern European countries, where 
there is a higher prevalence of hypertension.94  
Incidence rates for stroke, defined as the number of new or recurrent definite strokes 
per 100,000 population, also vary widely among nations, from 121 in Italy to 359 in Finland 
for men and from 58 in Germany to 294 in Russia for women.95 Between 75% and 90% of 
these strokes were initial events. Case-fatality, defined as death within 28 days after the onset 
of symptoms, ranged from 15% to 49% for men and from 18% to 57% among women, with 
the highest case-fatality rates among both men and women in Poland.  
Increased age is a strong risk factor for stroke, with two-thirds of strokes occurring in 
persons ages 75 years and older and with the incidence of stroke more than doubling with 
each progressive decade after the age of 55. Racial differences in stroke mortality rates have 
been noted in the US, with blacks at increased risk over whites. When gender is factored in, 
men are at increased risk of stroke among whites, while women are at increased risk of stroke 
among blacks, although gender differences have been decreasing since the 1950s.  Age, race 
and gender differences are notable in comparison of stroke mortality rates (per 100,000 
population) in the US. For example, in 1989 rates for black males, black females, white 
males and white females were 720, 706, 558 and 483, respectively, for persons ages 75-84 
years and 1343, 1428, 1578 and 1706, respectively, for persons ages 85 years and older.96   
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 Although many modifiable factors increase the risk of stroke, the strongest modifiable 
risk factor identified for stroke is high blood pressure. Hypertension can cause a thickening 
of the walls of cerebral arteries, causing decreased blood flow and predisposition to 
thrombosis. The major risk caused by chronic hypertension, however, is a hemorrhagic 
stroke. Another, major modifiable risk factor for stroke is smoking, which elevates blood 
pressure, accelerates the atherosclerotic process, releases toxic enzymes linked to the 
formation of aneurysms and affects platelet function.97 Previous cardiovascular events and 
comorbidities such as previous TIA, prevalent CHD (particularly atrial fibrillation in the case 
of embolic stroke) and prevalent diabetes mellitus (which accelerates the atherosclerotic 
process) are also highly associated with future strokes. Other risk factors for stroke include 
alcohol and drug use, obesity, physical activity, poor diet, oral contraceptive use, 
inflammatory factors, subclinical disease, TIAs and other prevalent cardiovascular 
conditions.  
 Individual risk factors for stroke have been most widely studied in the Prospective 
Studies Collaboration, which reviewed 45 cohort studies of stroke, including a total of nearly 
450,000 participants and over 13,000 stroke events, mainly deaths.98 This study confirmed 
the importance of blood pressure in the risk of stroke, particularly among younger persons. 
The largest single cohort study of stroke mortality was of decedents of over 350,000 US men 
screened for the Multiple Risk Factor Intervention Trial (MRFIT) study.99 This study 
reported higher mortality rates for different stroke subtypes among persons with higher 
values of systolic and diastolic blood pressure and among smokers. Serum cholesterol levels 
were modestly associated with an increased risk of death from nonhemorrhagic, SAH and 
ICH stroke subtypes, suggesting differences in the contribution of cholesterol as a risk factor 
 28 
for different stroke subtypes.  The Framingham Study was key in discovering the importance 
of hypertension, CHD and atrial fibrillation as risk factors for stroke. 
 
Combat Exposure and Cardiovascular Disease 
Advances in the prevention and treatment of CHD have resulted in a considerable 
decline in CHD mortality over the past four decades.100,101  Despite continued reductions in 
traditional cardiovascular risk factors such as smoking, hypertension, and 
hypercholesterolemia in recent years,102,103 the decline in CHD has begun to subside, and the 
incidence of myocardial infarction is on the rise.104 Traditional risk factors—including high 
levels of total cholesterol and low-density lipoprotein (LDL), low levels of high-density 
lipoprotein (HDL) cholesterol, hypertension, smoking, diabetes, and a family history of 
coronary artery disease (CAD)—are estimated to predict only 58 to 75 percent of new cases 
of CAD.105 Given the large amount still unknown about the causes of CVD, researchers have 
been exploring the contribution of nontraditional risk factors. Of these, psychosocial stress 
has emerged as a particularly promising potential risk factor.106,107,108,109 Thus far, the 
literature has focused primarily on distinct areas of chronic life stress including generalized 
self-perceived stress, job stress, socioeconomic stress, marital strain and stress that results 
from exposure to traumatic events such as natural disasters. Epidemiological studies have 
demonstrated an association between these types of psychosocial stress and increased 
morbidity and mortality from CVD. However, less is known about the long-term effects of 
combat-related stress on cardiovascular health.110,111  
The specific psychosocial stress experienced by veterans who have engaged in active 
combat is a unique stressor that includes psychological, moral, and physical components.112 
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The effects of military service in general and military combat in particular are so pervasive 
yet so little studied that they have been termed the “hidden variable” in the aging of older 
American men.113,114 Among older American men, the prevalence of exposure to military 
service and military combat is high; according to the 2000 U.S. Census, over 26 million or 
12.7% of the adult U.S. population served in the military at some time in their lives. Over 
90% are men and 37% are over the age of 65 years.115 According to results of the third 
Survey of Veterans, approximately 65% of men over the age of 55 served in World War II or 
the Korean War. Further, 52% of those who served in World War II and 35.3% of those who 
served during the Korean conflict were exposed to combat.116 Accordingly, it is estimated 
that a quarter of all older American men were exposed to military combat.117 Between 1990 
and 2000, the number of veterans ages 65 years and older increased from six to nine 
million.118 
Exposure to military service can have positive as well as negative consequences119,120 
and can both short-term and long-term effects121 that act both directly and indirectly on 
servicemen’s’ lives.122 Combat is typically the most traumatic or stressful aspect of military 
service.123 Studies report higher rates of adverse behavioral risk profiles,124,125 psychological 
conditions126,127,128,129 and self-reported health conditions130,131,132 among those exposed to 
military combat. Exposure to psychological stress has been linked with short-term increases 
in rates of coronary events.133,134  Similarly, long term residence in a war zone has been 
linked to higher frequency of occurrence of CVD.135 However, studies of the longer-term 
cardiovascular consequences of combat stress are limited, and to date have been 
inconclusive.136,137  
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Variation in the effect of war-related stress on cardiovascular mortality has been 
noted by the war theater in which veterans served.138,139 For example, while a number of 
recent studies found that combat veterans who served during the eras of World War II and 
the Korean War have higher self-reported chronic health problems, more diagnosed illnesses, 
and are more likely to engage in adverse health behaviors such as smoking and drinking and 
have poorer self-rated health,140,141,142,143 a study of Vietnam veterans that compared self-
reported health with physical examinations did not find excess burden of physical illness 
among those exposed to combat.144,145 The few studies that have assessed whether the 
association between cardiovascular mortality and war-related trauma varies by age or time 
since exposure have been inconsistent and based on limited samples.146,147,148,149  
 
Epidemiologic Evidence 
Most studies of the deleterious health effects of combat-related stress focus on short-
term psychological, behavioral, and self-reported health symptoms. By contrast, relatively 
little attention has been given to the directly measured, long-term cardiovascular effects of 
military stress.  Of the studies that have been conducted, many have investigated the effects 
of military combat—most commonly depression or PTSD—rather than exposure to combat 
itself. (Table 1) To date, the long-term physiological effects of military combat have been 
most thoroughly investigated in the Vietnam Experience Study (VES), a retrospective study 
of a random sample of all male US Army veterans who served during the Vietnam conflict. 
In VES studies of Vietnam theater veterans with PTSD and without, Boscarino and 
colleagues reported that theater veterans with PTSD were more likely to have clinically 
elevated leukocyte and total T-cell counts,150 a higher prevalence of arrhythmias,151 and a 
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higher lifetime prevalence of circulatory diseases152 than those without PTSD twenty years 
after the conclusion of the conflict. PTSD-positive theater veterans seem to have a higher 
lifetime prevalence of CVD and a higher all-cause mortality rate as many as 30 years after 
military service.  
The majority of studies that have investigated the effects of military combat itself, 
rather than PTSD, have been conducted in retrospective cohorts and have compared veterans 
who served in the primary theater of combat to veterans who served during the same era but 
outside the region of the major conflict. Therefore, the specific combat exposure of serving in 
a combat zone has been the primary focus of the current literature, although other combat 
exposures—such as seeing someone killed, killing another individual, and other traumas—
could occur in either theater or era veterans. Overall and cause-specific mortality  are the 
primary outcome measures in these studies, with results, on the whole, finding little 
difference between all-cause or cardiovascular mortality between theater veterans and era 
veterans. The most prominent of these studies are those conducted by VES investigators, 
who noted that Vietnam veterans had 45% higher all-cause mortality than veterans of World 
War II and the Korean conflict within five years after conclusion of service, although the 
largest increase in relative mortality was due to motor vehicle accidents and other external 
causes (suicide, homicide, poisonings).153 Thereafter, mortality between Vietnam veterans 
and other veterans were similar, with the exception of drug-related deaths. Although authors 
reported a lower circulatory disease mortality rate among Vietnam theater veterans 
(standardized mortality ratio (SMR) = 0.48; 95% CI = 0.25, 0.85) compared to Vietnam era 
veterans (SMR = 0.87; 95% CI = 0.54, 1.34)), this finding was reversed in a later study.154 In 
this follow-up study, conducted a 30-years after exposure, researchers still found no 
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difference in all-cause mortality between veterans of the Vietnam conflict and veterans of 
World War II and the Korean conflict, although increased mortality from drug-related deaths 
persisted.155 Also, a small but not statistically significant increase in mortality fifteen years 
after discharge from circulatory diseases was noted among a subgroup of Vietnam veterans 
who discharged from active duty in 1970 or later. Although neither a non-combat nor a non-
military comparison group was included in these analyses, the mortality rates were compared 
to those reported elsewhere for the US population.  
Similarly, in a large-sample retrospective cohort study of US Marine veterans, 
Wantanabe and colleagues found that those who served in Vietnam had higher overall 
mortality, after 22 years of follow-up, compared to veterans who did not serve in Vietnam, 
even after adjustment for age and military rank.156 Similar to VES findings, the elevated 
overall mortality was primarily due to excess deaths from external causes and was higher in 
the first five years of follow-up (rate ratio (RR)=1.26) than at the completion of the study 
(RR=1.14). Increased risk of death from cancer was elevated although not statistically 
significant. Mortality specifically from CVD was not assessed. Fett and colleagues reported 
comparable results, noting a significant increase in the rate of all-cause mortality among 
Australian veterans who served in Vietnam compared to those who served during the same 
period but in Australia (rate ratio (RR) = 1.0; 95% CI = 1.0, 1.4)157 and an elevated but not 
significant difference in the rate of mortality from circulatory disease.158 In a study of the 
effects of Vietnam theater exposure among women, Thomas and colleagues reported results 
similar to those of initial VES studies,159 noting no significant differences found in all-cause 
or cancer-related mortality but moderately reduced circulatory disease mortality among 
theater era veterans. (mortality rate ratio (MRR) = 0.67; 95% CI = 0.38, 1.18). However, 
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because women are excluded from combat-related jobs and training, findings from this study 
are less informative for the research question at hand.  
 A similar pattern of results was obtained in a series of retrospective cohort studies of 
U.S. veterans of the Persian Gulf War. In 1996, Kang and colleagues reported that during the 
first 2.4 years after conclusion of the war, Gulf War theater veterans had mortality rates that 
were slightly but significantly elevated compared to era veterans in the National Guard and 
military reserves, after adjustment for age, sex, race and military variables.160 Excess deaths 
were primarily due to those caused by external causes rather than disease. Theater veterans 
and controls did not have significantly elevated rates of circulatory disease. Further, 
compared to the U.S. population, both Gulf War theater and era veterans had significantly 
lower cause-specific standardized mortality ratios, after adjustment for age, sex, race and 
year of death, in line with the theory of the healthy veteran effect. In a 2001 follow-up study, 
the authors investigated differences in mortality after 7 years time.161 As found in VES 
reports,162 excess deaths among war theater veterans due to accidents and other external 
causes dissipated over time and no significant difference was found in mortality rates from 
cardiovascular disease. Significantly lower mortality from infectious diseases persisted 
among Gulf War theater veterans, primarily due to significant excess deaths among Gulf War 
era veterans from human immunodeficiency virus. Although these studies were retrospective 
and had only 2.4 and 7 years of follow-up time, these limitations were minimized by the very 
large sample of veterans included. However, neither study included measures of 
socioeconomic status. A study of post-war mortality of British Gulf War veterans reported 
similar results, finding no difference in all-cause mortality between Gulf War theater and era 
veterans.163 Higher mortality from external causes and lower mortality from diseases of the 
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circulatory system were noted, although neither finding was statistically significant. 
However, this study was limited by the relatively young age of the cohort and the relatively 
small number of deaths. 
VES investigators also studied the effects of varying levels of combat exposure on 
cardiovascular risk factors, finding that cortisol levels were inversely associated with combat 
exposure level among Vietnam theater veterans, with veterans exposed to heavy combat 
having the lowest plasma cortisol concentrations.164 VES investigators also found a slight 
increased odds of left ventricular hypertrophy among Vietnam era veterans (OR=1.8; 95% CI 
= 1.0, 3.3) but few overall differences in the prevalence of any abnormal electrocardiograph 
findings of VES veterans. In terms of behavioral risk factors, Boscarino and colleagues found 
that while both Vietnam theater and era veterans had a higher adjusted prevalence of drug 
abuse165 but not alcohol consumption166,167,168  than non-veterans, combat exposure among 
veterans was not significantly associated with increased alcohol or drug abuse.169 Although 
these studies did adjust for major demographic and risk factor covariates as well as 
education, participants were only from the Army branch of the US military and veterans from 
wars other than the Vietnam conflict were not studied. 
Studies of combat exposures other than service in a combat zone are more limited. 
However, there is reason to believe that these additional exposures—such as whether or not 
they were ever under fire or fired at the enemy, saw others wounded or killed, or were ever 
wounded or missing in action—would have an effect beyond that of service in a combat 
zone. In a study of the prevalence of specific psychiatric disorders among Vietnam veterans 
and controls, Jordan and colleagues noted that although there were few differences between 
Vietnam theater and era veterans in the lifetime and current prevalence of depression and 
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other psychiatric diagnoses, there were striking differences in the rates for male theater 
veterans with high levels of war zone stress compared to other male veterans or civilians.170  
Although the majority of studies to date have focused on mortality as the outcome, 
Gill and Bell studied the effects of being a prisoner of war (POW) during World War II on 
the prevalence of CHD forty years after the conclusion of military service. In this study, Gill 
and Bell compared the prevalence of self-reported CHD among ex-POWs to the prevalence 
among veterans who served during the same time but who were not captured.171 The POWs 
had a slightly elevated prevalence of angina and history of MI compared to controls (21.7% 
versus 18.1%, respectively), although not statistically significant. Elder and colleagues 
studied the effects of military combat on both physical decline and mortality in male veterans 
of the Korean War and World War II in the Berkeley Growth Study, the Berkeley Guidance 
Study, and the Oakland Growth Study172,173,174, as well as in the Stanford-Terman Study.175, 
176,177
 Findings from these studies include that the effect of exposure to combat significantly 
increased the odds of physical decline or all-cause mortality fifteen years after conclusion of 
World War II, even after adjustment for age, physical health at the conclusion of the war, 
military rank, branch and division of service, theater of engagement, and geographic region 
of combat exposure.  
  In the context of the current literature, the proposed study is unique in that it has a 
long average follow-up time, an older cohort (ages at the LC-SES interview range from 60 to 
80 years), includes veterans who served during the eras of multiple conflicts (World War II, 
the Koran War and the Vietnam Conflict), and includes measures of specific combat 
exposures and both military and civilian controls. The contribution of a wide range of 
measures of behavioral risk factors, psychological measures and pre-conflict SES also sets 
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apart the proposed study from the extant literature. Further, the proposed study will assess 
not only mortality, but also incident cardiovascular event rates and the burden of subclinical 
atherosclerosis. 
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  Table 1. Published Effects of Military Combat Exposure on Long-Term Physical Health and Mortality. 
Author, 
Year 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect 
Estimate (95% CI) 
Covariates 
Veterans with PTSD vs. Veterans without PTSD 
Boscarino, 
1996178 
Vietnam theater veterans 
with 4 levels of combat 
exposure (none-very 
heavy)  
 
1971  
 
(579 None/low; 
542 Moderate; 
711 Heavy; 
650 Very heavy) 
 
20 years Plasma cortisol  
 
Adjusted Odds Ratio 
Moderate vs. none/low:  
OR = 5.32 (2.0, 13.9) 
 
Heavy vs. none/low:  
OR = 10.00 (3.9, 25.1) 
 
Very heavy vs. none/low:  
OR = 24.75 (9.6, 62.4) 
 
Age, income, 
education, race, pre-
service, military 
adjustment, post-
service adjustment 
Boscarino, 
1997179 
Vietnam theater veterans 
with lifetime PTSD vs. 
no lifetime PTSD 
 
1,399 
 
(332 PTSD; 
1,067 No PTSD) 
20 years  
Circulatory disorders 
 
Endocrine-nutritional  
–metabolic disorders 
 
Any chronic disease  
 
Adjusted Odds Ratio 
OR = 1.64 (1.17, 2.30) 
 
OR = 1.75 (1.03, 2.97) 
 
 
OR = 1.72 (1.30, 2.27) 
 
Intelligence, race, 
region of birth, 
enlistment status, 
volunteer status, Army 
marital status, Army 
medical profile, 
hypochondriasis, age, 
smoking history, 
substance abuse, 
education, income 
 
Boscarino, 
1999a180 
Vietnam theater veterans 
with current PTSD vs. 
no current PTSD 
 
2,490 
 
(293 PTSD;  
2,197 No PTSD) 
20 years  
Leukocyte  
 
T-cell lymphocyte 
 
CD8 
 
Adjusted Odds Ratio 
OR = 1.83 (1.03, 3.25) 
 
OR = 1.82 (1.01, 3.26) 
 
OR = 1.80 (0.97, 3.35) 
Intelligence, race, age, 
income, education, type 
of enlistment, Vietnam 
volunteer status, region 
of birth, cigarette 
smoking, illicit drug 
use, body mass index, 
and alcohol 
consumption 
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Author, 
Year 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect 
Estimate (95% CI) 
Covariates 
Boscarino, 
1999b181 
Vietnam theater 
veterans with current 
PTSD vs. no current 
PTSD 
 
4,462 
 
(54 PTSD;  
4408 No PTSD) 
20 years  
Atrioventricular (AV) 
conduction defects 
 
AV infarctions  
 
Adjusted Odds Ratio 
OR = 2.81 (1.03-7.66)  
 
 
OR = 4.44 (1.20-16.43) 
Age, place of service, 
illicit drug use, 
medication use, race, 
body mass index, 
alcohol use, cigarette 
smoking, and education 
 
Boscarino, 
2006182 
 
Vietnam theater 
veterans with current 
PTSD vs. no current 
PTSD 
 
 
Vietnam era veterans 
with current PTSD vs. 
no current PTSD 
 
7,924  
 
(214 PTSD;  
7,710 No PTSD) 
 
 
7,364  
 
(836 PTSD;  
6,528 No PTSD) 
 
30 years 
 
 
 
 
 
 
All-cause mortality 
 
Cardiovascular mortality 
 
 
All-cause mortality 
 
Cardiovascular mortality 
Adjusted Hazard Ratio 
HR = 2.2 (1.7-2.7)  
 
HR = 1.7 (1.0-2.7) 
 
 
HR = 2.0 (1.3-3.0) 
 
HR = 1.2 (0.4-3.4) 
 
 
Age, race, Army 
volunteer status, Army 
entry age, Army 
discharge status, Army 
illicit drug abuse, and 
intelligence 
 
Theater vs. Non-theater veterans 
Boehmer, 
2004183 
Vietnam theater 
veterans vs. Vietnam 
era veterans 
 
18,313 
 
(9,324 theater 
veterans; 8,989 
era veterans) 
30 years  
 
All-cause  
 
 
 
All-cause  
 
Circulatory disease 
 
Adjusted Mortality Rate 
Ratio 
MRR = 1.08 (0.97, 1.20) 
 
Crude Mortality Rate 
Ratio 
MRR = 1.07 (0.97, 1.18) 
 
MRR = 1.01 (0.82, 1.49) 
 
Age, race, year of 
enlistment, enlistment 
status (volunteer  vs. 
draftee), score on 
general technical test, 
primary military 
occupational specialty 
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Author, 
Year 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect 
Estimate (95% CI) 
Covariates 
Boscarino, 
1995184 
Vietnam theater 
veterans with combat 
exposure vs. no combat 
exposure  
4,462 
 
(2,490 theater 
veterans;  
1,972 era 
veterans) 
 
20 years  
PTSD 
 
Generalized anxiety 
 
Depression 
 
Alcohol Dependency 
 
Drug Dependency 
Adjusted Odds Ratio 
OR = 2.42 (p < 0.001) 
 
OR = 1.33 (p < 0.001) 
 
OR = 1.53 (p < 0.001) 
 
OR = 1.04 (p > 0.05) 
 
OR = 0.97 (p > 0.05) 
 
Geographic region, 
army entry age, army 
enlistment status, 
Vietnam volunteer 
status 
 
CDC, 
1987185 
Vietnam theater 
veterans vs. Vietnam 
era veterans 
 
18,313  
 
(9,324 theater 
veterans;  8,989 
era veterans) 
 
5 years 
 
13.5 years 
 
 
All-cause  
 
All-cause  
Adjusted Mortality Rate 
Ratio 
MRR = 1.58 (1.16, 2.14) 
 
MRR = 1.04 (0.81, 1.33) 
 
Age, race, Army 
General Technical 
score, pay grade at 
discharge, year of 
discharge 
CDC, 
1988b186 
Vietnam theater 
veterans vs. Vietnam 
era veterans 
 
4,462 
 
(2,490 theater 
veterans;  1,972 
era veterans) 
13.5 years 
 
 
Hypertension 
 
Altered peripheral arterial 
hemodynamic finding 
 
Any abnormal 
electrocardiographic 
finding 
 
Any chest roentgenogram 
finding 
 
Adjusted Odds Ratio 
OR = 0.8 (0.4, 1.7) 
 
OR = 1.2 (0.9, 1.7) 
 
 
OR = 1.1 (0.9, 1.3) 
 
 
 
OR = 1.1 (1.0, 1.4)  
Age, race, year of 
enlistment, enlistment 
status (volunteer  vs. 
draftee), score on 
general technical test, 
primary military 
occupational specialty 
 
Fett, 
1987a187 
Australian Vietnam 
theater vs. era veterans  
 
44,882 
 
(19,205 theater 
veterans; 25,677 
era veterans) 
9-16 years  
 
All-cause mortality 
Adjusted Mortality Rate 
Ratio 
MRR = 1.2 (1.0, 1.4)  
Branch of the military 
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Author, 
Year 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect 
Estimate (95% CI) 
Covariates 
Fett, 
1987b188 
Australian Vietnam 
theater vs. era veterans  
 
44,882 
 
(19,205 theater 
veterans; 25,677 
era veterans) 
 
9-16 years  
 
All circulatory disease 
 
All external causes  
 
Adjusted Mortality Rate 
Ratio 
MRR = 1.6 (0.8, 3.2) 
 
MRR = 1.1 (0.9, 1.4) 
Branch of the military 
Jordan, 
1991189 
Male Vietnam theater 
veterans vs. era veterans 
vs. civilians  
 
 
 
 
Vietnam theater 
veterans with high vs. 
low levels of combat  
2,070 
 
(1,200 theater 
veterans; 419 era 
veterans; 451 
civilians) 
 
887 
 
(406 high-level 
combat veterans; 
783 low to 
moderate-level 
combat veterans) 
 
11-24 
years 
 Summary measures not 
provided; Prevalence 
Rates contrasted 
Age, race/ethnicity 
Kang, 
1996190 
Gulf War theater 
veterans vs. Gulf War 
era veterans 
1,441,807  
 
(695,516 theater 
veterans; 
746,291 era 
veterans) 
2.4 years  
 
All cause 
 
Circulatory diseases 
 
Adjusted Mortality Rate 
Ratio 
RR = 1.09 (1.01, 1.16) 
 
RR = 1.12 (0.90, 1.40) 
 
 
Age, sex, race, branch 
of service, type of unit 
(Active; Reserve; 
National Guard) 
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Author, 
Year 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect Estimate 
(95% CI) 
Covariates 
Kang, 
2001191 
Gulf War theater 
veterans vs. Gulf War 
era veterans 
1,441,807  
 
(695,516 theater 
veterans; 
746,291 era 
veterans) 
 
7 years  
 
All cause 
 
Circulatory diseases 
 
Adjusted Mortality Rate 
Ratio 
MRR = 0.95 (0.92, 0.99) 
 
MRR = 0.90 (0.81, 1.01) 
 
Age, sex, race, 
branch of service, 
type of unit (Active; 
Reserve; National 
Guard); marital 
status 
Macfarlane, 
2000192 
UK Gulf War theater 
veterans vs. UK Gulf 
War era veterans 
 
53,462 Gulf War 
theater veterans 
and 53,450 Gulf 
War era veterans 
 
8 years  
 
All cause 
 
All disease-related 
 
All cancer 
 
All circulatory disease 
 
All external causes  
 
Adjusted Mortality Rate 
Ratio 
MRR = 1.05 (0.91, 1.21) 
 
MRR = 0.87 (0.67, 1.11) 
 
MRR = 1.11 (0.73, 1.67) 
 
MRR = 0.74 (0.49, 1.12) 
 
MRR = 1.18 (0.98, 1.42)  
Matched on age, 
sex, branch of 
military, rank 
(commissioned 
officer/other rank) 
Thomas, 
1991193 
Female Vietnam 
theater veterans vs. 
Female Vietnam era 
veterans 
4,644 Vietnam 
theater veterans 
and 6,575 
Vietnam era 
veterans 
16.5 years  
All cause 
 
Circulatory disease 
 
Adjusted Relative Risk 
RR = 0.93 (0.74, 1.16) 
 
RR = 0.67 (0.38, 1.18)  
 
Military rank, 
military occupation, 
duration of military 
service, age, race 
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Author, 
Year 
 
Comparison Groups N Follow-
up time 
Outcome(s) Adjusted Effect Estimate 
(95% CI) 
Covariates 
Visintainer, 
1995194 
Deceased male 
Vietnam veterans vs. 
deceased male non-
Vietnam veterans  
 
8,593 
 
(5,229 theater 
veterans; 3,364 
era veterans) 
 
3-24 years  
Endocrine, nutritional, 
metabolic, and immune 
diseases 
 
Circulatory system 
 
Proportionate Mortality Ratio 
PMR = 1.56 (1.11, 2.13) 
 
 
 
PMR = 1.00 (0.93, 1.07)  
None 
Wantanabe, 
1995195 
Vietnam theater 
veterans vs. Vietnam 
era veterans 
 
20,062 
 
(10,716 theater 
veterans; 9,346 
era veterans) 
 
22 years  
All-cause  
 
 
Adjusted Mortality Rate Ratio 
RR = 1.15 (1.02, 1.29) 
 
Age, rank in military 
POW veterans vs. Non-POW veterans 
Gill, 1997196 World War II 
prisoners of war 
(POWs) vs. non-
POWs 
 
1,140 
 
(635 POWs; 505 
non-POWs) 
39 years  
Prevalent CHD 
Unadjusted OR 
OR = 1.25 (p = 0.221) 
None 
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Pathways and Mechanisms 
The mechanisms through which psychosocial stress acts to affect physical health are 
still not well understood. Stress has been shown to have direct effects on cardiovascular risk, 
through neuroendocrine and immune functioning,197, 198 as well as indirect effects, through 
unhealthy behaviors (e.g., smoking, alcohol and drug abuse).199, 200,201 In addition, individual 
coping mechanisms may alter the way one individual responds to a psychosocial stressor, 
compared to another.202, 203 Factors affecting the way an individual responds to stress may 
include psychological health factors (e.g., depression, hostility) as well as individual 
socioeconomic factors (e.g., income, education, employment) and community socioeconomic 
factors (e.g., mean neighborhood wealth, education, employment). Also, the timing of 
different stress exposure in an individual’s life are thought to play a role in how an individual 
perceives and responds to that stressor.204  
  The process by which stress acts as an independent risk factor for atherogenesis 
involves behavioral, neurological, endocrine, and immunological components.205206 
Hypersecretion of cortisol in response to stress has been shown to play a role in the 
development of CHD.207 Proinflammatory cytokines have been shown to be associated with 
both stress and the development of CHD,208,209 and thus represent intermediate mechanisms 
through which stress can influence CVD. Because stimuli or events experienced as stressful 
trigger physiologic responses (cortisol, insulin, and catecholamine levels and their systemic 
effects), repeated or prolonged exposure to stress is thought to lead to elevations in 
cardiovascular risk factors and ultimately increased risk of CVD.210, 211,212  Chronic stress is 
also associated with higher rates of behavioral risk factors such as smoking, higher fat and 
caloric intake, obesity, sedentary behavior, sleep disorders, and drug and alcohol use.213, 
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214,215
  In turn, many of these behaviors have been associated with higher rates of 
hypertension, atherosclerosis, hypercholesterolemia, and diabetes.216, 217 Importantly, 
individual personality traits and coping mechanisms can act as a “filters” for psychological 
exposures and partly determine the degree to which an exposure is experienced as a 
stressor.218,219 Higher levels of risk factors and clustering of risk factors has been reported in 
numerous studies of the association between stress and cardiovascular risk factors assessed 
by a variety of measures.220 This clustering of risk factors, through physiological, 
psychological and behavioral mechanisms, may work in concert to lead to elevated CVD 
risk. In addition to these factors, individual characteristics may alter how an individual 
recovers from a stressor, and may help explain why one individual returns to homeostasis 
and while another remains in a state of disequilibrium and carries an additional allostatic 
load.  
  One of the predominant conceptual frameworks used to describe the process through 
which stress affects physiological heath is the theory of allosatic load, which holds that stress 
causes a disruption in homeostasis and allostasis. Homeostatic theory was originally 
developed by 19th Century French physiologist and "father" of modern experimental 
physiology Claude Bernard in an effort to describe the fundamental principles of physiology. 
This theory was later promulgated and expanded into areas of social epidemiology by noted 
researchers including epidemiologist John Cassel, physiologist Walter B. Cannon (who 
coined the term “homeostasis”), and endocrinologist Hans Selye.221, 222,223  According to 
homeostatic theory, when an individual is exposed to an environmental change, the body 
responds to the stressor and resists in an attempt to restore itself to its original state.224 If the 
stress persists, it is thought that the body becomes exhausted and results in disordered 
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functioning of the homeostatic process.225 An extension of this hypothesis, the allostatic load 
theory holds that chronic, repeated, or traumatic (i.e., perceived as potentially life-
threatening) stress can disrupt the body’s ability to maintain physiologic stability in a manner 
that promotes disease.226 In this way, the nature of the stressor—its duration, severity, and 
persistence—affect how the stressor is perceived.227 As shown in Figure 5, individual 
differences in genetics, development, and experiences throughout the life course further 
affect whether or not an event is perceived as stressful. The perceived stressor may then have 
a direct physiological response or act indirectly through changes in behavior such as 
smoking, alcohol drinking, diet, and physical activity.  The sum of an individual’s 
physiologic responses add to an individual’s allostatic load, and, if too overwhelming, can 
lead to neuroendocrine and immune changes that adversely effect various organ systems and 
promote disease.228   
 
Figure 5. The Stress Response and Development of Allostatic Load. 
Source:  Adapted from McEwen, 1998.229  
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Direct Physiolologic Mechanisms 
  There are a number of pathways through which a stressor directly affects physical 
functioning and cardiovascular health. One of the ways in which allostatic load is thought to 
be influenced is by a disturbance in the functioning of the neuroendocrine system, which 
regulates the functioning of the cardiovascular system.230 According to both physiological 
and epidemiological evidence, the autonomic nervous system and the hypothalamic-pituitary-
adrenal (HPA) axis are critically involved in the mechanism through which chronic 
psychosocial stress affects cardiovascular functioning. Secretion of cortisol is one of the 
primary metabolic responses of the autonomic nervous system to the exposure to 
psychosocial stress.231 A large part of the effect of chronic stress on the regulation of cortisol 
is mediated by an increase in the level of catecholamines and epinephrine (adrenaline) 
circulating in the plasma.232, 233 When adrenaline and catecholamines are released, beta-
adrenergic receptors stimulate the secretion of interleukin 6 (IL-6) and other inflammatory 
molecules.234,235 This, in turn, leads to stimulation of the HPA axis, which transports cortisol 
from the adrenal glands back to the hypothalamus and other parts of the brain.236,237,238 
Exposure to chronic stress, during which there is a period of hypersecretion of cortisol, can 
cause a disruption in the HPA axis and lead to resistance and impaired feedback control. 
239,240,241,242,243,244 
The process of atherogenesis can also be viewed as an inflammatory response, and 
the autonomic nervous system, which is engaged in a period of stress, interacts directly with 
the immune system.245, 246,247,248  Prolonged elevation of cortisol levels, as can occur through 
the autonomic nervous system’s response to periods of stress, can inhibit proper functioning 
of the immune system, increase blood pressure and promote inflammatory vascular lesions. 
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Such lesions can advance into a state of endothelial dysfunction, which is considered the first 
step in atherosclerosis.249 The role of stress in this process has been recognized through the 
finding that levels of endogenous IL-6 and other pro-inflammatory cytokines are elevated 
during periods of acute and chronic stress, independent of the presence of smoking, 
hypercholesterolemia, and other established cardiovascular risk factors.250, 251,252,253  The role 
of stress in the inflammatory process of atherogenesis is based on the definition of stress as 
“a state of threatened homeostasis provoked by a psychological, environmental, or 
physiologic stressor.” 254,255,256,257 The response-to-injury hypothesis of atherosclerosis is 
founded on the finding that an injury or stressor alters the homeostasis of the endothelium, 
leading to an increased adhesiveness of the endothelium to leukocytes and platelets, 
increased coagulation, increased migration and proliferation of smooth muscle cells at the 
area of inflammation, and increased permeability of the dysfunctional endothelial wall.258  
These inflammatory mechanisms act in concert to thicken the arterial wall, leading to dilation 
and, eventually, remodeling of the artery and restriction of the arterial lumen.259  Specifically, 
the increased adhesion of platelets and leukocytes to the dysfunctional endothelium and to 
monocyte-derived macrophages that are assembled in response to injury accumulate on the 
arterial wall and further expand the lesion.260  Monocyte-derived macrophages and T 
lymphocytes are key inflammatory cells and are key participants in the inflammatory 
response.  Activated platelets also release cytokines and growth factors that further call upon 
the migration and proliferation of smooth muscle cells and monocyte-derived 
macrophages.261,262  Smooth muscle cells, further activated in the presence of pro-
inflammatory cytokines,263 migrate and proliferate at the site of inflammation to create an 
intermediate lesion, while monocyte-derived macrophages and T-lympocytes from the blood 
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multiply within the lesion.  These inflammatory cells, in turn, are activated to release 
cytokines, chemokines, and growth factors, which cause further damage that can lead to 
necrosis. At this point, the lesion has become advanced and may begin to narrow the lumen.  
Injury also acts to increase the permeability of the dysfunctional endothelial wall to low-
density lipoprotein (LDL) cholesterol.264,265 Macrophages recruited to the site of 
inflammation oxidize LDL cholesterol and internalize the oxidized cholesterol. This process 
leads to further stimulation of the replication and recruitment of monocytes which, in turn, 
create macrophages to continue the inflammatory process. The inflammatory response can 
continue indefinitely if the offending agents are not effectively deactivated.266  
 
Psychological Mechanisms 
The effect of psychosocial stress in the development of atherosclerosis can be 
modified by individual personality traits and coping mechanisms. In other words, the 
physiological effect of a stressor on an individual may differ based on the psychological state 
of that individual. For example, the effect of exposure to an unstable social environment by 
cynomolgus monkeys (Macaca fascicularis) differs based on whether the animal presents a 
dominant or subordinate personality type.267,268  In these studies, socially dominant monkeys 
exposed to periodic changing of the social structure of the group had a higher incidence of 
coronary artery disease than subordinate monkeys, both in the presence and absence of an 
atherogenic diet.  In humans, the finding that traits such as hostility, aggression, and vital 
exhaustion (a condition of fatigue associated with depression) but not emotions such as anger 
or sadness, are associated with an increased expression of proinflammatory cytokines, 
suggests that there is a biological as well as contextual pathway in which the mechanisms 
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through which stress acts to increase cardiovascular risk.269,270,271  Although few differences 
in the rates of psychiatric disorders between theater and era veterans have been noted, 
veterans have higher morbidity than non-veterans, and veterans with combat experience have 
significantly higher burden of psychiatric disorders compared to veterans without combat 
exposure and non-veterans.272  
 Alternatively, exposure to psychosocial stress may cause an individual to be more 
susceptible to the development of a psychological condition that leads to CVD.  According to 
this mechanism, stress may interact with psychological distress to place an individual at 
higher risk of CVD.  Still another mechanism through which psychological distress may act 
is by placing an individual at higher risk of engaging in atherogenic behaviors such as 
smoking, drinking alcohol, sedentary lifestyle, and high caloric intake.273 For example, 
Beckham and colleagues found that Vietnam veterans with symptoms of post-traumatic 
stress disorder (PTSD) who smoked were more likely than veterans who did not smoke to 
report symptoms of depression trait anxiety.274 These multiple potential mechanisms are not 
mutually exclusive and may act separately or in concert. The main psychological conditions 
and personality types that have been connected to the development of CHD and stroke are 
vital exhaustion and hopelessness (both associated with depression),275, 276,277,278,279 
anxiety,280 trait anger and hostility.281,282,283,284,285,286,287 
A number of systematic reviews suggest that depression is a prospective risk factor 
for coronary artery disease (CAD).288, 289,290,291,292 According to these studies, individuals 
with depression are twice as likely to develop CAD as non-depressed individuals. In a 
prospective study of 2,397 persons without CAD at baseline, those with a diagnosis of major 
depressive disorder were 3.9 times more likely to die of cardiac causes compared to non-
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depressed counterparts within four years of follow-up, even after adjustment for major risk 
factors.293 Other prospective studies have reported rate ratios (RR) ranging from 1.6 to 3.45 
for CHD or ischemic heart disease incidence and RRs ranging from 1.5 to 2.34 for CHD 
mortality.294,295,296 In their 2003 systematic review, Wulsin and colleagues found that 
depression is a significant independent risk factor for the onset of CHD, and that it poses a 
greater risk than that of passive smoking but less than that of active smoking.297 Further, 
there is a dose-effect relationship, whereby the more severe the depression the higher the risk 
of CAD (but not the more severe the disease).298, 299 Physiologically, an elevated 
catecholamine response to stress has been observed among women with elevated depression 
scores.300 In this way, depression may act directly to increase the inflammatory processes 
associated with development of atherosclerosis and CAD. Alternatively, a common factor 
such as chronic stress may result in an inflammatory process leading to both depression and 
CHD.301 In addition, depression may increase CHD risk through increased adoption of 
intermediate, unhealthy lifestyles and behaviors such as smoking, atherogeneic diet and lack 
of physical activity. 302 
A similar construct as depression,303 vital exhaustion has been found to be associated 
with a wider range of markers of inflammation than depression.304, 305 Vital exhaustion has 
been has also been shown to be prospectively associated with risk of myocardial infarction, 
even after adjustment for major risk factors.306 Among women ages 65 years and older, a one 
standard deviation (8.4 points) increase in the Maastricht Questionnaire of vital exhaustion 
was associated with a 53% increased risk of recurrent acute myocardial infarction (AMI).307  
Like depression and vital exhaustion, anxiety is prospectively associated with risk for 
CHD.308,309,310 Anxiety has been demonstrated to have a dose-response relationship with 
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development of sudden cardiac death (SCD).311 Decreased heart rate variability has been 
noted in individuals with phobic anxiety312,313 and is thought to play a role in the 
development of arrhythmia leading to SCD. A 2002 systematic review, however, found less 
conclusive evidence of an association between anxiety and nonfatal coronary events or 
CAD.314  
A recent study of veterans of the first Gulf War found that 32% of surveyed veterans 
met the clinical criteria for a current or lifetime depressive disorder, including major 
depression, dysthymia, or depressive disorder—not otherwise specified (NOS).315 In a 
prospective study of veterans of the US conflicts in Iraq, Hoge et al found that the proportion 
of study subjects who met clinical criteria for major depression or generalized anxiety was 
significantly higher after duty in Iraq than before deployment.316 In a study of 6,903 male-
male twins from the Vietnam Era Twin Registry, Scherrer and colleagues found that having 
one or more symptoms of depression was significantly associated with an increased 
prevalence of CHD and hypertension.317 Similarly, vital exhaustion has been shown to be 
associated with higher odds of CVD. In a cohort study of 1955 World War II veteran twins, 
Fitzpatrick and colleagues found that prolonged fatigue is significantly associated with 
myocardial infarction or coronary artery surgery, even after adjustment for age, 
socioeconomic status, smoking, alcohol use and depression.318  
Similarly, trait anger, hostility, and Type A personality type have been investigated 
for their association with the development of CHD and stroke. Although early evidence 
suggested that Type A personality (a combination of time urgency or compulsion and 
generalized hostility)319 is an independent risk factor for CAD, more recent research is 
inconclusive.320,321 Reanalysis of earlier data from large-scale studies of Type A 
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personality322,323,324,325 and failure to replicate earlier findings in other large-scale cohort 
studies326,327 suggest that the hostility component, rather than Type A personality as a whole, 
is associated with sudden death and myocardial infarction. Although other studies suggest 
that, after adjustment for other factors, hostility is only weakly associated with CHD or not 
associated at all,328, 329,330,331,332 a 1996 45-study meta-analysis on the association between 
CHD and trait hostility, which includes “cynical mistrust, anger, and aggression”333 
concluded that hostility is an independent risk factor for CHD, even after adjustment for 
other risk factors.334 A recent Framingham Offspring study found that, compared to men with 
low hostility scores, men with high hostility scores were 30 percent more likely to develop 
atrial fibrillation during a ten-year follow-up period, even after adjustment for traditional risk 
factors.335  
Trait anger, however, has emerged as a more consistent predictor of CAD.336,337 
Results from a prospective Finnish study of middle-aged men found that men who were most 
likely to demonstrate anger outwardly were also had twice the risk of stroke as men where 
were least likely to openly demonstrate anger.338 Results from a large-scale prospective study 
found a dose response relationship between trait and the risk of AMI, SCD, and angina,339 
and results from a longitudinal study of men found that anger is associated with a three-fold 
increase in the risk of premature CVD. According to the Framingham Offspring study, 
compared to men without trait anger, men with high trait anger scores had a 10 percent 
higher adjusted ten-year risk of developing atrial fibrillation.340 A recent ARIC study found 
that angry temperament—but not anger in reaction to criticism, frustration, or unfair 
treatment—increases the risk of cardiac events among normotensive persons at a magnitude 
similar to that of hypertension.341 Also in the ARIC study, trait anger was found to be 
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associated with an increased incidence of stroke,342 CHD morbidity and CHD mortality 
independent of traditional risk factors.343 
A review of the literature suggests that Vietnam veterans are both more likely than 
non-veterans to exhibit cynical hostility-like characteristics and more likely to develop 
cardiovascular disease.344 In terms of biological mechanisms, anger-induced mental stress 
has been shown to induce myocardial ischemia in individuals with CAD both in the 
laboratory setting345 and in populations.346 Anger-induced hypertension is thought to be a 
likely mechanism for the trait anger-CVD association.347, 348 Both chronic anger and hostility 
have been found to be independently associated with increases in plasma epinephrine and 
chronic sympathetic activation.349,350  
Low social support has also been found to be associated with the development of 
CVD,351, 352,353 as lack of social support can leave an individual less equipped to cope with 
stress.354,355 For example, Russak and Schwartz noted that undergraduate students who rated 
their relationship with their parents as “cold and detached” had four times greater risk of 
developing depression and alcoholism as well as heart disease and diabetes 35 years later.356 
Similarly, in a prospective study of the effects of stressful life events on all-cause mortality, 
Rosengren and colleagues found that the association was present only among middle-age 
men who reported low emotional support.357 In a systematic review by Kuper and colleagues, 
six of seven prospective etiologic studies reviewed reported showed increased risk of CAD 
among socially isolated persons.358 In a systematic review of 15 studies, Rozanski et al 
reported a positive association between low social support and increased CVD risk in almost 
all cases.359 It is estimated that persons with low social support have two to three times the 
CAD risk of persons with high social support, even after adjustment for traditional risk 
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factors.360 Although clinical trials are not possible for the study of the association between 
social support and CVD, the finding of an inverse dose-response relationship between level 
of social support and cardiovascular risk further supports the role of social support in the 
development of cardiovascular disease.361,362  
Conversely, positive parental relationships can act to reduce the effects of other less 
favorable factors and are associated with better resilience in the face of chronic 
stress.363,364,365 For example, Conger and colleagues noted that the negative effects of poverty 
on child development were removed when the child had positive relationships with their 
parents.366 With regard to veteran populations, researchers for the National Vietnam Veterans 
Readjustment Study (NVVRS)367 and the Hawaii Vietnam Veterans Project (HVVP) 
concluded that one of the main predictors of the persistence of symptoms of PTSD is the 
level of social support and “emotional sustenance.”368 The primary mechanisms through 
which low social support is thought to modify the association between psychosocial stress 
and cardiovascular disease is through increased risk of hypertension and hyperlipidemia and 
through adverse health behaviors such as increased smoking and alcohol drinking.369,370,371,372 
 Social support is considered a potentially important coping strategy for veterans who 
were exposed to combat during the war. In a longitudinal study of veterans of World War II 
and the Korean conflict, combat veterans who reported having a supportive post-service 
social network also reported fewer stress symptoms forty years after conclusion of 
service.373,374 Similar findings were reported in a study of the effect of social support on 
veterans who participated in the NVVRS study.375 In accordance with Pennebaker and 
Susman’s (1998) psychosomatic theory of inhibition,376 social support is thought to mitigate 
the long-term effects of traumatic experiences by relieving the inhibition of “lingering 
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stresses and emotions of war” that “veterans learned to bury within their psyches.”377 In 
support of this theory, researchers who studied the unusually low PTSD rates (<10%) among 
Finnish veterans of World War II concluded that the community’s acceptance of discussion 
of wartime experiences and the ability of Finnish veterans to speak freely about their 
experiences was noted as a potentially important factor in the high levels of well-being 
reported by survivors.378 Further, different types of relationships may help veterans cope with 
traumatic experiences in different ways. Hunt and colleagues reported that while veterans 
rely on spouses and family members to help with physical and practical means of coping, 
they were more likely to discuss traumatic memories with fellow veterans.379 However, the 
literature is not completely consistent on the strength of social support in the reduction of the 
long-term adverse effects of combat-related stress. For example, results from a study of 
participants in the Veterans Health Study (VHS), suggest that although social support is 
associated with abatement of the adverse effects of non-military traumatic events, a similar 
reduction in stress symptoms among those who experienced combat-related traumas was not 
observed.380 The authors concluded that combat-related stressors may have an unusually 
strong and persistent effect on the health status of veterans.  
 
Behavioral Mechanisms 
  Psychosocial stress may also affect cardiovascular risk indirectly, through behavioral 
mediators.381,382 Chronic stress is associated with higher rates of smoking, diet (higher fat and 
calorie intake), obesity, sedentary behavior, sleep disorders, drug and alcohol use.383 These 
behaviors, in turn, have been shown to be associated with higher rates of hypertension, 
atherosclerosis, hypercholesterolemia, and diabetes. Such unhealthy behaviors may be 
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associated with increased cardiovascular risk either directly or indirectly, through certain 
psychological conditions or profiles. For example, although hostility is associated with the 
development of myocardial infarction and sudden coronary death (SCD), its effect is 
weakened or even removed after adjustment for health behaviors such as fat and calorie 
intake, decreased physical activity, and alcohol and tobacco use.384,385,386,387,388,389 Similarly, 
smokers and heavy drinkers are more likely to have symptoms of depression, anxiety, 
fatigue, and panic, worry and irritability, even after adjustment for gender, age, 
socioeconomic position, and geographic location in the United States.390,391,392 In this way, 
stress and unhealthy behaviors may be associated with increased cardiovascular risk directly 
or may be modified by the effects of certain psychological conditions or profiles.   
  Smoking (compared to non-smoking) is strongly associated with incident acute 
myocardial infarction AMI, with a five-fold increase in risk among 30-49-year olds who 
smoke.393 The association between psychosocial stress and smoking, however, is more 
complex. Nicotine is classified as a stimulant, as it increases heart rate and causes autonomic 
arousal,394,395 and therefore acts as a stressor. However, a calming effect of smoking has been 
reported by smokers,396 and individuals who are subject to increased psychosocial stress are 
more likely to engage in smoking in an effort to manage this stress.397 This divergence has 
been the “physiological and subjective effects of smoking” has been termed the “nicotine 
paradox.”398 Current theory holds that although individuals experiencing psychosocial stress 
may engage in smoking in an effort to reduce this stress, its calming effects are transient as 
an effort to prevent developing nicotine withdrawal.399, 400,401,402 Thus, although smoking may 
be initiated as a way to decrease psychosocial stress, its effects very likely increase 
physiological stress. In a recent study of the health behaviors of US veterans, Gizlice found 
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that veterans have significantly higher odds of current smoking, former smoking, and 
smokeless tobacco use compared to non-veterans, even after adjustment for age, race, 
education, and household income.403 Other studies have reported similar results, finding that 
the prevalence of ever and current smoking is higher among US veterans compared to non-
veterans.404, 405,406 Studies of veterans from World War II, the Korean War407 and the 
Vietnam conflict408,409 found that combat veterans with symptoms of PTSD had significantly 
increased likelihood of former or current smoking. Thus, it appears that the adverse 
cardiovascular effects of smoking—as measured by higher diastolic blood pressure and 
higher mean arterial pressure—may be amplified in smokers with PTSD.410 A study of 
Vietnam-era veterans found that the prevalence of smoking up to 35 years after exposure to 
combat increased with combat intensity.411 The mechanisms through which smoking 
promotes CVD is well-studied; smoking damages the endothelium, promotes oxidation and 
thrombosis, increases the release of catecholamines and fibrinogen, causes the myocardium 
to work harder.412,413 
  Unhealthy diet (high caloric and fat intake) has been shown to be highly associated 
with increased cardiovascular risk.414,415 Diets high in total calories, saturated fat, cholesterol, 
and sodium are associated with increased blood pressure, and may lead to the development of 
and destabilization of atherosclerotic plaques. Directly associated with energy balance, 
increased central and overall obesity are similarly associated with increase cardiovascular 
risk.416  
Increased levels of psychosocial stress have also been associated with adverse changes in 
diet.417 Behaviorally, stress has been shown to act either to increase or to decrease food 
intake in animal studies418,419 and to be associated with a preference for diets high in 
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sucrose.420 In humans, prospective survey studies have found that negative life events are 
positively associated with weight gain that was temporary in men and enduring in women.421, 
422,423,424
 Similar to animal studies, a study of depression and dietary preferences found that 
individuals with depression show preference for diets with higher concentrations of 
sucrose.425 The manner in which stress affects food intake has also been shown to vary based 
on the type of stressor (fear-inducing or ego-threatening)426 as well as the individual (whether 
or not an individual is an “emotional eater”).427 However, studies on stress and eating 
behaviors in humans have been fraught with methodologic challenges, given the difficulty of 
measuring both food intake and psychosocial stress level.428  
  When psychosocial stress activates the sympathetic nervous system through 
mechanisms described above, a number of physiologic changes occur that affect food 
consumption, food preferences, and the digestive process. While mild or moderate and 
temporally limited stressors tend to produce an adaptive response of delaying or reducing 
food intake so that energy can be diverted away from digestion and towards coping 
mechanisms, chronic, frequent, or traumatic stressors tend to result in a disrupted response 
and, generally, increased rather than decreased intake.429 For example, McCann et al found 
that increased job stress and workload was associated with higher self-reported total calorie 
intake and a higher percentage of calories consumed as fat.430 Studies of stressors such as 
academic workload and examinations431 have found similar results, while others found that 
academic workload was associated with a more unhealthy diet only among those with lower 
positive affect scores.432 In a recent study of the health behaviors of US veterans, Gizlice 
found that veterans have significantly higher odds of being overweight compared to non-
veterans, even after adjustment for age, race, education, and household income.433  
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  In a typical physiologic response to a non-traumatic acute stressor, the HPA axis is 
engaged, leading to the release of corticotrophin releasing hormone which leads to 
hypophasia (the suppression of food intake).434, 435,436,437 Reciprocally, in response to a 
traumatic, chronic, or periodic stressor, the functioning of the HPA axis is disrupted, leading 
to the release of corticotrophin antagonist and, consequently, leading to hyperphasia, or the 
increase of food intake. Additionally, the release of epinephrine (adrenaline) and 
norepinephrine (noradrenaline) in response to an environmental stressor stimulates lipolysis 
in adipose tissue and glycogenolysis in the liver thereby increasing the free fatty acid and 
glucose supply to muscles and other tissues.438  
  Physical activity is recognized as a protective factor against coronary heart disease.439, 
440,441,442
 In 1992 the American Heart Association added physical inactivity as a primary risk 
factor for coronary heart disease, and the 1996 United States Surgeon General’s Report 
concluded that regular physical activity decreases CHD mortality and is as important a risk 
factor as other behaviors such as smoking.443 An inverse, dose-response association between 
level of physical activity and risk of CVD has been documented.444,445,446,447 The association 
between physical inactivity and psychosocial stress is also recognized in the literature. A 
1999 study of 194 men and women hospitalized for myocardial infarction found that patients 
with depression were less likely to adhere to a regimen of healthy diet and regular 
exercise.448 In a 1984 consensus statement, the National Institute of Mental Health (NIMH) 
concluded that physical activity is associated with a reduced risk of mild to moderate 
depression and that exercise may be used as a collateral treatment for severe depression.449 In 
a study of the effects of chronic social stress on physical activity in mice, Bartolomucci and 
colleagues found that intruders whose social position was changed to being subordinate had 
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marked reduced physical activity.450 In humans, the psychosocial stress associated with lower 
job control was found to be associated with lower levels of physical activity.451  
  Consensus has not yet been reached as to the primary mechanism through which 
physical activity and psychosocial stress, together, act to reduce the risk of CVD, although a 
number of possible mechanisms have been identified.452 Mechanisms include the release of 
endorphins, which causes a calmer mood known as “exerciser’s euphoria;” a relaxation of 
muscles, an increase of Beta-endorphins; and an increase in corticotrophin and other 
hormones that counteract the effects of psychosocial stress.453,454,455 Physical activity is also 
associated with decreased levels of a number of inflammatory markers.456 Physical inactivity 
may also act indirectly, through the protective effects of lipid and blood pressure control, to 
reduce cardiovascular risk.457 Physical activity has been shown to be directly associated with 
HDL levels and inversely associated with LDL and triglyceride levels in fasting plasma.458, 
459,460
  
  The association between average volume of alcohol consumed and CVD shows a U-
shaped relationship in epidemiological studies in developed nations.461 Heavy alcohol 
consumption has been found to be associated with increased cardiovascular risk; intake of 
more than two drinks per day may be associated with an increased risk of ischemic stroke.462 
However, light or moderate consumption is associated with decreased cardiovascular risk 
compared to non-drinkers.463,464,465,466,467 The type of alcohol and the pattern of use also 
modify the effect of alcohol consumption on cardiovascular risk.468 Binge drinking—
drinking large amounts in a short period—has been found to be associated with increased 
platelet aggregation and a higher incidence of CVD.469 In terms of the type of alcoholic 
beverage, regular, modest consumption of red wine, in contrast to other types of alcoholic 
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beverages, does not result in increased platelet aggregation, and is associated with a 
reduction of CVD.470 Thus, while drinking one glass of red wine each day may be 
cardioprotective, drinking a week’s worth of wine in one day may be damaging to the 
cardiovascular system.471, 472,473 Although wine is most commonly associated with 
cardiovascular protection, most alcoholic beverages, in moderation, appear to be inversely 
associated with incidence of CHD.474, 475,476,477  
  Heavy alcohol consumption is also associated with increased levels of psychosocial 
stress.478 Studies have also noted that found that the expectation of feelings of relaxation and 
reduced tension was the strongest predictor of problematic drinking among college students, 
even stronger than the expectation of physical or social pleasure.479, 480 This expectation was 
also found to be associated with both quantity and frequency of drinking.481 A 2003 study of 
job stress noted similar results, reporting that frequent overtime work was associated with 
heavy alcohol use 24 years later.482 Similarly, Tsutsumi and colleagues noted that high 
psychosocial demands on the job and low job control were associated with a higher 
prevalence of current alcohol drinking.483 In a study of Israeli witnesses of traumatic events, 
Hourani and colleagues noted a higher risk of heavy alcohol consumption among men but not 
women.484 A study of US veterans from the first Gulf War found that deployed veterans were 
significantly more likely to have alcohol disorders than non-deployed veterans.485 Similarly, 
Elder and colleagues found that Vietnam veterans who were exposed to combat were 
significantly more likely to be self-reported heavy or problem drinkers than non-combat 
veterans.486  
  Alcohol consumption and stress can work through multiple pathways to increase or 
decrease the risk for cardiovascular disease. In small amounts, alcohol consumption increases 
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beneficial high-density lipoprotein (HDL) concentrations,487 which decreases the risk of 
carotid atherosclerosis, CHD and stroke.488,489 It is thought that 40 to 50 percent of the 
protective effect of moderate alcohol consumption is attributable to this mechanism.490, 491,492  
  Small amounts of alcohol, particularly in red wine, also have the effect of inhibiting 
the adhesion of platelets to fibrinogen-coated surface under blood flow, presumably 
contributing to the cardioprotective effects of alcohol.493 A meta-analysis of 42 published 
trials confirmed the contribution of both the influence of alcohol on lipids and on blood-
clotting factors.494 Limited alcohol consumption is also associated with increased insulin 
sensitivity495 and lower central abdominal adiposity.496,497 Moderate alcohol consumption 
may also reduce cardiovascular risk through anti-inflammatory pathways, as evidenced by 
the finding that, compared to non-drinkers, persons who consume moderate amounts of 
alcohol have lower levels of C-reactive protein (CRP), which is a circulating inflammatory 
marker.498, 499,500,501,Moderate alcohol consumption is also thought to reduce CHD risk 
through protective hormonal, specifically estrogenic, effects502 and by promoting 
vasodilatation,503 although fewer studies have been conducted in support of these hypotheses.  
  Conversely, heavy alcohol consumption acts to increase cardiovascular risk through 
the mechanisms of increased clotting and reduced threshold for ventricular fibrillation.504 
Heavy drinking, particularly in irregular patterns, has been shown to increase low-density 
lipoprotein (LDL) concentrations, which are associated with less favorable cardiovascular 
outcomes. These increases in unfavorable LDL levels do not come with the subsequent 
increases in favorable HDL and levels as found among persons who drink lightly or 
moderately on a regular basis.505 Irregular, heavy drinking is also associated with an 
increased risk of thrombosis506 and a predisposition to histological changes in the 
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myocardium and conducting system.507 All of these pathways lead to an increased risk of 
sudden cardiac death and other unfavorable cardiovascular outcomes.508,509,510 
  
Sociodemographic Factors  
The association between combat-related stress and CVD risk may be affected by 
socioeconomic status, which refers distribution of wealth, power, status and opportunities. In 
other words, the association between combat-related stress and CVD risk may be different 
for persons based on their social, education, and economic backgrounds and current 
situations. In most industrialized countries today, the incidence of CHD511 and stroke512 is 
lowest among high SES groups. Inverse associations between socioeconomic status (SES) 
and CVD morbidity and mortality as well as mortality from other health related outcomes 
have been demonstrated repeatedly. This has been the case for individual513,514 and 
neighborhood-level SES indices515,516,517 as well as for SES measures assessing conditions in 
childhood,518,519 adulthood520,521 and across the life course.522 
There are several mechanisms through which SES factors are thought to modify the 
stress-CVD association. Lower SES at the individual level is associated with increased risk 
of smoking, less healthy diet, less adequate housing, increased obesity, and reduced physical 
activity.523, 524,525,526 In addition, persons from lower SES groups have less self-reported 
social mobility, increased financial strain and more stressful life events. In this way, the 
mechanisms through which SES act to increase risk for CVD are thought to be similar to 
those for other chronic psychosocial stressors.527  
 Overall, the education level of veterans has increased over time. As of 2001, 
approximately 89% of veterans had a high school diploma, up from 83% in 1992. In 2000, 
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55% of veterans were employed, 32% were retired, 4% were not working but were looking 
for a job, and 7% were disabled, differing little from veterans polled in 1992. More than one 
third of the veteran population polled in 2000 had a combined family income of over 
$50,000.528   
Differences in the SES of veterans versus non-veterans as well as combat veterans 
versus non-combat veterans have been reported in the literature. In a study of Vietnam 
veterans up to 35 years after exposure to combat, Stellman and colleagues found that income 
was significantly lower among high-combat veterans compared to low- and medium-combat 
veterans.529 In a study of British veterans from the Gulf War, Ismail and colleagues noted 
that military rank, used as a proxy for socioeconomic status, was positively associated with 
psychological and physical health.530 Elder and colleagues found that the association between 
combat exposure and physical health did not differ by military rank among veterans of World 
War II.531 However, according to results of the Veteran’s Administration National Survey of 
Veterans (NSV), the sociodemographic profile and distribution of the veteran population has 
changed over time, this finding may or may not hold true for more recent cohorts of veterans.  
Further, in a study of the role of SES in the effects of wartime stress on civilians, 
Sibai and colleagues reported that both the degree and type of wartime exposure as well as 
SES affects the strength of association between exposure to wartime stress and 
cardiovascular (CVD) risk.532 In a longitudinal study of Vietnam era veterans and non-
veterans, Cordray and colleagues noted that while PTSD is associated with military combat 
exposure, level of combat is related to pre-military SES.533 In this study, the authors found 
that those from lower SES backgrounds were more likely to experience higher levels of 
combat, and those who experienced higher levels of combat were more likely to have PTSD 
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symptoms ten years after the war. An effect in the opposite direction has also been 
hypothesized, however, as described by the “healthy warrior effect.” This hypothesis holds 
that those who are at higher SES are also healthier and thus more likely to be found fit for 
war. In the context of a military draft, such as occurred in Vietnam and Korea, this concept 
may be particularly relevant. Modification by SES was further investigated in the VES study 
by Bohemer and colleagues, who noted that the adjusted rate of mortality from cancer was 
elevated among Vietnam theater veterans compared to other veterans serving during the same 
era, but only among those at a low pay grade (MRR = 1.64; 95% CI = .0.94, 2.89).534 
Conversely, Vietnam theater veterans discharged at a high pay grade had lower adjusted 
cancer mortality rates compared to other high pay grade veterans who served during the 
Vietnam era. (MRR = 0.82; 95% CI = 0.63, 1.07) These findings support the theory that 
higher SES may provide protection against the effects of traumatic stress.  
SES has the potential to influence the combat stress-CVD association at many 
levels.535 One way the effect of SES on the combat stress-CVD association will be studied is 
within the framework of life course theory, which views life exposures in the context of 
timing, life events and life transitions. Life course theory views meaningful life exposures as 
changes that are rooted within dynamic trajectories of social roles and the events that give 
them meaning. In other words, the defining feature of life course theory—and the reason that 
it is used in this analysis—is that it holds that fundamental life experiences must be studied 
within the context of both social surroundings and changes over time.  
The contribution of life course socioeconomic studies of long-term health outcomes 
has been assessed in three main studies. The National Longitudinal Survey (NLS) of Labor 
Market Experience of Mature Men is a panel survey of approximately 500 US men who were 
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between the ages of 45 and 59 in 1966.536 During the 19-year follow-up period of this study, 
occupational, educational, and family history were recorded retrospectively, while mortality 
and other information was collected prospectively. A primary finding in this study was that 
the association between father’s occupation and participant’s mortality risk was eliminated 
after controlling for the participant’s education, suggesting that the effect of childhood SES 
works through subsequent experiences such as educational attainment. The more favorable 
mortality rates experienced by those with higher educational attainment was further found to 
be attributable mainly to financial and occupational factors that come with advanced 
schooling. In addition to education, first occupation on entering the labor market was found 
to be independently associated with 25-year mortality in this cohort. The effects of first job 
were found to be attributable mainly to increased wealth and family assets associated with a 
managerial or professional occupation compared to other types of jobs.  
 Results from a Norwegian longitudinal data set linking decennial census information 
from 1960-1980 and vital registry statistics before 1985 are similar to those from the NLS.537 
In this study, the types, sequence, and timing of socioeconomic experiences were assessed in 
relation to approximately 180,000 deaths in the study population. The highest mortality was 
found among those with the lowest educational attainment, manual occupations, early 
retirement, and poor early-life housing conditions. Differences in the importance and effects 
of some socioeconomic factors were noted by gender, whereby high educational attainment 
and high-level employment conferred significant protective effects among men only.  
 The West of Scotland Collaborative (WSC) Study is a third source of information on 
the contribution of life course SES on health and mortality. In the early 1970’s, 
approximately 5,500 male employees aged 35 to 64 years were screened for cardiovascular 
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risk factors and cardiovascular health. Early-life SES information was collected, and men 
were followed for 21 years. 538Some of the main findings from this study include that while 
physiological risk factors such as diastolic blood pressure, serum cholesterol, and forced 
expiratory volume (FEV) are associated with both adulthood and childhood SES, behavioral 
risk factors such as recreational exercise and cigarette smoking are related to adult but not 
childhood SES. Results of this study were interpreted to mean that while physiological health 
is reflected in an accumulation of both past and present socioeconomic exposures, health and 
related behaviors are more heavily influence by the current social environment. When 
accumulated SES was measured by summing the number of times a non-manual occupation 
was held by the father, by the individual at first market entry, and by the individual during 
adulthood, authors reported that the most favorable health was found among those who held 
non-manual positions at all three time points.539 Further, the authors noted a stepwise 
association between accumulated SES and a number of health outcomes as well as all-cause 
mortality, with each time point that included a manual labor position being associated with 
an additional reduction in health or longevity. Control of psychological and behavioral risk 
factors only modestly reduced the effect of cumulative SES on 21-year all-cause mortality.540  
 Subsequent WSC studies have found that life course SES does not related to specific 
causes of mortality in a consistent manner.541 While most cancers are related to adult but not 
childhood SES, CHD, stroke, respiratory disease, lung cancer and stomach cancer are 
independently associated with both child and adulthood SES. Other more subtle differences 
have also been noted. For example, while control of adults SES and risk factors attenuates 
the association between childhood SES and CHD or respiratory disease mortality, it does not 
affect the particularly strong association between childhood SES and stroke or stomach 
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cancer mortality. In a systematic review of the effects of individual-level childhood SES on 
overall and cardiovascular mortality, Galobardes and colleagues concluded that the 
persistence of the effect of childhood SES over and above the effects of adult SES and 
traditional risk factors as an adult differed somewhat by study population. However, overall, 
the studies showed that individuals with lower childhood SES levels carried an elevated risk 
of both overall and cardiovascular mortality, independent of adult SES.542  
 The contribution of life course SES in the context of its effect on the association 
between military service and physiological health has been most extensively studied in the 
Standford-Terman study, a longitudinal study of the work and life histories of 1,500 men and 
women. Begun in 1922 when the participants were in elementary and secondary school, the 
Stanford-Terman study incorporated follow-up interviews every few years until 1992.543 This 
longitudinal cohort study found that participation in military combat in World War II was 
associated with elevated physical decline or death 15 years after conclusion of the war, 
suggesting that this traumatic exposure had a notable effect on the course of men’s lives.544  
There are three main mechanisms through which social processes are thought to 
interact with health.545 First, according to the cumulative disadvantage theory, the 
accumulation of even small differences in SES from childhood to adulthood is associated 
with a “chain of disadvantage” throughout life.546 The example most commonly cited is the 
association between parental SES and birth weight as well as height in childhood and 
adolescence.547,548 Disadvantage at birth and in childhood has also been shown to be 
associated with longer-term effects, such as increased risk of unemployment.549 Mechanisms 
underlying these findings are thought to include financial difficulties, poor nutrition, 
disrupted sleep patterns, delayed growth and other social disadvantages. Slower childhood 
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growth is further associated with later educational disadvantages, which can, in turn, lead 
individuals to employment positions that are more hazardous and poorly regulated. These 
combined factors, over time, accumulate to form a “chain of disadvantage.”  
A second mechanism through which life course SES is associated with long-term 
health is that of social protection. According to this theory, previous socioeconomic 
conditions can act to either amplify the effects of new disadvantage in the case of previous 
disadvantage or attenuate these effects in the case of previous advantage.550 Findings from 
the General Household Survey support this theory and further demonstrate that the effect of 
social protection increases as the magnitude of new disadvantage increases.551 In this study it 
was found that men of working age with chronic illness and from a higher SES are more 
likely to be employed than chronically ill men from a lower SES, suggesting that social 
disadvantage is associated with protection from subsequent social disadvantage. Further, the 
finding that the positive association between SES and employment rates among the 
chronically ill suggests that socioeconomic disadvantage Inherent in this theory is that there 
are critical periods of development during which exposures have particularly long-lasting 
effects on future social status, health and well-being.552 The primary critical period of 
susceptibility and development is that of in-utero growth, during which time environmental 
exposures to substances such as lead, thalidomide, hepatitis B, and other exposures influence 
future development and risk.553, 554,555 Critical periods of social transition include the move 
from primary to secondary school, entry into the labor market, first residence, job changes, 
retirement, and onset of chronic illness.556  
A third mechanism linking life course SES and health is that of social mobility. This 
mechanism highlights the contribution of young life SES on the probability and direction of 
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social mobility, and the contribution of this trajectory on subsequent health and wellbeing. 
Young life experiences associated with advantage or disadvantage such as childhood health 
and growth, education, number of siblings, family housing conditions are significantly and 
independently associated with adult SES.557 The effect of social mobility on long-term 
morbidity558 and mortality559 has been studied most extensively in the Office of National 
Statistics (ONS) Longitudinal Study and the WSC Study.560 Results from these studies show 
that upward mobility from a lower SES in childhood to a higher SES in adulthood is 
associated with more favorable health and advantage compared to those who remain stable at 
a lower SES in both childhood and adulthood, but not as favorable as those who remain 
stable at a higher SES. Reciprocally, those who are downwardly mobile and move from a 
higher SES in childhood to a lower SES in adulthood are more disadvantaged than those who 
remain at a higher SES but more advantageous than those who are stable at a low SES. 
Results from these studies are described in further detail in the next section of this proposal.  
Life course theory in the context of this third mechanism is particularly applicable in 
the study of combat exposures. Life course socioeconomic exposures relate to changes in 
trajectories in two main ways. First, previously accumulated socioeconomic experiences of 
advantage or disadvantage influence whether or not particular transitions occur. For example, 
childhood SES is associated with the probability of attending college,561 continued 
employment in a manual occupation,562 and probability of disability in midlife.563 In this 
way, those with a history of socioeconomic disadvantage are more likely to experience 
transitions such as loss of employment and physical disability and less likely to experience 
transitions such as enrollment in college and promotion into non-manual labor positions.  
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Life course socioeconomic exposures also relate to critical social transitions in that 
prior accumulated advantage or disadvantage can affect whether or not the transition results 
in a favorable outcome564 For example, researchers for the General Household Survey 
reported that among men with chronic illness, those with a history of socioeconomic 
advantage were more likely to retain employment than those with a history of 
disadvantage.565 Also, continuation in the same line of work over time is more commonly 
followed by unemployment or casual re-employment among persons with a history of 
disadvantage, who are more likely to work in more insecure and hazardous labor markets.566  
 In the context of military and combat exposures, war may act to either improve or 
deteriorate future social, psychological and physical health.567 The socioeconomic position 
from which individuals enter the military may further affect the way in which this exposure 
affects their future trajectory. SES early in life may influence whether individuals enter the 
military, and also their rank and role in the military that, in turn, are associated with stress 
burden as well as with skills and resources to cope with such stress. For example, during the 
Vietnam conflict, sons of more highly educated fathers were disproportionately more both 
likely to enter the military and more likely to die in combat compared to sons of fathers with 
fewer years of education.568 Between 1970 and 1973, priority for the draft into the military 
was randomly assigned to eligible men in a series of lotteries. However, many men avoided 
the draft by enrolling in school and obtaining educational deferment. According to a Current 
Population Survey (CPS) study, each additional year of schooling acquired in response to the 
draft is associated with a 6.6 percent increase in current weekly earnings.569  
Further, attributes related to SES are also likely associated with the opportunities and 
resources available to individuals upon leaving the military, and possibly with the adoption 
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of unfavorable behavioral profiles (smoking, physical inactivity). It is thus plausible that the 
potential long-term cardiovascular sequelae of combat stress would be greater among 
individuals from lower SES groups. Similarly, SES in adulthood may in part be determined 
by participation in the military. Education received during the military or after service via the 
Montgomery G.I. Bill (which supplements educational costs) could lead to higher SES 
among those who served. Table 2 below lists the economic and educational benefits provided 
to veterans of World War II, Korean War, and Vietnam conflict era veterans. While some 
have theorized that the educational benefits provided by the military would be used 
disproportionately by those individuals who were at a higher SES at the outset and who could 
have funded additional education at their own expense,570 a study by Mettler and Welch 
reported that use of the G.I. bill was not based on prior SES.571 Thus, while some used these 
benefits to further their education in ways that they could have without them, others were 
able to gain access to education that they would not otherwise have been able. In 1999 Bound 
and Turner tested the hypothesis that the G.I. Bill increased educational attainment for 
returning World War II veterans. Using U.S. census data, Bound and Turner found that the 
educational benefits offered through the G.I. Bill did, in fact, lead to a modest gain in the 
postsecondary educational attainment of World War II veterans.572 Results from a 
longitudinal study of Depression-era men suggest that the GI Bill allowed for veterans to 
keep pace with, but not exceed, non-veterans in terms of educational attainment.573 Further, 
results from qualitative studies of veterans suggest that military service cultivates a stronger 
sense of self-efficacy, assertiveness, discipline, proclivity to teamwork, leadership, and 
positive self-image, which may be advantageous in future educational and occupational 
endeavors. 574,575  
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Table 2. Economic and Educational Benefits Provided to US Veterans during the Eras 
of World War II, the Korean War and the Vietnam Conflict. 
 
Servicemen’s Readjustment Act of 1944 (Original World War II-era GI Bill of Rights) 
• Education and training: Paid tuition, books, fees, and other 
training costs and provided a monthly living allowance 
• Loan guarantees: For a home, farm, or business 
• Unemployment pay: $20 a week for up to 52 weeks 
• Job-search assistance 
• Total educated: 7.8 million 
• Total cost: $14.5 billion 
• Expired: July 25, 1956 
Veterans Readjustment Assistance Act of 1952 (Korean War GI Bill) 
• Education and training: Up to $110 per month 
• Loan guarantees: For a home, farm, or business 
• Total educated: 2.4 million 
• Total cost: $4.5 billion 
• Expired: January 31, 1965 
Veterans Readjustment Benefits Act of 1966 (Vietnam-era GI Bill) 
• Education and training: One month of coverage provided 
for each month of service, for a maximum of 36 months, 
later extended to 45 months; payment increased from $100 
a month in 1966 to $376 per month in 1984 
• Loan guarantees: For a home or farm 
• Job counseling: Employment placement service 
• Total educated: 8.2 million 
• Total cost: $42 billion 
• Expired: December 31, 1989 
 
 
Source: Adapted from the Raleigh News and Observer, 2004.576 
 
Conversely, if psychological and physical conditions related to combat stress 
adversely affect access to or use of subsequent educational and occupational opportunities, a 
lower SES could result, with its attendant unfavorable CVD risk factor profile. For example, 
collaborators for the National Survey of the Vietnam Generation found that the adverse 
psychological sequelae of military service affects post-service employment and income. In 
this study, collaborators found that veterans who met clinical criteria for PTSD, anxiety 
disorders or major depression were significantly less likely to be employed and, if working, 
had significantly lower wage earnings than veterans without one or more of these 
diagnoses.577 Such findings support the importance of considering SES, both prior to entry 
into the military and in subsequent civilian life.  
  Further, a number of differences in the timing of life events have been noted among 
American veterans. Results from longitudinal studies also suggest that compared to non-
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veterans, veterans of World War II and the Korean War were more likely to have 
considerable delay in timing of school completion, marriage, full-time employment, and 
child-rearing.578,579 Not only was military service associated with different timing of 
important life events, but it is also associated with different order of events. For example, 
Elder and colleagues found that marriage before finishing school is more common among 
veterans than non-veterans.580 Although the additional effects of combat exposure among 
veterans was not able to be assessed in these studies, it was theorized that combat experience 
would play an important role in the timing and order of live events, particularly through the 
mechanisms of psychological health and impairment.581  
 
Birth Cohort and Gender 
The age of participants arose is also thought to affect the association between 
exposure to military combat and cardiovascular risk. Advanced age is associated with 
increased risk of CVD; however, categorization into birth cohorts rather than age in years 
allows for connections to be made between individual aging and historical period in which 
one lived. In descriptive analyses, acknowledgement of birth cohorts highlights the 
intersection of age, period, and cohort, which together act to produce different life patterns 
among different age groups or generations.  
 Although the U.S. is constantly engaged in some level military involvement, the 
prevalence of exposure to military combat in the U.S. population is not constant and changes 
with political climate. Many generational differences exist in both military service and 
combat exposures. Currently, the average age of the veteran population is increasing, as there 
are fewer military conflicts now than there were in earlier years and as veterans of World 
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War II, the Korean War and the Vietnam conflict continue to age. Between 1992 and 2001, 
the percentage of veterans under the age of 45 decreased from 32 to 21 percent, while the 
percentage of veterans over the age of 65 increased from 26 to 38 percent.528 Currently, the 
average veteran is 58 years of age, employed, have completed high school and are enjoying a 
family income of more than $50,000 per year. 582 The proportion of veterans that is female 
has increased over time; currently 6 percent of veterans are female, compared to 4% in 1992. 
Female veterans tend to be younger, more highly educated, and include a greater proportion 
of minorities. These differences likely reflect the fact that few women entered the military 
before 1975.583 
Male veterans are far more likely to have served in a combat or war zone compared to 
female veterans (40.6% versus 12.0%, respectively) and more likely to have been exposed to 
dead, dying, or wounded persons (37.2% versus 24.4%, respectively). (Table 3, below) A 
requirement for the receipt of disability compensation, service-related disability was reported 
by a slightly higher proportion of male veterans compared to female veterans (13.9% versus 
12.7%, respectively). (Table 4, below) However, the proportion of veterans reporting any 
self-reported disabling condition incurred during active military service was similar for male 
and female veterans (13.8% and 13.5%, respectively).  
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Table 3. Percent Distribution of United States Veterans by Service in Combat or War 
Zone and Exposure to Dead, Dying or Wounded, by Gender. 
 Total Males Females 
Served in combat or war zone    
Yes 38.9 40.6 12.0 
No 60.1 58.3 87.8 
Unknown 1.0 1.1 0.2 
Total 100.0 100.0 100.0 
Exposed to dead, dying, or wounded people    
Yes 36.4 37.2 24.4 
No 62.9 62.1 75.2 
Unknown 0.7 0.7 0.4 
Total 100.0 100.0 100.0 
Number of veterans * 25,095,000 23,629,800 1,465,200 
* Estimates of number of veterans are rounded to the nearest hundred. 
Note: This table excludes veterans who received a medical discharge from the National 
Guard or Reserves but never served on active duty.  
Source: Adapted from Department of Veterans Affairs, 2001.528  
 
 
Table 4. Percent Distribution of United States Veterans with Service-Related Disability, 
by Gender. 
 Total Males Females 
Experienced a service-related disability     
Yes 13.8 13.9 12.7 
No 16.6 16.8 12.0 
Unknown 69.6 69.3 75.3 
Total 100.0 100.0 100.0 
Experienced a service-connected disability rating    
Yes 13.8 13.8 13.5 
No 85.1 85.1 85.6 
Unknown 1.1 1.1 0.9 † 
Total 100.0 100.0 100.0 
Number of veterans * 25,196,000 23,712,400 1,483,600 
* Estimates of number of veterans are rounded to the nearest hundred. 
† Low precision and/or sample size for the denominator between 30 and 59. 
Note: This table excludes veterans who received a medical discharge from the National 
Guard or Reserves but never served on active duty.  
Source: Adapted from Department of Veterans Affairs, 2001.528 
 
 
 
 
  77 
Era of service 
 Exposure to combat and general military experiences further differed by era of 
service. Specifically, the probability of combat or war zone exposure decreased after World 
War II and increased again during the eras of the Vietnam conflict and the Gulf War. (Table 
5) The highest percentage of veterans to report exposure to combat or war zones is among 
those who served during the World War II period, followed by veterans who served between 
World War II and the Korean conflict and those who served during the period of the Vietnam 
conflict. Because veterans polled by the National Survey of Veterans could indicate more 
than one period of service, the relatively high percentage of veterans reporting combat 
exposure who served between World War II and the Korean conflict may be due to veterans 
who experienced combat during the World War II era but continued to serve in the military 
after the conclusion of the war. Similarly, exposure to dead, dying or wounded persons was 
most commonly reported among veterans of WWII and the following period. The proportion 
of veterans who reported a service-related disability was highest during the Vietnam, Post-
Vietnam, and Gulf War eras, compared to previous periods of service. However, as Veterans 
Administration researchers note, this finding may be an artifact reflecting the higher 
mortality among veterans from earlier periods of service.584
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Table 5. Percent Distribution of United States Veterans by Service in Combat or War Zone; Exposure to Dead, Dying or 
Wounded Persons; Experience of a Service-Related Disability; or Experience of a Service-Connected Disability Rating,  by 
Period of Service. 
 Total 
World 
War II 
Between 
World  
War II 
and 
Korean 
War 
Korean 
War 
Between 
Korean 
Conflict  
and  
Vietnam 
War 
Vietnam 
Conflict 
Post- 
Vietnam 
Conflict Gulf War 
Served in combat or war zone         
Yes 38.9 60.3 52.8 42.4 31.9 48.1 31.5 38.1 
No 60.1 38.7 46.5 56.9 67.1 51.1 67.3 60.7 
Unknown 1.0 1.0 0.7 0.7 1.0 0.8 1.2 1.2 
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Exposed to dead, dying, or wounded people          
Yes 36.4 49.7 42.9 34.8 30.0 45.9 32.3 31.7 
No 62.9 49.2 56.3 64.6 69.4 53.5 67.0 67.6 
Unknown 0.7 1.1 0.8 0.6 0.6 0.6 0.7 0.7 
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Experienced a service-related disability          
Yes 13.9 13.6 14.0 11.7 12.5 18.5 19.6 22.5 
No 16.5 28.6 25.1 22.7 18.8 11.6 7.4 3.0 
Unknown 69.6 57.8 60.9 65.6 68.7 69.9 73.0 74.5 
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Experienced a service-connected disability 
rating 
        
Yes 13.8 14.2 16.3 13.3 12.8 18.1 20.4 24.2 
No 85.1 84.6 85.9 85.9 86.6 80.9 78.6 74.5 
Unknown 1.1 1.2 1.1 * 0.8 0.6 1.0 1.0 1.3 
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Number of veterans † 25,095,000 5,149,100 1,680,600 4,245,600 6,426,500 9,057,200 7,005,000 3,483,600 
* Low precision and/or sample size for the denominator between 30 and 59.  
† Estimates of number of veterans are rounded to the nearest hundred; the total estimate is smaller than the sum of the groups because veterans could indicate 
more than one period of service. 
Note: This table excludes veterans who received a medical discharge from the National Guard or Reserves but never served on active duty.  
Source: Department of Veterans Affairs, 2001.528 
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Notable differences exist, not only in post-military benefits, but also in the draft, the 
nature of the combat and the social and political context surrounding the conflicts.585 
Involuntary conscription was in effect when these men served, and it was not until the time 
of the Vietnam War when educational deferments were commonly granted and used as a 
means to avoid military service. Similarly, the lower rates of military service among blacks 
may reflect a lower demand or acceptance of black recruits, particularly prior to a racially 
integrated military (Korean War era). Also, Vietnam veterans are reported to have been 
subject to unusually high levels of “barbarity and moral ambiguity” while in the line of 
duty.586, 587,588,589,590 Veterans of the Vietnam conflict also returned from war to a social and 
political environment that was particularly unsupportive of the US involvement in the 
conflict.591,592 In contrast, World War II has been referred to as a “good” war that had 
overwhelming support of the American public.593, 594,595 A 1994 study by Fontana and 
Rosenheck found that the manner in which solders were received at homecoming had a 
significant effect on the risk of developing PTSD and other psychiatric symptoms later in 
life.596 The authors suggested that the more favorable homecoming experienced by World 
War II veterans may have mitigated the negative impact of combat experiences on 
psychological health. Alternatively, the greater stigma associated with mental illness during 
the era of the World War II generation may have led to underreporting of the presence or 
severity of symptoms. Further, World War II was a more traditional war with a clearly 
identified enemy. Like World War II, the Korean War was fought by defined armies for 
territory; however, civilians were also involved in the conflict. Unlike World War II, the 
Korean War lost support from the American public over the course of the war. Additionally, 
the nature of the combat experiences to which soldiers were exposed differed by conflict. 
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According to a findings from Fontana and colleagues’ study of 5,138 war zone veterans who 
sought treatment from Veterans Affairs outpatient clinics, Vietnam veterans were more likely 
to have witnessed abusive violence or killings compared to veterans of World War II and the 
Korean War.597 The confluence of divergent factors such as the clarity of identification of the 
enemy, involvement of civilians in combat, transparency of the goals of the war, and level of 
public support may result in different associations between combat-related stress and health 
among men from different eras.  
Differences in effect by era may occur directly, due to differential socioeconomic, 
racial, sociopolitical or post-military readjustment stress, or indirectly, through differential 
adoption of resultant maladaptive health behaviors. In a study of Vietnam and World War II 
era veterans, Boscarino found that Vietnam era veterans had higher unadjusted alcohol 
consumption, binge drinking, and drug involvement, compared to both non-veterans and 
veterans of World War II.598 Though considerably reduced, differences persisted even after 
adjustment for demographic variables. Adoption of atherogeneic behaviors such as smoking, 
drinking, and drug use may also have increased differentially during military service itself. 
During the Vietnam conflict, for example, drug use, alcohol consumption and smoking were 
particularly common. Although drug use declined sharply after conclusion of military 
service, high rates of drinking problems persisted.599, 600,601  
 Differences by era may also reflect different effects of military branch service. The 
proportion of veterans who served in the Army, compared to the Marines, Air Force, Navy, 
or Coast Guard has decreased over time, from 60% of veterans age 75 years and over to 43% 
of veterans less than 35 years of age. Conversely, the proportion of veterans who served in 
the Marine Corps has increased over time, from 6% among veterans age 75 years and over to 
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18% of veterans 35 years and under. Distributions of service in the other branches of the 
military have varied little over time.602 Distribution of veterans by branch of service may 
impact probability of exposure to particular combat experiences. For example, those who 
served in the Marine Corps or Army have historically had a higher probability of incurring a 
service-related disability compared to those who served in the Navy, Air Force, or Coast 
Guard. 603  Unfortunately, rank and branch of service was not recorded during the LC-SES 
interview. Results from the Stanford Terman Study suggest no evidence of modification by 
rank or theater of engagement.604  
 
Race and Ethnicity  
  Although race/ethnicity is commonly controlled for in epidemiologic studies, 605  the 
mechanism through which it acts in the development of disease is not well understood.606 
Currently it is thought that underlying gene-environment interactions and/or socioeconomic 
differences may explain differences that are found.607, 608,609,610 However, even when the 
researcher controls for socioeconomic differences, residual confounding may persist due to 
the difficulty in measuring the complex schema of SES. Such residual confounding may 
subsequently and inappropriately be attributed to race.611Although considering race as a 
biological construct has been convincingly refuted,612,613,614 it is still unclear whether race is 
indicative of a direct gene-environment interaction or, alternatively, whether it is instead a 
“broad indicator of risk factor status.”615  
  Although U.S. veterans are a diverse group, the majority are white, non-Hispanic 
males. The proportion of non-white veterans has increased over time, and currently 
approximately 9 percent of veterans identify themselves as black and less than one percent of 
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veterans identify themselves as American Indian, Asian or Native Hawaiian, respectively. It 
follows then that although white veterans are most likely to have served during the Vietnam 
Era (35.9%), black veterans are most likely to have served during the Post-Vietnam era 
(45.8%). (Table 6) Similarly, while persons of Hispanic ethnicity were most likely to serve 
during the post-Vietnam era (35.9%), persons of non-Hispanic ethnicity were most likely to 
serve during the Vietnam era (36.1%). (Table 7) 
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Table 6. Percent Distribution of United States Veterans by Period of Service and Race. 
Era of service  One race Two or more races 
 
Unknown 
race 
 
Total Total  
one race 
White Black American 
Indian or 
Alaska 
Native 
Asian Native 
Hawaiian 
or Other 
Pacific 
Islander 
Total two 
or more 
races 
American 
Indian or 
Alaska 
Native/White 
 
World War II 20.5 21.1 2.4 10.1 8.1 20.4 4.9* 11.1 12.0 9.7 
Between World War 
II and Korean War 
6.7 6.8 7.1 4.6 5.7* 9.8* 4.0* 5.7 7.2 3.5 
Korean War 6.9 17.2 17.7 13.3 11.5 13.5* 18.0* 13.6 16.5 9.5 
Between Korean War 
and Vietnam Conflict 
25.6 26.0 26.8 18.8 18.9 24.1 27.0* 21.2 25.9 17.9 
Vietnam Conflict 36.1 35.8 35.9 34.8 34.6 36.3 56.1* 44.2 45.0 38.2 
Post-Vietnam Conflict 27.9 27.3 25.2 45.8 50.5 32.5 56.2* 39.1 34.1 37.7 
Gulf War 13.9 13.3 11.9 26.4 19.6 32.0 16.6* 19.2 14.9 27.0 
Number of veterans † 25,095,000 23,763,200 21,289,000 2,206,000 158,500 73,200 36,500 552,900 360,600 778,800 
* Low precision and/or sample size for the denominator between 30 and 59.  
† Estimates of number of veterans are rounded to the nearest hundred; only one sub-category of “Total Two or More Races” is shown because all other 
categories were too small to report; percent estimates sum to greater than 100% because veterans could indicate more than one period of service. 
Note: This table excludes veterans who received a medical discharge from the National Guard or Reserves but never served on active duty.  
Source: Department of Veterans Affairs, 2001.528 
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Table 7. Percent Distribution of United States Veterans by Period of Service and Ethnicity. 
Era of service Total Spanish, Hispanic, or Latino/Latina Not Spanish, Hispanic, or Latino/Latina 
World War II 20.5 10.2 21.0 
Between World War II 
and Korean War 
6.7 3.1 6.9 
Korean War 16.9 10.6 17.2 
Between Korean War 
and Vietnam Conflict 
25.6 17.9 26.0 
Vietnam Conflict 36.1 34.9 36.1 
Post-Vietnam Conflict 27.9 35.9 27.5 
Gulf War 13.9 25.9 13.3 
Number of veterans † 25,095,000 1,111,800 23,899,600 
* Low precision and/or sample size for the denominator between 30 and 59.  
† Estimates of number of veterans are rounded to the nearest hundred; the total estimate is larger than the sum of the groups because some veterans did not 
provide a category of Ethnicity; percent estimates sum to greater than 100% because veterans could indicate more than one period of service. 
Note: This table excludes veterans who received a medical discharge from the National Guard or Reserves but never served on active duty.  
Source: Department of Veterans Affairs, 2001.528 
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Female veterans are more likely than male veterans to be non-white; 17 percent of female 
veterans are non-white compared to 9 percent of male veterans. Approximately 4 percent of 
both male and female veterans identify themselves as Hispanic or Latino/Latina.616 
Compared to veterans of other races, black veterans have historically been more likely to 
serve in the Army and less likely to serve in the Navy than the other branches of the military. 
Conversely, white veterans have been more likely to serve in the Air Force compared to 
black veterans.  
  With regard to the particular association between combat stress and CVD, the 
literature is inconclusive on the effect of race and ethnicity. This area has been studied most 
extensively by NVVRS and its ancillary studies. For example, researchers with the HVVP, a 
congressionally-mandated follow-up study of NVVRS designed to assess current and lifetime 
prevalence of PTSD among male Vietnam veterans, noted significant differences in PTSD 
prevalence by race, whereby Hawaiian veterans of Japanese ancestry reported significantly 
lower prevalence of current full, current partial, and lifetime full PTSD compared to white 
veterans, even after adjustment for age and war zone.617 In the NVVRS study, Kulka and 
colleagues also found that Hispanic veterans exhibited higher risk of developing PTSD 
compared to veterans of other racial and ethnic backgrounds.618, 619 Similarly, NVVRS 
researchers Ortega and colleagues reported similar results, finding that Hispanic Vietnam 
veterans reported significantly more and more severe PTSD symptoms than non-Hispanic 
white veterans, even after adjustment for pre-military and military experiences. However, the 
authors conceded that differences in symptom reporting may reflect differences in expressive 
style rather than true differences in symptomology. Conversely, collaborators for the 
American Indian Vietnam Veterans Project and NVVRS found that adjustment for exposure 
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to war zone stress eliminated previously significant elevations in the prevalence of 1-month 
and lifetime PTSD among American Indian male Vietnam veterans compared to white 
Vietnam veterans.620 Due to findings such as these, race will be assessed as a potential 
covariate.  
 
Individual Susceptibility and Resilience  
Although physiological, psychological and behavioral health factors play a strong 
role in an individual’s susceptibility to both stress and cardiovascular disease, individual 
differences in susceptibility to and resilience in the face of stressors persist. McEwen and 
Stellar have described the additional individual factors as “cascading relationships” that 
begin in early life, between environmental and genetic factors that may or may not 
predispose an individual to susceptibility to both stress and cardiovascular disease.621 
According to Lazarus and Folkman, the way an individual assesses and responds to stress is 
based on not only on the level of the demand but also on the resources the individual has to 
cope with that demand.622,623 Such individual traits favoring resilience include optimism, 
effective behaviors in spite of fear, adaptive social behavior and faith.624,625  As described in 
the previous section, the contribution of individual factors and resilience will be assessed 
within the context of life course theory, which holds that the interaction of social processes 
with physiological health from childhood to adulthood creates cumulative advantage or 
disadvantage throughout life.626  
Individual factors may also affect whether or not an individual perceives an event or 
situation as stressful and, further, may affect how an individual adjusts to or copes with a 
stressor. For example, family instability and childhood antisocial behavior have been found 
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to be associated with the development of post-service PTSD symptoms among Vietnam 
veterans.627 In a study of patients with myocardial infarction (MI) and hospital controls with 
less serious illness, Byrne and colleagues found that although the two groups did not differ in 
the frequency of traumatic life events, individual impact scales of emotional distress were 
significantly higher among those who had suffered and MI.628 Traumatic or stressful life 
events during the postwar period have been found to affect how an individual recovers from 
traumas experienced during military service.629 In a recent study of the effect of factors that 
occur before, during, and after a traumatic event on recovery from PTSD, Schnurr and 
colleagues reported that failure to recover is related predominantly to experiences that 
occurred during or after, rather than before the event.630  
  A combination of familial and cultural factors may also play a role in an individual’s 
susceptibility to psychosocial stress. For example, in a study of the effects on blood pressure 
of being exposed to an arithmetic test, Gerin and colleagues noted that parental history of 
hypertension was more common among those whose blood pressure remained elevated for 
several hours after taking the test.631 However, a recent study of chronic fatigue and CVD in 
World War II veteran twins concluded that, although the association between chronic fatigue 
and CVD remains strong, genetics alone did not appear to play an important role.632 Still, the 
effects of the combination of genetics and environmental factors such has psychosocial stress 
on the development of CAD has gathered much interest over the past decade.633, 634 Such 
gene-environment interactions are thought to work through a process whereby genetic 
variation influences an individual’s disease risk by affecting susceptibility to environmental 
risk factors. Such factors include behavioral factors such as smoking, alcohol use, poor diet, 
and physical inactivity.635, 636 For example, individuals with the apolipoprotein E (APOE) 
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allele epsilon4, which is associated with an increased risk of CVD, experience a smaller 
cardioprotective increase in HDL associated with alcohol compared to those without the 
epsilon4 allele. (Djousse, 2004) Also associated with familial factors as well as behavioral 
and lifestyle choices, an individual’s general physical health can affect how susceptible he or 
she is to the effects of psychosocial stress.637, 638   
  With regard to military combat stressors in particular, some, such as Hendin and 
colleagues hold that pre-military individual personality factors affect the way that individuals 
respond to traumatic events both psychologically and physiologically. This postulate is 
consistent with the finding that not all combat veterans develop PTSD. Further, among those 
who are diagnosed with PTSD, subgroup differences persist. The different ways that veterans 
respond to stressors associated with military combat was highlighted by a 2002 study of 
veterans of the Vietnam conflict and the Gulf War.639 In this study, Glenn and colleagues 
identified subtypes of veterans that, despite similar exposures and common PTSD diagnosis, 
presented very different psychological profiles. While some veterans presented psychological 
profiles marked by distrust, anger, alienation and irregular or unusual thoughts, others had 
profiles dominated by anxiety, agitation, and irregular or unusual thoughts, and still others 
presented symptoms dominated by anxiety, worry and depression or symptoms primarily of 
depression, alienation, irregular or unusual thought processes and a history of odd or unusual 
experiences. A final group displayed symptoms of somatic complaints. When investigated as 
a single group, subgroup differences are obscured, highlighting the importance of individual 
differences in the reaction to a stressor.  
  Despite these differences in response, others maintain that pre-trauma personality 
factors or “predispositions” do not, in fact, modify the association between military combat 
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and later health.640 This position is reinforced by studies of Vietnam veterans that found that 
pre-war personality factors were not predictive of subsequent PTSD scores, even after 
adjustment for military and combat exposures.641, 642 This hypothesis is further supported by 
findings from Elder and colleagues’ study of veterans of World War II that prewar 
psychological factors did not modify the association between overseas combat and rates of 
physical decline or all-cause mortality fifteen years after the conclusion of the war.643 Others, 
however, maintain that individual personality factors or psychological profiles affect 
selection into the military. Research has shown that veterans with a history of difficulty with 
authority, academic problems, conduct disorders, unstable family life, and drug use were 
more likely to be exposed to heavier combat or more abusive combat during military 
service.644,645,646  
 
Age at Entry into the Military and Duration of Service 
  Susceptibility to the adverse effects of military combat is further thought to differ by 
age at entry into the military. Earlier age at entry has been found to be associated with greater 
gains in psychological health from adolescence to midlife, compared to non-veterans.647 In 
contrast, late entrance into the military has been found to be associated with higher negative 
trajectories on physical health compared to earlier entrants.648,649 Because men who are 
mobilized later tend to carry more social obligations, particularly regarding family and work, 
their lives stand to be more disrupted upon entrance into the military compared to younger 
entrants with less experience and social responsibility.650 Age at entry has also been shown to 
be associated with likelihood of developing PTSD, suggesting that the effects of traumatic 
military exposures may be modified by age at mobilization. Further, late entry into the 
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military was found to be positively associated with increased odds of physical decline or 
death in a cohort of World War II veterans.651 Duration of service will be assessed as a 
potential covariate in the association between combat exposure and CVD risk, as it may alter 
the magnitude of the effect of exposure.  
 
Public Health Significance 
As a result of the Gulf War in the early 1990s and now the Iraqi occupation, younger 
cohorts of men and women have and are being exposed to combat related stress. Given the 
pervasiveness of combat exposure in our community, it is important that we explore and 
understand the long-term effects it has on the individuals who experience it. If deleterious 
effects are identified, evidence from studies like the one proposed could be used to help 
influence public health programs designed for veteran and active service populations and 
potentially reduce the burden of chronic disease in these populations in middle and older age.  
From a more scientific perspective, this study of men with a history of distant military 
and combat exposure will contribute to the body of knowledge about the long-term effects of 
traumatic psychosocial stress. If an association is identified, this study could lead the way for 
future research aimed at elucidating the pathways—including biological, psychological, 
behavioral and lifestyle mechanisms—through which stress can place an individual at long-
term risk for CVD. The findings in this study have implications for our understanding of the 
lasting effects of traumatic stress on long-term cardiovascular health.  
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CHAPTER 4  
RESEARCH PLAN 
 
Overview  
In this study, we investigated the effect of military combat on the incidence of CHD 
and IS and the burden of subclinical atherosclerosis in a large, community-based sample of 
men whose military service spanned World War II, the Korean War and the Vietnam 
Conflict. Data were drawn from the cohort component of the ARIC Study, a prospective, 
community-based study that was designed to investigate the etiology and natural history of 
CVD and atherosclerosis. This study has both cohort and surveillance components; the 
current analyses include only members of the cohort study. At baseline (1987-1989), the 
cohort included 15,792 African-American and Caucasian men and women between the ages 
of 45 and 64 years, selected by probability sampling from four US communities: 
Minneapolis, MN; Washington County, MD; Jackson, MS; and Forsyth County, NC. 
Standardized interviews were conducted at baseline to establish health history and to obtain 
demographic, socioeconomic and behavioral risk data.  Using standard protocols, trained and 
certified technicians performed physical exams and subclinical CVD procedures and 
collected fasting blood samples. After baseline, there were three triennial examinations, the 
last of which occurred in 1997-1999. In addition, approximately 94% of cohort survivors are 
successfully contacted and interviewed annually to ascertain vital status, health status and 
hospitalizations. Cardiovascular measurements were taken an average of 36 years after entry 
into military service.  
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For Manuscript 1, coronary artery plaque and carotid intima-media thickness (CIMT) 
were compared between non-veterans and veterans with and without one or more self-
reported combat exposures. Linear regression was used to estimate risk differences (RDs) 
and 95% confidence intervals (CIs) for continuous CIMT, averaged over Visits 1 and 2, 
while modified Poisson regression was used to estimate risk ratios (RRs) and 95% CIs for 
binary CIMT and plaque variables.  Results were stratified according to era of service and 
race. 
For Manuscript 2, risk of coronary heart disease (CHD) and ischemic stroke (IS) were 
compared between non-veterans and veterans with and without one or more self-reported 
combat exposures. Incidence rates and incidence rate ratios were calculated using Poisson 
regression. Results were stratified according to era of service. 
 
The ARIC Study  
The Atherosclerosis Risk in Communities (ARIC) Study is a prospective, 
community-based study that was designed to investigate the etiology and natural history of 
CVD and atherosclerosis. This study has both cohort and surveillance components; the 
current analyses include only members of the cohort study. At baseline (1987-1989), the 
cohort included 15,792 African-American and Caucasian men and women between the ages 
of 45 and 64 years, selected by probability sampling from four US communities: 
Minneapolis, MN; Washington County, MD; Jackson, MS; and Forsyth County, NC. 
Participants from MN and MD were Caucasian, while African-American participants were 
sampled exclusively in MS. The NC center included both African-American and Caucasian 
participants, with African-Americans being over-sampled to assure a larger sample size. 
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Standardized interviews were conducted at baseline to establish health history and to obtain 
demographic, socioeconomic and behavioral risk data. Using standard protocols, trained and 
certified technicians performed physical exams and subclinical CVD procedures and 
collected fasting blood samples. A detailed account of the design and procedures has been 
published,652, 653 and the study protocols and information on quality control and assurance 
can be found on the ARIC website (http://www.cscc.unc.edu/aric). After baseline, there were 
three triennial examinations, the last of which occurred in 1997-1999. In addition, 
approximately 94% of cohort survivors are successfully contacted and interviewed annually 
to ascertain vital status, health status and hospitalizations.  
 
The LC-SES Study 
The Life Course Socioeconomic Status, Social Context and Cardiovascular Disease 
(LC-SES) Study is an ancillary study to ARIC that was initiated in 2001 to examine the 
association between SES across the life course and adult cardiovascular conditions.  
Additional details about its design and procedures are published654 and are available at the 
LC-SES website (http://www.lifecourseepi.info). After an average of fifteen years of follow-
up, the ages of cohort participants ranged from 57 to 79 years. During this interview, 12,716 
or 81% of the baseline ARIC participants (94% of cohort survivors) were interviewed by 
trained and certified interviewers who administered a telephone questionnaire that included 
44 questions about parental and early adulthood occupational and educational exposures, 
place of residence during early childhood and earlier adulthood and military service and 
combat exposures. Mortality prior to participation in LC-SES varied considerably by race 
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and gender (22% for black men; 13% for white men; 13% for black women; 8% for white 
women). 
 
Study Population 
The study populations used for the two manuscripts included in this study were drawn 
from the LC-SES population. Female LC-SES Survey participants were excluded from this 
study, as only 49 reported a history of military service. Also, because their numbers were 
insufficient for analysis, men with a race other than African-American or Caucasian (n=14) 
and African-Americans from Washington County or Minneapolis (n=21) were excluded. 
Further excluded were men who had missing or unknown military service status (n=53), 
leaving a final study population of 5,347 men for the first manuscript. Further excluded for 
the second manuscript were 727 men who served outside the defined periods of conflict for 
World War II (1941-1945), the Korean War (1950-1953) and the Vietnam Conflict (1961-
1975). After these exclusions, the study population for the second manuscript included 4,620 
men. 
 
Outcome Assessment  
Prevalent Subclinical Atherosclerosis  
Two measures of subclinical atherosclerosis were included: carotid intima-media 
thickness (CIMT) and carotid plaque. CIMT is a marker of subclinical atherosclerosis that 
has been validated by pathology655 and that accurately predicts future cardiovascular 
events656,657,,658, 659,660 The presence of carotid plaque by B-mode ultrasound measurement is 
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a significant predictor of advanced atherosclerosis,661 incident CHD662 and cardiovascular 
mortality.663 
At each of the four ARIC visits, using a standardized protocol, B-mode ultrasound 
measurements were taken to measure CIMT and identify carotid plaque. Measurements were 
taken bilaterally at three specific 1-cm segments of the carotid artery located within the 
common carotid, the bifurcation and the internal carotid, for a total of six measurements.  
Readers measured the CIMT within these regions, reported whether they observed a plaque 
and reported whether acoustic shadowing was present. Plaques were defined as the presence 
of abnormalities in the arterial wall thickness, shape (protrusion into the lumen, rough or 
misaligned boundary with adjacent arterial wall) or texture (brighter echoes than adjacent 
wall boundaries).662 Acoustic shadowing was defined as a dampened amplitude of echoes in 
the ultrasound. Images were video recorded at each study center, and tapes were read at a 
central ultrasound reading center. Further information about ultrasound scanning and reading 
have been published 664,665,655 A participant was categorized as having plaque if plaque with 
or without acoustic shadowing was found at one or more of the six sites at Visit 1 or Visit 2 
versus no plaque at either visit. 
For the purposes of the analyses presented here, CIMT was defined as the average far 
wall thickness across the six carotid sites. Adjustment for carotid site-specific reader 
differences and measurement drift across visits and imputation for missing sites was 
implemented using maximum likelihood techniques for linear mixed models.666  Data from 
the six individual carotid sites were missing at random conditional on age, race, body mass 
and arterial depth. Methods used for the imputation of missing values use sex and race 
specific linear models developed for the ARIC Study and are published 667 Average values 
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from the mean CIMT measurements from Visits 1 and 2 were used in the following analyses 
in order to ensure consistent scanning technology and comparability with carotid plaque 
assessment. CIMT was assessed in two ways. First, it was assessed as a continuous measure. 
Second, it was assessed as a binary measure (≥1 mm versus < 1 mm), as this commonly-used 
cutpoint has been demonstrated reliable. 664   
 
Incident Coronary Heart Disease and Ischemic Stroke  
Detailed descriptions of the methods of ascertainment of incident CHD and IS events 
have been provided in previous work.668,669 Briefly, CHD and IS incidence were ascertained 
by annual follow-up interview and validated by review of hospital discharge records and 
death certificates.670,671,672 Out-of-hospital deaths were ascertained through death certificates 
and, when available, coroner or autopsy reports. In the majority of out-of-hospital deaths, 
cause of death was further validated by an interview with one or more next of kin as well as 
by a questionnaire completed by the patient’s treating physician. Incident events were 
included from enrollment in ARIC until December 31, 2002. 
An incident CHD event was defined as: (a.) a validated definite or probable 
hospitalized myocardial infarction (based on a combination of chest pain symptoms, ECG 
changes, and cardiac enzyme levels); (b.) a definite CHD death (based on chest pain 
symptoms, underlying cause of death from death certificate, and other information from the 
hospital chart, medical history or ARIC visit); (c.) an unrecognized MI identified by ECG 
readings at one or more of the ARIC examinations (based on ECG readings with a major Q-
wave or a minor Q-wave with ischemic ST-T changes, or an MI by computerized NOVA-
  97 
CODE criteria confirmed by a side-by-side visual comparison of baseline and follow-up 
ECGs); or (d.) a recorded coronary revascularization procedure.  
An incident IS event was defined as a validated definite or probable hospitalized 
embolic or thrombotic stroke, classified according to symptom type, duration and severity as 
well as results of neuroimaging and other diagnostic procedures and autopsy evidence, when 
available.673,674 
 
Exposure Assessment  
Military service is based on self-report from the LC-SES follow-up interview. 
Participants who reported that they had served in the military were asked a series of 
questions detailing military experience, including: (1) age at entry into the service, (2) length 
of service, and whether they (4) served in a combat zone, (5) were ever under fire or fired at 
the enemy, (6) saw others wounded or killed or (7) were ever wounded or missing in 
action.675 A copy of the LC-SES questionnaire, which contains the military service-related 
questions (items 37-44), can be found in Appendix B of this proposal. While history of 
military service was directly queried, exposure to combat was established based on a positive 
response to one or more of questions 4-7 above. In this way, a three-level exposure variable 
was derived: no history of military service (non-veterans), history of military service without 
exposure to combat stress (non-combat veterans) and history of military service with 
exposure to combat stress (combat veterans). Throughout these analyses, combat veterans 
and non-combat veterans are treated as two levels of exposure and are compared separately 
to non-veteran “controls.”  
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Although it would be ideal to ascertain combat exposure concurrent with military 
service rather than relying on recall, to our knowledge, no cohorts exist that collected combat 
exposure during military service and which include long-term follow-up with a rigorous 
measurement of CVD outcomes. Use of recalled measures of combat stress has 
precedent676,677,678 and has high validity and reliability.679 Dr. Glen Elder, a renowned expert 
on the physiological health effects of military service and combat exposures over the life 
course,680,681,682,683 developed the combat exposures questionnaire used in this study.  
 
Assessment of Covariates 
Era of Service  
Era of military service was determined using information provided during the LC-
SES interview on age at entry into the military and duration of service. Those exposed to 
combat served during the World War II (1941-1945), Korean (1950-1953) and Vietnam 
(1961-1975) eras. Men who served during multiple conflict eras (e.g., both World War II and 
the Korean War or both the Korean War and the Vietnam Conflict) were categorized 
according to their first era of service, as this was their initial military experience. Men who 
served between periods of defined conflict were not included in a separate category, as they 
were deemed too heterogeneous to provide results from which meaningful conclusions could 
be drawn. 
For the second manuscript, veterans who served between periods of defined conflict 
were excluded from analysis. Non-veterans were placed into era of service categories 
according to the chronological age category into which they fell at Visit 1 (<52, 52-59 and 
60+ years). These age categories matched up closely with era of service categories in this 
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study population, with 94% of World War II era veterans ages 60 years and greater, 89% of 
Korean War era veterans ages 52-59 years and 91% of Vietnam era veterans under the age of 
52 years. 
Assessed in both manuscripts were age at induction into service and duration of 
service in the military, both explicitly queried in the LC-SES interview and both measured in 
years. Although there is inadequate statistical power to formally address hypotheses about 
modification by age at entry and duration of service on the association between combat 
exposure and CVD risk, differences in the distribution of these variables by exposure status 
were explored in descriptive analysis. 
 
Sociodemographics  
 Sociodemographic profiles were prepared and compared descriptively for men in the 
three exposure categories. Sociodemographic information was collected by standardized 
interviews at the baseline ARIC visit. Variables included in this study were mean age at 
baseline ARIC visit, race (black versus white), education (less than high school versus high 
school or greater), combined family income (less than $25,000 versus $25,000 or greater) 
and occupation (managerial/professional versus other occupations) Also included was 
father’s education as a measure of childhood socioeconomic status (less than high school 
versus high school or greater).  
 
Cardiovascular Risk Factors  
Differences in the age-adjusted distribution of established biological and behavioral 
cardiovascular risk factors measured at the baseline assessment (Visit 1; 1987-1989) among 
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each of the three exposure groups were examined individually. Behavioral risk factors 
include current smoking status, self-reported pack years of cigarette smoking, alcohol intake 
(average number of drinks per week) and physical activity (sports activity index ranging 
from 1 to 5). Current cigarette smoking is defined as self-report of smoking one or more 
cigarettes per year at baseline (vs. former or never smoker). Pack years were categorized into 
four levels: heavy (660+), moderate (266-659), light (1-265) or none (0). The sports activity 
index was further collapsed into three levels of physical activity: inactive (1-1.9), moderate 
(2-2.9) or active (3-5). 
Additional risk factors include overall and central obesity, measured by body mass 
index (BMI, kg/m2) and waist circumference (cm), respectively, as well as self-reported 
health status, which was assessed on a 4-point scale ranging from poor to excellent. In 
addition, low density lipoprotein (LDL) cholesterol (mg/dL), high density lipoprotein 
cholesterol (HDL), as well as total cholesterol, triglycerides and systolic blood pressure 
(SBP, mmHg) were included. Prevalent left ventricular hypertrophy (LVH), prevalent 
diabetes mellitus, prevalent CHD, and blood pressure medication use were further assessed 
as covariates. For systolic blood pressure, three seated blood pressure measurements were 
taken with a random-zero sphygmomanometer, and the last two measurements were 
averaged. Plasma total cholesterol (mg/dL) and triglycerides were measured using an 
established enzymatic method,684 and high density lipoprotein (HDL) cholesterol (mg/dL) 
was measured after dextran-magnesium precipitation of non-high density lipoproteins.685 The 
presence of hypertension was defined as having a SBP of 140 mmHg or higher or a diastolic 
BP of 90 mmHg or higher or the self-reported use of hypertension-lowering medications in 
the last two weeks. Self-reported use of cholesterol-reducing medications in the past two 
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weeks was also assessed. Diabetes was defined as having a fasting glucose level of 126 
mg/dL or higher, a non-fasting glucose level of 200 mg/dL or higher, or a self-reported 
diagnosis of diabetes or use of diabetic medication. Prevalent left ventricular hypertrophy 
was defined according to the Cornell definition. Coronary heart disease was defined as 
history of a myocardial infarction (MI), presence of an MI from adjudicated Visit 1 
electrocardiographic (ECG) data, or history of heart or arterial surgery, coronary bypass 
surgery, balloon angioplasty or angioplasty of one or more coronary arteries. More details on 
the procedures used to obtain the risk factor data as well as the quality assurance procedures 
are published686,687 and are detailed at http://www.cscc.unc.edu/aric. 
An overall measure of predicted risk, composite CHD and IS risk scores optimized 
for race-gender groups within the ARIC population were also calculated using the ARIC risk 
equations for the second manuscript. Methods for calculating these risk scores and the 
parameter estimates used have been published.688,689 The use of risk prediction equations has 
become increasingly common in both research and clinical applications.690,691,692 Predicted 
CHD risk scores for men are stratified by race and incorporate baseline values for age in 
years, total and HDL cholesterol, SBP, prevalent diabetes, current smoking status and blood 
pressure medication use. Predicted IS risk scores incorporate age, race, current smoking 
status, SBP, prevalent diabetes, blood pressure medication use, LVH and prevalent CHD. 
 
Statistical Analysis  
SAS statistical software Version 8.02 was used for all analyses.693 Descriptive 
statistics were calculated for baseline distributions of sociodemographic characteristics and 
military and combat exposures. Statistical evaluation of differences in risk factor 
  102 
distributions compared combat veterans and non-combat veterans separately with non-
combat “controls” and also contrasted the two veteran groups: combat veterans with non-
combat veterans. 
 
Analysis of Prevalent Carotid Intima Media Thickness and Plaque  
 Linear regression was used to estimate risk differences (RDs) and 95% confidence 
intervals (CIs) for continuous CIMT, averaged over Visits 1 and 2. Although the distribution 
of CIMT is right-skewed, a log transformation did not change the back-transformed RD more 
than 4%. Ordinary least squares regression has been shown to be robust to non-normality of 
the outcome variable distribution in large samples, and all subgroups in the current analysis 
are sufficiently large that there would be little benefit to transforming the outcome variable. 
694
 Modified Poisson regression using PROC GENMOD was used to estimate risk ratios 
(RRs) and 95% CIs for binary CIMT and plaque variables.695,696  
 
Analysis of Incident Coronary Heart Disease and Ischemic Stroke  
Incidence rates (IR) were calculated by dividing the number of events by the total 
time experienced for the participants followed. Incidence rate ratios (IRR) and 95% 
confidence intervals (CI) were calculated using Poisson regression697 using PROC 
GENMOD with the log link and Poisson distribution options. In this way, CHD and stroke 
event rates were modeled on a logarithmic scale as a function of military and combat 
exposure status, and residuals followed a Poisson distribution. Combat veterans and non-
combat veterans were compared separately with non-combat “controls,” and the two veteran 
groups—combat veterans and non-combat veterans—were also compared with one another. 
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Assessment of the Role of Age 
 Because age is not associated with the exposure in these data, it could not be treated 
as a typical confounder in statistical analyses. However, because it is strongly associated with 
the outcomes, age at identification of the outcome was accounted for in the following ways. 
For the first manuscript, continuous CIMT was modeled linearly against age, and these 
residuals were used in linear regression to estimate RDs and 95% CIs for deviation from the 
average age-adjusted CIMT. Lack-of-fit tests using PROC RSREG could not be rejected, 
suggesting the data are appropriately fit by the linear model. For binary CIMT, age-specific 
cutpoints at the 85th percentile of CIMT at Visits 1, 2 or both were calculated and modeled 
against the exposure using modified Poisson regression to estimate RRs and 95% CIs. For 
plaque, the expected probability of having plaque at Visit 1 was calculated from a logistic 
regression equation modeling plaque against age at Visit 1 and was subtracted from the 
observed value (0 or 1) to obtain a value that measured the excess percentage of plaque for 
age at Visit 1. These values were then modeled against the exposure in linear regression to 
estimate RDs and 95% CIs. 
 For the second manuscript, results were stratified according to era of service (World 
War II, the Korean War or the Vietnam Conflict), which had the secondary effect of 
stratifying by age. Non-veterans were grouped into three age categories (<52, 52-59, 60+ 
years) that most closely mirrored the age categories of veterans who served during the eras of 
World War II, the Korean War and the Vietnam Conflict, respectively.   
 
Assessment of Modification by Era of Service 
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Stratified results for era of service (World War II, the Korean War or the Vietnam 
Conflict) were presented in both manuscripts to assess potentially important heterogeneity in 
effects. Interaction by era was assessed using Wald chi-square tests for homogeneity of the 
effect measures using an a priori rejection level of 0.05. Due to generally low power to 
detect statistical interactions, a relatively stringent Type I error level such as p<0.05 yields a 
screen for interactions that is more specific and less sensitive. Therefore, interaction by race 
and era of service on the risk ratio and risk difference scales could not be confidently ruled 
out if p>0.05, due to elevated Type II error levels.698 
 
Assessment of Modification by Race  
Interaction by race (black or white) was also assessed using Wald chi-square tests for 
homogeneity of the RRs and RDs in the first manuscript using an a priori rejection level of 
0.05. Although stratification by race was not conducted in the second manuscript, descriptive 
military, combat and sociodemographic profiles were presented in order to highlight 
differences by race among the three eras of service investigated. 
 
Sample Size and Statistical Power  
PS Software Version 2.1.31, available through Vanderbilt University, was used to 
calculate power for the proposed study.699  To simplify presentation, we examples below are 
limited to a comparison of the combat veteran to the non-combat veteran groups. However, 
equivalent power is expected for the contrasts of the combat veterans to the non-veterans, as 
roughly the same number of persons is in each of the comparison groups. Also provided are 
figures stratified by era of service.  
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For continuous outcomes we present information on the mean detectable differences 
(MDD), calculated with a t-test (α=0.05 and β=0.20). (Table 8) Overall, power (1- β) is 
adequate to detect small differences in levels of predicted risk scores and risk factors. When 
stratified by era, the minimum detectable differences, though larger, are still modest. 
 
Table 8. Minimal Detectable Differences (MDD) for Continuous Study Outcomes:  
Contrasting Combat Veteran to Non-combat Veteran Groups.1 
 Predicted IS  
Risk Score1 (0-1) 
Predicted CHD  
Risk Score1 (0-1) 
CIMT (mm) 
Mean (SD)2 0.03  (0.02) 0.11  (0.10) 0.79 (0.20) 
Total 3 0.01 0.01 0.02 
By Era of Service    
World War II  0.02 0.01 0.04 
Korean War  0.01 0.01 0.03 
Vietnam Conflict  0.02 0.01 0.04 
1
 MDD are rounded up to the next largest unit at which the attributes would typically be expressed. 
2 Standard deviations (SD) used in calculations were obtained from data available for men in the ARIC cohort.  
3 The ratio of unexposed to exposed used in the calculation of MDD is as follows: 1.8 total, 0.7 World War II, 
1.5 Korean War, 2.1 Vietnam Conflict.   
 
 
Table 9 below presents power calculations for a range of possible relative risks (RR) 
for binary outcomes. Calculations are based on chi-square and assume a Type I error 
probability for a two-sided test (α) of 0.05. For CHD, overall and within era subgroups, 
power is 0.80 or higher to detect a RR as small as 1.5 for the total population and white men 
and 1.8 for the World War II and Korean War eras; however, power is insufficient to test 
hypotheses among black men and men from the Vietnam Conflict era. Due to the low 
prevalence of IS, power is less than 0.80 to detect a RR of 1.8 or lower overall and within era 
and race subgroups. Power is adequate (>0.80) to detect differences as small as RR=1.3 for 
the outcome of carotid plaque both for the total population and within era and race subgroups 
but inadequate to detect differences even as large as RR=1.8 for the outcome of CIMT > 
1mm, even in the total population.  
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Table 9. Power Calculations for Detecting Differences of Effect Overall and by Era of Service and Race (Binary Outcomes). 
Power (1-β) 
 
Probability of 
Outcome1 
NCV vs. NV 2 
 
CV vs. NV 
 
CV vs. NCV 
 
Power to detect RR=… Power to detect RR=… Power to detect RR=… 
Outcome 1 
NV NCV CV 
n 
cases 
Ratio of 
controls 
to cases 1.3 1.5 1.8 
n  
cases 
Ratio of 
controls 
to cases 1.3 1.5 1.8 
n  
cases 
Ratio of 
controls 
to cases 1.3 1.5 1.8 
CHD                    
Total  0.2 0.18 0.2 601 0.96 0.70 0.98 >0.99 542 1.73 0.76 0.97 >0.99 483 1.81 0.67 0.97 >0.99 
    WWII3 0.28 0.23 0.21 132 NA NA NA NA 162 NA NA NA NA 174 0.66 0.25 0.55 0.91 
    Korea  0.18 0.2 0.22 258 NA NA NA NA 211 NA NA NA NA 223 1.66 0.40 0.79 0.99 
    Vietnam 0.13 0.13 0.11 211 NA NA NA NA 169 NA NA NA NA 86 2.56 0.15 0.31 0.60 
    Black 0.10 0.09 0.10 88 2.31 0.13 0.25 0.48 79 4.15 0.14 0.27 0.51 41 1.79 0.08 0.13 0.23 
    White 0.15 0.16 0.16 494 0.76 0.41 0.8 0.99 370 1.37 0.42 0.81 0.99 450 1.81 0.57 0.93 >0.99 
IS                     
Total  0.04 0.04 0.05 123 0.96 0.07 0.11 0.19 143 1.73 0.94 0.16 0.29 124 1.81 0.09 0.15 0.27 
    WWII  0.05 0.06 0.05 30 NA NA NA NA 35 NA NA NA NA 43 0.66 0.05 0.07 0.09 
    Korea  0.04 0.03 0.06 51 NA NA NA NA 53 NA NA NA NA 46 1.66 0.07 0.08 0.12 
    Vietnam 0.03 0.02 0.01 42 NA NA NA NA 55 NA NA NA NA 35 2.56 0.07 0.09 0.12 
    Black 0.07 0.04 0.08 58 2.31 0.09 0.15 0.27 59 4.15 0.11 0.18 0.32 23 1.79 0.06 0.08 0.11 
    White 0.02 0.03 0.04 77 0.76 0.05 0.06 0.08 65 1.37 0.10 0.08 0.06 94 1.81 0.08 0.11 0.18 
Plaque                     
Total  0.45 0.49 0.54 1828 0.96 >0.99 >0.99 >0.99 1453 1.73 >0.99 >0.99 >0.99 1565 1.81 >0.99 >0.99 >0.99 
    WWII  NA 0.58 0.63 N/A NA NA NA NA N/A NA NA NA NA 450 0.66 >0.99 >0.99 >0.99 
    Korea  NA 0.53 0.56 N/A NA NA NA NA N/A NA NA NA NA 552 1.66 >0.99 >0.99 >0.99 
    Vietnam NA 0.37 0.33 N/A NA NA NA NA N/A NA NA NA NA 238 2.56 0.84 >0.99 >0.99 
    Black 0.39 0.39 0.40 359 2.31 0.96 >0.99 >0.99 312 4.15 0.96 >0.99 >0.99 171 1.79 0.70 0.99 >0.99 
    White 0.43 0.47 0.52 1469 0.76 >0.99 >0.99 >0.99 1141 1.37 >0.99 >0.99 >0.99 1394 1.81 >0.99 >0.99 >0.99 
CIMT>1mm                     
Total  0.06 0.07 0.12 264 0.96 0.13 0.26 0.51 266 1.73 0.16 0.34 0.64 286 1.81 0.20 0.41 0.74 
    WWII NA 0.15 0.17 N/A NA NA NA NA N/A NA NA NA NA 128 0.66 0.13 0.26 0.54 
    Korea  NA 0.08 0.12 N/A NA NA NA NA N/A NA NA NA NA 103 1.66 0.11 0.20 0.40 
    Vietnam NA 0.02 0.02 N/A NA NA NA NA N/A NA NA NA NA 15 2.56 0.07 0.08 0.10 
    Black 0.05 0.05 0.09 44 2.31 0.08 0.11 0.18 44 4.15 0.09 0.13 0.22 28 1.79 0.07 0.09 0.13 
    White 0.07 0.07 0.13 220 0.76 0.11 0.22 0.44 222 1.37 0.15 0.30 0.58 258 1.81 0.18 0.38 0.70 
1 Based on prevalence rates among men in the LC-SES cohort; CHD = Coronary heart disease; IS = Ischemic stroke; Plaque = Carotid plaque; CIMT>1mm = 
Intima Media Thickness of Carotid Artery > 1 millimeter 
2 NV = Non-veteran; NCV = Non-combat veteran; CV = Combat veteran 
3 WWII = World War II 
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CHAPTER 5  
RESULTS 
 
Manuscript 1: Military Combat and Burden of Subclinical Atherosclerosis in Middle 
Aged Men: the Atherosclerosis Risk in Communities (ARIC) Study 
 
Abstract 
Studies of the long-term cardiovascular consequences of combat stress are few and 
inconclusive.  The association between remote exposure to combat and subclinical 
atherosclerosis was assessed among 5,347 men in the Atherosclerosis Risk in Communities 
study. Coronary artery plaque and carotid intima-media thickness (CIMT) were compared 
between non-veterans and veterans with and without one or more self-reported combat 
exposures. Cardiovascular measurements were taken an average of 36 years after entry into 
military service. Combat veterans (n=1178) and non-combat veterans (n=2127) tended to be 
older, white and of higher socioeconomic status than non-veterans (n=2042). Veterans were 
more likely to be current drinkers and heavy smokers but less likely to be current smokers 
and physically inactive. Combat veterans had the highest average blood pressure and total 
cholesterol and were most likely to have coronary disease. Compared to non-veterans, 
combat veterans (Risk Ratio (RR): 1.19; 95% Confidence Interval (95% CI): 1.11, 1.28) and 
non-combat veterans (RR: 1.08; 95% CI: 1.01, 1.15) had a higher risk of carotid plaque, and 
both combat veterans (Risk Difference (RD): 57.2µm; 95% CI: 45.1, 69.2) and non-combat 
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veterans (RD: 12.48µm; 95% CI: 2.64, 22.32) had higher average CIMT. Compared to non-
combat veterans, combat veterans had a higher risk of carotid plaque (RR: 1.11; 95% CI: 
1.03, 1.19) and higher average CIMT (RD: 44.68µm; 95% CI: 32.47, 56.89). Differences 
remained when CIMT was dichotomized and when age was taken into account. Combat 
exposure may exert long-term adverse effects on the burden of subclinical atherosclerosis. 
 
Introduction 
 Stress is widely considered to have both psychological and physiological effects and 
is thought to influence the development of cardiovascular disease (CVD).1,2,3 A primary 
mechanism through which stress may increase the risk of CVD is through an inflammatory or 
atherosclerotic process, involving behavioral, neurological, endocrine, and immunological 
components.4,5 Stress experienced by veterans who have engaged in active combat includes 
both psychological and physical components.112 
The epidemiologic evidence supports a possible effect on increased cardiovascular 
risk from exposure to military combat, although the data are limited.17 Exposure to combat 
has been associated with higher rates of behavioral problems, 20,112 psychological 
disorders,21,22 and self-reported health conditions 23,24 Many studies have investigated the 
effects of military combat—typically depression or post-traumatic stress disorder (PTSD)—
rather than exposure to combat itself. Further, most studies have focused on psychological 
and short-term health outcomes rather than long-term physiological outcomes. To date, no 
studies have directly assessed the association between exposure to combat and the prevalence 
of subclinical atherosclerosis.  In this study, we take advantage of a unique opportunity to 
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investigate this association in a large, community-based sample of men whose military 
service spanned World War II, the Korean War and the Vietnam Conflict. 
 
 
Methods 
The Atherosclerosis Risk in Communities (ARIC) Study is a prospective, 
community-based study that was designed to investigate the etiology and natural history of 
CVD and atherosclerosis. This study has both cohort and surveillance components; the 
current analyses include only members of the cohort study. At baseline (1987-1989), the 
cohort included 15,792 African-American and Caucasian men and women between the ages 
of 45 and 64 years, selected by probability sampling from four US communities: 
Minneapolis, MN; Washington County, MD; Jackson, MS; and Forsyth County, NC. 
Participants from MN and MD were Caucasian, while African-American participants were 
sampled exclusively in MS. The NC center included both African-American and Caucasian 
participants, with African-Americans being over-sampled to assure a larger sample size. 
Standardized interviews were conducted at baseline to establish health history and to obtain 
demographic, socioeconomic and behavioral risk data. Using standard protocols, trained and 
certified technicians performed physical exams and subclinical CVD procedures and 
collected fasting blood samples. A detailed account of the design and procedures has been 
published,652,653 and the study protocols and information on quality control and assurance can 
be found on the ARIC website (http://www.cscc.unc.edu/aric). After baseline, there were 
three triennial examinations, the last of which occurred in 1997-1999. In addition, 
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approximately 94% of cohort survivors are successfully contacted and interviewed annually 
to ascertain vital status, health status and hospitalizations.  
The Life Course Socioeconomic Status, Social Context and Cardiovascular Disease 
(LC-SES) Study is an ancillary study to ARIC that was initiated in 2001 to examine the 
association between SES across the life course and adult cardiovascular conditions. 
Additional details about its design and procedures are published654 and are also available at 
the LC-SES website (http://www.lifecourseepi.info). After an average of fifteen years of 
follow-up, the ages of cohort participants ranged from 57 to 79 years. During this interview, 
12,716 or 81% of the baseline ARIC participants (91% of cohort survivors) were queried 
about socioeconomic conditions at various life stages, military service and combat exposures.  
Female LC-SES Survey participants were excluded from this study, as only 49 
reported a history of military service. Also, because their numbers were insufficient for 
analysis, men with a race other than African-American or Caucasian (n=14) and African-
Americans from Washington County or Minneapolis (n=21) were excluded. Further excluded 
were men who had missing or unknown military service status (n=53), leaving a final study 
population of 5,347 men.  
Military service is based on self-report from the LC-SES follow-up interview. 
Participants who reported that they had served in the military were asked a series of 
questions detailing military experience, including: (1) age at entry into the service, (2) length 
of service, and whether they (4) served in a combat zone, (5) were ever under fire or fired at 
the enemy, (6) saw others wounded or killed or (7) were ever wounded or missing in 
action.675 Era of military service was determined using information provided on age at entry 
into the military and duration of service. Those exposed to combat served during the World 
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War II (1941-1945), Korean (1950-1953) and Vietnam (1961-1975) eras. Although it is 
possible that some veterans had their first exposure to combat in an era later than the first, 
men who served during multiple conflict eras (e.g., both World War II and the Korean War 
or both the Korean War and the Vietnam Conflict) were categorized according to their first 
era of service, as this was their initial—and possibly defining—military experience. Using 
this method to categorize veterans has precedents in the literature.22 
A three-level exposure variable was derived: no history of military service (non-
veterans), history of military service without exposure to combat stress (non-combat 
veterans) and history of military service with exposure to combat stress (combat veterans). 
While history of military service was directly queried, exposure to combat was established 
based on a positive response to one or more of questions 4-7 above. Throughout these 
analyses, combat veterans and non-combat veterans are treated as two levels of exposure and 
are compared separately to non-veteran “controls.”  
Two measures of subclinical atherosclerosis were included: carotid intima-media 
thickness (CIMT) and carotid plaque. CIMT is a marker of subclinical atherosclerosis that 
has been validated by pathology655 and that accurately predicts future cardiovascular 
events656,657,658,659,660  The presence of carotid plaque by B-mode ultrasound measurement is a 
significant predictor of advanced atherosclerosis,661 incident CHD662 and cardiovascular 
mortality.663  
At each of the four ARIC visits, using a standardized protocol, B-mode ultrasound 
measurements were taken to measure CIMT and identify carotid plaque. Measurements were 
taken bilaterally at three specific 1-cm segments of the carotid artery located within the 
common carotid, the bifurcation and the internal carotid, for a total of six measurements.  
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Readers measured the CIMT within these regions, reported whether they observed a plaque 
and reported whether acoustic shadowing was present. Plaques were defined as the presence 
of abnormalities in the arterial wall thickness, shape (protrusion into the lumen, rough or 
misaligned boundary with adjacent arterial wall) or texture (brighter echoes than adjacent 
wall boundaries).660  Acoustic shadowing was defined as a dampened amplitude of echoes in 
the ultrasound. Images were video recorded at each study center, and tapes were read at a 
central ultrasound reading center. Further information about ultrasound scanning and reading 
have been published654,664,665 A participant was categorized as having plaque if plaque with 
or without acoustic shadowing was found at one or more of the six sites at Visit 1 or Visit 2 
versus no plaque at either visit. 
For the purposes of the analyses presented here, CIMT was defined as the average far 
wall thickness across the six carotid sites. Adjustment for carotid site-specific reader 
differences and measurement drift across visits and imputation for missing sites was 
implemented using maximum likelihood techniques for linear mixed models.666 Data from 
the six individual carotid sites were missing at random conditional on age, race, body mass 
and arterial depth. Methods used for the imputation of missing values use sex and race 
specific linear models developed for the ARIC Study and are published.667 Average values 
from the mean CIMT measurements from Visits 1 and 2 were used in the following analyses 
in order to ensure consistent scanning technology and comparability with carotid plaque 
assessment. CIMT was assessed in two ways. First, it was assessed as a continuous measure. 
Second, it was assessed as a binary measure (≥1 mm versus < 1 mm), as this commonly-used 
cutpoint has been demonstrated reliable.662   
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Differences in the age-adjusted distribution of established biological and behavioral 
cardiovascular risk factors measured at the baseline assessment (Visit 1; 1987-1989) among 
each of the three exposure groups were examined individually. Behavioral risk factors 
include self-reported pack years of cigarette smoking, alcohol intake (average number of 
drinks per week) and physical activity (sports activity index ranging from 1 to 5). Pack years 
were categorized into four levels: heavy (660+), moderate (266-659), light (1-265) or none 
(0). The sports activity index was further collapsed into three levels of physical activity: 
inactive (1-1.9), moderate (2-2.9) or active (3-5). 
Additional risk factors include overall and central obesity, measured by body mass 
index (BMI, kg/m2) and waist circumference (cm), respectively, as well as self-reported 
health status, which was assessed on a 4-point scale ranging from poor to excellent. In 
addition, low density lipoprotein (LDL) cholesterol (mg/dL), as well as triglycerides and 
systolic blood pressure (SBP, mmHg) were included. Three seated blood pressure 
measurements were taken with a random-zero sphygmomanometer, and the last two 
measurements were averaged. Plasma total cholesterol (mg/dL) was measured using an 
established enzymatic method,684 and high density lipoprotein (HDL) cholesterol (mg/dL) 
was measured after dextran-magnesium precipitation of non-high density lipoproteins.685 The 
presence of hypertension was defined as having a SBP of 140 mmHg or higher or a diastolic 
BP of 90 mmHg or higher or the self-reported use of hypertension-lowering medications in 
the last two weeks. Self-reported use of cholesterol-reducing medications in the past two 
weeks was also assessed. Diabetes was defined as having a fasting glucose level of 126 
mg/dL or higher, a non-fasting glucose level of 200 mg/dL or higher, or a self-reported 
diagnosis of diabetes or use of diabetic medication. Coronary heart disease was defined as 
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history of a myocardial infarction (MI), presence of an MI from adjudicated Visit 1 
electrocardiographic (ECG) data, or history of heart or arterial surgery, coronary bypass 
surgery, balloon angioplasty or angioplasty of one or more coronary arteries. More details on 
the procedures used to obtain the risk factor data as well as the quality assurance procedures 
are published.652,653 
 SAS statistical software Version 8.02 was used for all analyses.693 Descriptive 
statistics were calculated for baseline distributions of sociodemographic characteristics and 
military and combat exposures. Statistical evaluation of differences in risk factor 
distributions compared combat veterans and non-combat veterans separately with non-
veteran “controls” and also contrasted the two veteran groups: combat veterans with non-
combat veterans. Linear regression was used to estimate risk differences (RDs) and 95% 
confidence intervals (CIs) for continuous CIMT, averaged over Visits 1 and 2. Although the 
distribution of CIMT is right-skewed, a log  
transformation did not change the back-transformed RD more than 4%. Ordinary least 
squares regression has been shown to be robust to non-normality of the outcome variable 
distribution in large samples, and all subgroups in the current analysis are sufficiently large 
that there would be little benefit to transforming the outcome variable.694 Modified Poisson 
regression using PROC GENMOD was used to estimate risk ratios (RRs) and 95% CIs for 
binary CIMT and plaque variables.695,696 
 Because age is not associated with the exposure in these data, it could not be treated 
as a typical confounder in statistical analyses. However, because it is strongly associated with 
the outcomes, age at identification of the outcome was accounted for in the following ways. 
Continuous CIMT was modeled linearly against age, and these residuals were used in linear 
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regression to estimate RDs and 95% CIs for deviation from the average age-adjusted CIMT. 
Lack-of-fit tests using PROC RSREG could not be rejected, suggesting the data are 
appropriately fit by the linear model. For binary CIMT, age-specific cutpoints at the 85th 
percentile of CIMT at Visits 1, 2 or both were calculated and modeled against the exposure 
using modified Poisson regression to estimate RRs and 95% CIs. For plaque, the expected 
probability of having plaque at Visit 1 was calculated from a logistic regression equation 
modeling plaque against age at Visit 1 and was subtracted from the observed value (0 or 1) to 
obtain a value that measured the excess percentage of plaque for age at Visit 1. These values 
were then modeled against the exposure in linear regression to estimate RDs and 95% CIs.  
Stratified results for era of service (World War II, the Korean War or the Vietnam 
Conflict) and race (black or white) are presented to assess potentially important heterogeneity 
in effects. Interaction by era and race was assessed using Wald chi-square tests for 
homogeneity of the risk ratios and risk differences using an a priori rejection level of 0.05. 
Due to generally low power to detect statistical interactions, a relatively stringent Type I 
error level such as p<0.05 yields a screen for interactions that is more specific and less 
sensitive. Therefore, interaction by race and era of service on the risk ratio and risk 
difference scales cannot be confidently ruled out if p>0.05, due to elevated Type II error 
levels.698 
 
Results 
 Of the 5,347 men included, 38% reported no military service, 40% reported military 
service but no combat exposures and 22% reported both military service and exposure to one 
or more combat experiences. (Table 10) Of those who served in the military, 24% served 
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during the era of World War II, 33% served during the era of the Korean War, 21% served 
during the era of the Vietnam Conflict and 22% served between periods of defined conflict. 
Likelihood of reporting exposure to combat was greatest among World War II era combat 
veterans (41%) and least among those serving during the Vietnam Conflict (17%). Non-
combat veterans were most likely to serve during the Korean War (32%) and least likely to 
serve during World War II (15%).  
 Mean age at induction into military service (19-20 years) differed little between 
combat and non-combat veterans, although induction ages increased slightly in later conflicts 
(Table 10). The average time elapsed between the time of induction into the service (i.e., the 
earliest time of exposure) and the date of ARIC Visit 1 (i.e., the time that the first outcomes 
were measured) differed somewhat between combat and non-combat veterans, with combat 
veterans having a slightly longer time since entry (mean of 38.2 versus 34.3 years), reflecting 
a population that served disproportionately in earlier conflicts. Combat veterans also tended 
to serve for longer periods of time compared to non-combat veterans (mean of 4.9 versus 3.1 
years), and Vietnam era veterans tended to serve in the military for longer periods than other 
veterans. All four queried combat exposures were most commonly reported by World War II 
era veterans and least commonly reported by Vietnam era veterans. Service in a formally 
designated combat zone was the most commonly reported combat exposure (83%), and 
having ever been wounded or missing during the war was the least reported combat exposure 
(13%).  
 Veterans tended to be older, Caucasian and of higher SES compared to non-veterans 
(Table 11). Combat veterans tended to be slightly older than non-combat veterans or non-
veterans, and both combat and non-combat veterans were less likely to be African-American 
  117 
than non-veterans. Non-combat veterans were least likely to have less than a high school 
education than combat veterans or non-veterans, although there was little difference among 
the three groups in the proportion that reported having a father who had less than a high 
school education. Non-combat veterans were also least likely to have a combined family 
income below $25,000 or to work in a non-managerial or non-professional occupation.  
 Combat and non-combat veterans were more likely to be current drinkers and heavy 
smokers than non-veterans, but less likely to be current smokers and physically inactive 
(Table 12). Combat veterans and non-veterans were most likely to have prevalent diabetes, 
and combat veterans were most likely to have prevalent heart disease. The three exposure 
groups differed little on BMI or waist circumference, but compared to non-combat veterans 
or non-veterans, combat veterans had higher average SBP, total cholesterol and triglycerides 
(Table 13). Overall, men that participated in the LCSES survey had slightly more favorable 
behavioral and physical risk factor profiles at Visit 1 than the larger ARIC cohort from which 
they were drawn.  
 Little heterogeneity in the effect of combat by race was noted with the exception of 
heavy cigarette years of smoking (among blacks, combat veterans were least likely to smoke, 
while among whites they were most likely to smoke) and prevalent diabetes (among blacks, 
non-veterans had the highest rates, while among whites, combat veterans had the highest 
rates) (Table 12). Heterogeneity in effect by era of service was more notable (Tables 3 and 
4). In particular, among World War II veterans, those exposed to combat were more likely to 
be current drinkers and heavy smokers, less likely to be physically inactive and less likely to 
have prevalent diabetes or CHD compared to non-combat veterans. Among Korean War 
veterans, combat veterans were more likely to be current and heavy smokers and more likely 
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to have diabetes or CHD, higher waist circumference, higher SBP and higher triglycerides 
compared to non-combat veterans. Among veterans of the Vietnam Conflict, those exposed 
to combat were less likely to be current or heavy smokers but more likely to have diabetes, 
higher waist circumference and higher triglycerides than non-veterans.  
 Combat veterans, followed by non-combat veterans, consistently had the least 
favorable carotid plaque and CIMT profiles (Table 14). Specifically, compared to either non-
combat veterans or non-veterans, combat veterans were more likely to have plaque present at 
Visit 1 or Visit 2 (53.8, 48.5 and 45.1%, respectively). Excess burden of plaque at Visit 1 
remained among combat veterans when observed percentages were compared to those 
expected for men their age. Combat veterans also had greater mean CIMT (802.4, 757.7 and 
745.2 µm) and higher observed CIMT than expected for men their age. This finding held true 
when CIMT was assessed as binary variable: 12.3% of combat veterans had CIMT ≥ 1 µm, 
compared to only 6.7% of non-combat veterans and 6.1% of non-veterans, even when age 
was taken into account. In race and era stratified analyses these patterns tended to persist, 
with the exception of Vietnam era veterans, where the finding tended to be attenuated or 
reversed.  
In comparative analysis, both combat and non-combat veterans had significantly less 
favorable plaque and CIMT profiles than non-veterans, although the relationship was more 
pronounced for combat veterans (Table 15). Compared to non-veterans, the relative risk of 
having carotid plaque at Visit 1 or 2 was 1.19 among combat veterans (95% confidence 
interval (95% CI): 1.11, 1.28) and 1.08 among non-combat veterans (95% CI: 1.01, 1.15). 
Results from analyses of continuous CIMT were similar: compared to non-veterans, combat 
veterans had an average of 57.2 µm thicker arterial wall (95% CI: 45.1, 69.2) and non-
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combat veterans had an average of 12.5 µm thicker arterial wall (95% CI: 2.6, 22.3). A 
similar pattern was noted when CIMT was assessed as a binary variable and when age at 
identification was incorporated.  
When combat and non-combat veterans were compared, combat veterans consistently 
had less favorable plaque and CIMT profiles (Table 14). Combat veterans had 1.11 times the 
risk of non-combat veterans of having plaque detected at Visit 1or 2 (95% CI: 1.03, 1.19) and 
an average excess of 10.8 percentage points of plaque compared to other men their age (95% 
CI: 7.0, 14.7). Combat veterans also had an average of 44.7 µm thicker arterial wall 
compared to non-combat veterans (95% CI: 32.5, 56.9), and an additional 14.9 µm (95% CI: 
2.1, 27.8) CIMT than other men their age, compared to non-veterans. When CIMT was 
assessed as a binary variable, results were comparable, both unadjusted and using age-
specific cutpoints of CIMT.  
Interaction by race and era of service on the risk ratio and risk difference scales were 
found to be non-significant; however, due to low power, interaction could not be ruled out. 
Overall, findings held true for veterans of the World War II and Korean War eras but were 
attenuated for those from the Vietnam Conflict era. Results for white men were similar to 
overall results, while results for black men were weaker or absent.  
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Table 10: Profile of Recalled Military Service and Combat History Reported by Black and White Male Participants in the LC-SES 
Interview (2001-2002), by War/Conflict Era. 
 Non-Combat Veteran * 
 
Combat Veteran * 
 
 Total † World  
War II 
Korean  
War 
Vietnam  
conflict 
Total † World  
War II 
Korean  
war 
Vietnam  
conflict 
N  2127 314 675 506 1178 478 407 198 
Mean (SD) Age in years at 
induction into service 
 
19.8 (2.4) 17.9 (0.9) 19.7 (1.9) 21.2 (2.8) 19.1 (2.2) 18.0 (1.0) 19.4 (1.9) 20.9 (3.3) 
Mean (SD) Years since 
inducted into service‡ 
 
34.3 (5.9) 43.6 (1.3) 36.6 (2.0) 27.0 (3.0) 38.2 (6.8) 44.5 (1.3) 37.3 (2.0) 26.7 (3.7) 
Mean (SD) Years of service 
 
3.1 (3.2) 2.5 (2.2) 3.5 (3.7) 4.0 (4.4) 4.9 (5.6) 4.2 (4.5) 5.2 (6.1) 7.2 (7.2) 
n (%) Served overseas 
 
1085 (51.0) 169 (54.2) 384 (56.9) 244 (48.2) 1108 (94.1) 460 (96.4) 392 (96.3) 182 (91.9) 
n (%) Served in combat 
zone 
 
N/A N/A N/A N/A 975 (82.8)          430 (90.0) 339 (83.3) 163 (82.3) 
n (%) Under enemy fire or 
fired at enemy 
 
N/A N/A N/A N/A 700 (59.7)          337 (70.7) 229 (56.8) 110 (55.6) 
n (%) Saw wounded or 
killed during war 
 
N/A N/A N/A N/A 853 (72.7)         357 (74.8) 294 (73.0) 139 (70.2) 
n (%) Ever wounded or 
missing during war 
 
N/A N/A N/A N/A 154 (13.1)         76 (15.9) 57 (14.1) 18 (9.1) 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether hel (1) 
served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans are defined as those who served in the military but did not report any combat exposures (1-4).  
† The 632 non-combat veterans and 95 combat veterans that served between periods of defined conflict are included in the totals but not as a 
distinct category in stratified results.  
‡
 Age at Visit 1 – self-reported age at entry into the military 
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Table 11: Sociodemographic Profile of Black and White Male Veterans at ARIC Baseline Examination (1987-1989), by Combat History 
and Era of Service. 
 Non- 
Veteran 
 
Non-Combat Veteran * 
 
Combat Veteran * 
 
Total Total† World  
War II 
Korean 
War 
Vietnam 
Conflict 
Total† World  
War II 
Korean 
War 
Vietnam 
Conflict 
2042 2127 314 675 506 1178 478 407 198 
Mean (SD) Age at Baseline ARIC Visit in 
years 
 
51.8 (5.2) 54.1 (5.1) 61.5 (1.6) 56.3 (2.4) 48.2 (2.5) 57.3 (5.8) 62.5 (1.5) 56.7 (2.2) 47.6 (2.6) 
n (%) African-American 
 
643 (31.5) 278 (13.1)  37 (11.8) 88 (13.0) 75 (14.8) 155 (13.2)  45 (9.4) 60 (14.7) 39 (19.7) 
n (%) Education < High School 
 
625 (30.7) 244 (11.5)  77 (24.5) 94 (14.0) 20 (4.0) 209 (17.8)  112 (23.4) 67 (16.5) 8 (4.1) 
n (%)Father’s Education  < High School ‡ 
 
1010 (61.0) 1102 (59.4) 178 (63.1) 374 (64.0) 219 (50.9) 634 (61.4) 282 (64.7) 229 (65.4) 79 (48.2) 
n (%) Combined Family Income < $25,000 
 
625 (32.5) 368 (18.0) 81 (26.8) 135 (20.6) 63 (12.9) 284 (25.3) 163 (35.8) 74 (19.2) 26 (13.7) 
n (%) Occupation Non-Managerial/ 
Professional 
 
1446 (70.9) 1382 (65.0) 245 (78.0) 446 (66.1) 302 (59.7) 903 (76.7) 412 (86.2) 290 (71.3) 132 (66.7) 
Note: columns may not sum to 100% due to rounding 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the 
individual (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever 
wounded during war; Non-Combat Veterans are defined as those who served in the military but did not report any combat exposures (1-4).  
† The 632 non-combat veterans and 95 combat veterans that served between periods of defined conflict are included in the totals but not as a 
distinct category in stratified results.  
‡
 804 values missing information on natural father’s education 
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Table 12: Risk Factor Profile of Black and White Men at ARIC Baseline Examination (1987-1989): LC-SES 
Participants (Overall and by Military/Combat Exposure) and All ARIC Participants, by Race and Era of 
Service (Binary Variables). 
LCSES men 
 
ARIC men 
 
Total Non- 
Veteran 
Non- 
Combat  
Veteran * 
Combat 
Veteran * 
Total 
N 5347 2042 2127 1178 7030 
n (%) Current alcoholic drinking †      
Total (n=5347) 3528 (66.0) 1212 (59.7) 1492 (70.3) 824 (70.3) 4526 (64.7) 
African-Americans (n=1076) 527 (49.6) 289 (45.7) 144 (52.2) 94 (61.4) 782 (49.5) 
Caucasians (n=4271) 3001 (70.5) 923 (66.1) 1348 (73.1) 730 (71.6) 3744 (69.2) 
World War II (n=792) 540 (68.5) N/A 199 (63.6) 341 (71.8) 540 (68.5) 
Korean War (n=1082) 727 (67.4) N/A   455 (67.7) 272 (66.8) 727 (67.4) 
Vietnam conflict (n=704) 524 (74.6) N/A 380 (75.1) 144 (73.5) 524 (74.6) 
n (%) Current smoking †      
Total (n=5347) 1261 (23.6) 541 (26.5) 473 (22.3) 247 (21.0)  1952 (27.8) 
African-Americans (n=1076) 361 (33.6) 233 (36.2) 82 (29.5)   46 (29.9) 615 (38.4) 
Caucasians (n=4271) 900 (21.1) 308 (22.0) 391 (21.2) 201 (19.7) 1337 (24.6) 
World War II (n=792) 114 (14.4) N/A 44 (14.0) 70 (14.6) 114 (14.4) 
Korean War (n=1082) 247 (22.9) N/A 139 (20.6) 108 (26.6) 247 (22.9) 
Vietnam conflict (n=704) 180 (25.6) N/A 136 (26.9) 44 (22.2) 18 (25.6) 
n (%) Years of heavy smoking †  
     
Total (n=5347) 1351 (25.3) 438 (21.9) 545 (25.9) 368 (31.7) 2111 (30.6) 
African-Americans (n=1076) 177 (17.07) 104 (16.8) 50 (18.5)   23 (15.7) 355 (23.1) 
Caucasians (n=4271) 1174 (27.8) 334 (24.1) 495 (27.0) 345 (34.1) 1756 (32.7) 
World War II (n=792) 257 (32.9) N/A 94 (30.3) 163 (34.6) 257 (32.9) 
Korean War (n=1082) 356 (33.3) N/A 209 (31.2) 147 (36.8) 356 (33.3) 
Vietnam conflict (n=704) 126 (18.1) N/A   94 (18.8) 32 (16.4) 126 (18.1) 
n (%) Physically inactive †      
Total (n=5347) 1131 (21.3) 616 (30.4) 843 (39.8) 515 (43.9) 1645 (23.5) 
African-Americans (n=1076) 362 (34.0) 217 (34.2) 95 (34.3) 50 (32.7) 588 (37.1) 
Caucasians (n=4271) 769 (18.1) 299 (21.5) 307 (16.7) 163 (16.0) 1057 (19.5) 
World War II (n=792) 132 (16.7) N/A 59 (18.9) 73 (15.3) 132 (16.7) 
Korean War (n=1082) 226 (21.0) N/A 142 (21.1) 84 (20.7) 226 (21.0) 
Vietnam conflict (n=704) 128 (18.2) N/A 90 (17.8) 38 (19.3) 128 (18.2) 
n (%) Prevalent Diabetes  
     
Total (n=5347) 503 (9.4) 213 (10.6) 167 (7.9) 123 (10.5) 844 (12.1) 
African-Americans (n=1076) 149 (14.2) 99 (15.9) 31 (11.4) 19 (12.5) 291 (18.6) 
Caucasians (n=4271) 354 (8.3) 114 (8.2) 136 (7.4) 104 (10.2) 553 (10.2) 
World War II (n=792) 96 (12.2) N/A 40 (12.7) 56 (11.8) 96 (12.2) 
Korean War (n=1082) 91 (8.4) N/A 55 (8.2) 36 (8.9) 91 (8.4) 
Vietnam conflict (n=704) 46 (6.6) N/A 29 (5.8) 17 (8.6) 46 (6.6) 
n (%) Prevalent CHD  
     
Total (n=5347) 311 (5.9) 107 (5.2) 117 (5.5) 94 (8.0) 574 (8.3) 
African-Americans (n=1076) 37 (3.50) 20 (3.2) 9 (3.3) 8 (5.2) 93 (5.92) 
Caucasians (n=4271) 274 (6.54) 85 (6.2) 105 (5.8) 84 (8.4) 481 (9.05) 
World War II (n=792) 81 (10.41) N/A 36 (11.6) 45 (9.6) 81 (10.41) 
Korean War (n=1082) 79 (7.47) N/A 42 (6.4) 37 (9.3) 79 (7.47) 
Vietnam conflict (n=704) 16 (2.31) N/A 12 (2.4) 4 (2.0) 16 (2.31) 
Because of missing data, N differs for some variables. 
Some columns may not sum to 100% due to rounding. 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, 
whether the individual (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed 
during war, and/or (4) was ever wounded during war; Non-Combat Veterans are defined as those who served in the military 
but did not report any combat exposures (1-4). 
†  Current alcohol drinking is defined as self-report of drinking any alcohol at baseline; Current cigarette smoking is defined as 
self-report of smoking one or more cigarettes per year at baseline; Heavy cigarette years of smoking is calculated by 
multiplying the number of cigarettes smoked per year by the number of years the individual has been smoking and is defined 
as having smoked 660 or more cigarettes; Physical inactivity is defined as having a sports activity index score less than 2.0.  
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Table 13: Risk Factor Profile of Black and White Men at ARIC Baseline Examination (1987-1989): LC-SES 
Participants (Overall and by Military/Combat Exposure) and All ARIC Participants, by Race and Era of 
Service (continuous variables). 
LCSES men ARIC men 
 
Total Non- 
Veteran 
Non- 
Combat  
Veteran * 
Combat  
Veteran * 
Total 
N 5347 2042 2127 1178 7030 
Mean (SD) BMI (m/kg2) 
     
Total (n=5347) 27.5 (4.1) 27.8 (4.4) 27.2 (3.8) 27.7 (4.0) 27.5 (4.2) 
African-Americans (n=1076) 27.9 (4.7) 27.9 (4.6) 27.9 (4.9) 27.8 (4.7) 27.6 (4.9) 
Caucasians (n=4271) 27.4 (3.9) 27.7 (4.3) 27.0 (3.6) 27.7 (3.8) 27.5 (4.0) 
World War II (n=792) 27.3 (3.7) N/A 27.4 (3.9) 27.3 (3.6) 27.3 (3.7) 
Korean War (n=1082) 27.4 (4.0) N/A 27.1 (3.8) 27.9 (4.2) 27.4 (4.0) 
Vietnam conflict (n=704) 27.2 (4.0) N/A 27.0 (3.9) 27.9 (4.1) 27.2 (4.0) 
Mean (SD) Waist circumference (cm)   
    
Total (n=5347) 98.9 (10.7) 99.1 (11.6) 98.4 (10.0)  99.6 (10.3) 99.1 (11.1) 
African-Americans (n=1076) 97.0 (12.3) 97.0 (12.3) 97.2 (12.2) 96.9 (12.1) 97.0 (12.9) 
Caucasians (n=4271) 99.4 (10.3) 100.0 (11.2) 98.6 (9.6) 100.0 (9.9) 99.7 (10.5) 
World War II (n=792) 99.4 (9.6) N/A 99.7 (9.9) 99.3 (9.5) 99.4 (9.6) 
Korean War (n=1082) 99.1 (10.2) N/A 98.7 (9.9) 99.7 (10.6) 99.1 (10.2) 
Vietnam conflict (n=704) 97.8 (10.5) N/A 97.1 (10.3)                                    99.4 (10.8) 97.8 (10.5) 
Mean (SD) Systolic BP (mmHg) 
     
Total (n=5347) 121.2 (16.9) 121.8 (17.6) 119.9 (16.3) 122.5 (16.7) 122.6 (18.1) 
African-Americans (n=1076) 128.3 (19.9) 128.2 (20.2) 127.6 (19.5) 130.2 (19.2) 130.5 (21.7) 
Caucasians (n=4271) 119.4 (15.6) 118.8 (15.4) 118.8 (15.4) 121.4 (16.0) 120.2 (16.2) 
World War II (n=792) 125.6 (18.0) N/A 125.7 (18.9) 125.6 (17.3) 125.6 (18.0) 
Korean War (n=1082) 121.4 (16.2) N/A 120.8 (16.3) 122.5 (16.0) 121.4 (16.2) 
Vietnam conflict (n=704) 116.2 (14.6) N/A 116.1 (14.6) 116.6 (14.5) 116.2 (14.6) 
Mean (SD) Total cholesterol (mg/dL) 
    
Total (n=5347) 210.9 (39.2) 209.7 (39.8) 210.7 (37.9) 213.5 (40.4) 211.1 (40.0) 
African-Americans (n=1076) 212.7 (43.3) 211.9 (43.3) 213.6 (41.9) 214.6 (45.4) 210.9 (44.1) 
Caucasians (n=4271) 210.5 (38.2) 208.7 (38.1) 210.2 (37.2) 213.4 (39.6) 211.1 (38.7) 
World War II (n=792) 213.4 (38.0) N/A 212.0 (37.9) 214.3 (38.0) 213.4 (38.0) 
Korean War (n=1082) 213.3 (39.3) N/A 212.5 (37.3) 214.6 (42.6) 213.3 (39.3) 
Vietnam conflict (n=704) 206.4 (39.6) N/A 205.9 (39.0) 207.7 (41.0) 206.4 (39.6) 
Mean (SD) LDL cholesterol (mg/dL) 
    
Total (n=5347) 139.6 (36.5) 138.3 (37.3) 139.6 (35.4) 141.9 (37.0) 139.4 (37.3) 
African-Americans (n=1076) 140.0 (41.3) 138.7 (41.3) 141.2 (41.0) 142.7 (41.9) 137.4 (42.1) 
Caucasians (n=4271) 139.5 (35.2) 138.0 (35.4) 139.4 (34.4) 141.7 (36.3) 140.0 (35.7) 
World War II (n=792) 141.2 (35.1) N/A 139.8 (35.0) 142.0 (35.1) 141.2 (35.1) 
Korean War (n=1082) 142.2 (36.7) N/A 141.5 (35.3) 143.4 (38.8) 142.2 (36.7) 
Vietnam conflict (n=704) 135.4 (36.2) N/A 134.9 (36.0) 136.5 (37.0) 135.4 (36.2) 
Mean (SD) HDL cholesterol (mg/dL) 
    
Total (n=5347) 44.3 (13.2) 44.8 (13.5) 44.2 (13.2) 43.7 (12.8) 44.4 (13.9) 
African-Americans (n=1076) 49.9 (15.5) 50.4 (15.9) 49.2 (14.9) 49.1 (15.2) 50.4 (16.9) 
Caucasians (n=4271) 43.0 (12.2) 42.4 (11.5) 43.4 (12.8) 42.9 (12.2) 42.6 (12.4) 
World War II (n=792) 44.3 (13.0) N/A 44.7 (14.1) 44.1 (12.2) 44.3 (13.0) 
Korean War (n=1082) 43.7 (13.0) N/A 43.9 (12.8) 43.3 (13.2) 43.7 (13.0) 
Vietnam conflict (n=704) 43.8 (13.0) N/A 43.9 (13.0) 43.6 (13.1) 43.8 (13.0) 
Mean (SD) Triglycerides (mg/dL) 
    
Total (n=5347) 140.8 (95.9) 137.0 (84.8) 140.3 (96.9) 148.1 (110.7) 142.1 (99.1) 
African-Americans (n=1076) 118.0 (75.3) 117.1 (73.2) 115.7 (61.0) 125.7 (102.1) 120.1 (94.0) 
Caucasians (n=4271) 146.3 (99.5) 145.8 (88.1) 143.9 (100.6) 151.4 (111.6) 148.3 (99.7) 
World War II (n=792) 142.4 (80.0) N/A 142.5 (92.0) 142.3 (71.1) 142.4 (80.0) 
Korean War (n=1082) 143.6 (97.5) N/A 139.3 (88.8) 150.8 (110.1) 143.6 (97.5) 
Vietnam conflict (n=704) 146.9 (125.4) N/A 141.7 (95.6) 160.2 (180.1) 146.9 (125.4) 
Because of missing data, N differs for some variables. 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, 
whether the individual (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed 
during war, and/or (4) was ever wounded during war; Non-Combat Veterans are defined as those who served in the military 
but did not report any combat exposures (1-4).
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Table 14: Observed Carotid Plaque and Carotid Intima-Media Thickness (CIMT), by Military Service and 
Combat History: Means (Standard Deviations) and Frequencies (Percentages). 
 
Non- 
Veteran 
Non- 
Combat  
Veteran * 
Combat  
Veteran * 
N  2042 2127 1178 
BINARY PLAQUE     
n (%) Plaque     
Total (n=5347) 858 (45.09) 970 (48.48) 595 (53.75) 
African-Americans (n=1076) 250 (44.01) 109 (44.13) 62 (43.97) 
Caucasians (n=4271) 608 (45.54) 861 (49.09) 533 (55.18) 
World War II (n=792) N/A 169 (58.08) 281 (62.86) 
Korean War (n=1082) N/A 340 (52.88) 212 (55.50) 
Vietnam conflict (n=704) N/A 177 (37.26) 61 (32.97) 
Mean (SD) Excess % of plaque for age     
Total (n=5347) -10.31 (52.29) -2.84 (52.06) 7.97 (53.06) 
African-Americans (n=1076) -11.79 (51.91) -7.16 (51.94) -3.82 (53.08) 
Caucasians (n=4271) -9.69 (52.45) -2.24 (52.06) 9.69 (52.87) 
World War II (n=792) N/A 19.59 (49.48) 26.14 (48.53) 
Korean War (n=1082) N/A 5.40 (50.20) 8.63 (50.26) 
Vietnam conflict (n=704) N/A   -24.30 (48.98) -29.73 (47.77) 
BINARY CIMT † 
   
n (%)CIMT ≥ 1 (µm) 
   
Total (n=5347) 122 (6.08)  142 (6.74) 144 (12.33) 
African-Americans (n=1076) 30 (4.88)  14 (5.20) 14 (9.33) 
Caucasians (n=4271) 92 (6.62)  128 (6.96) 130 (12.77) 
World War II (n=792) N/A 47 (15.06) 81 (17.02) 
Korean War (n=1082) N/A 53 (7.91) 50 (12.44)  
Vietnam conflict (n=704) N/A 11 (2.20) 4 (2.04) 
n (%) Age-specific CIMT >85th percentile (µm) ‡ 
   
Total (n=5347) 307 (15.03) 289 (13.59) 196 (16.64) 
African-Americans (n=1076) 19 (12.26) 30 (10.79) 93 (14.46) 
Caucasians (n=4271) 214 (15.30) 259 (14.01) 177 (17.30) 
World War II (n=792) N/A 46 (5.81) 80 (10.10) 
Korean War (n=1082) N/A 88 (13.04) 74 (18.18) 
Vietnam conflict (n=704) N/A 69 (13.64)   26 (13.13) 
CONTINUOUS CIMT (µm) * 
   
Mean (SD) Average CIMT (µm)  
   
Total (n=5347) 745.2 (157.7) 757.7 (164.1)  802.4 (182.2)  
African-Americans (n=1076) 745.7 (145.2) 742.9 (157.3) 774.9 (166.3)  
Caucasians (n=4271) 745.0 (163.0) 749.6 (165.1)  806.5 (184.1) 
World War II (n=792) N/A 826.3 (202.4) 853.6 (192.1)  
Korean War (n=1082) N/A 779.7 (164.5) 799.2 (180.2)  
Vietnam conflict (n=704) N/A 701.0 (124.6) 698.9 (114.9)  
Mean (SD) deviation from age-adjusted CIMT (µm) 
   
Total (n=5347) 2.74 (156.89) -6.96 (165.02) 7.97 (189.81) 
African-Americans (n=1076) 1.99 (145.43) -0.90 (158.21) -6.60 (157.58) 
Caucasians (n=4271) 3.06 (161.68) -7.81 (165.98) 10.11 (194.08) 
World War II (n=792) N/A -12.70 (196.95)   3.67 (203.61) 
Korean War (n=1082) N/A -7.53 (178.81) 13.51 (206.64) 
Vietnam conflict (n=704) N/A -5.89 (130.27) 6.55 (125.28) 
Because of missing data, N differs in some variables. 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the 
military and, if so, whether the individual (1) served in a combat zone, (2) was under enemy fire or fired at 
enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans 
are defined as those who served in the military but did not report any combat exposures (1-4).  
†
 Average far wall imputed CIMT over ARIC Visits 1 and 2 
‡ Average far wall imputed CIMT over ARIC Visits 1 and 2; 85th percentile of CIMT for all African-American or 
Caucasian male ARIC participants; four separate age and race-specific 85th percentile cutpoints were used: 
Black men ages 45-54, Black men ages 55-65, White men ages 45-54 and White men ages 55-65. 
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Table 15: Observed Carotid Plaque and Carotid Intima-Media Thickness (CIMT), by Military Service and 
Combat History. Risk Ratios (RR) or Risk Differences (RD). 
 
Non-Combat  
Veteran vs. 
 Non-Veteran* 
Combat Veteran 
vs. Non-Veteran* 
Combat Veteran 
vs. Non-Combat 
Veteran* 
BINARY PLAQUE  
   
Plaque (RR (95% CI)) 
   
Total (n=5347) 1.08 (1.01, 1.15) 1.19 (1.11, 1.28) 1.11 (1.03, 1.19) 
African-Americans (n=1076) 1.00 (0.85, 1.19) 1.00 (0.81, 1.23) 1.00 (0.79, 1.26) 
Caucasians (n=4271) 1.08 (1.00, 1.16) 1.21 (1.12, 1.31) 1.12 (1.04, 1.21) 
World War II (n=792) N/A N/A 1.08 (0.96, 1.22) 
Korean War (n=1082) N/A N/A 1.05 (0.93, 1.18) 
Vietnam conflict (n=704) N/A N/A 0.88 (0.70, 1.12) 
Excess % of plaque for age (RD (95% CI)) † 
  
Total (n=5347) 7.47 (4.18, 10.76) 18.28 (14.40, 22.16) 10.81 (6.96, 14.66) 
African-Americans (n=1076) 4.63 (-3.15, 12.42) 7.97 (-1.63, 17.58) 3.34 (-7.49, 14.17) 
Caucasians (n=4271) 7.45 (3.72, 11.18) 19.37 (15.03, 23.71) 11.92 (7.81, 16.03) 
World War II (n=792) N/A N/A 6.55 (-0.67, 13.77) 
Korean War (n=1082) N/A N/A 3.23 (-3.13, 9.59) 
Vietnam conflict (n=704) N/A N/A -5.43 (-13.70, 2.83) 
BINARY CIMT 
   
CIMT ≥ 1 mm (RR (95% CI)) † 
  
Total (n=5347) 1.11 (0.88, 1.40) 2.03 (1.61, 2.55) 1.83 (1.47, 2.28) 
African-Americans (n=1076) 1.07 (0.58, 1.98) 1.91 (1.04, 3.52) 1.79 (0.88, 3.66) 
Caucasians (n=4271) 1.05 (0.81, 1.36) 1.93 (1.50, 2.49) 1.83 (1.46, 2.31) 
World War II (n=792) N/A N/A 1.13 (0.81, 1.57) 
Korean War (n=1082) N/A N/A 1.57 (1.09, 2.27) 
Vietnam conflict (n=704) N/A N/A 0.93 (0.30, 2.88) 
Age-specific CIMT >85thpercentile (RR (95% CI)) ‡ 
  
Total (n=5347) 0.90 (0.78, 1.05) 1.11 (0.94, 1.30) 1.22 (1.04, 1.45) 
African-Americans (n=1076) 0.75 (0.51, 1.10) 0.85 (0.53, 1.34) 1.14 (0.66, 1.95) 
Caucasians (n=4271) 0.92 (0.77, 1.08) 1.13 (0.94, 1.36) 1.24 (1.04, 1.47) 
World War II (n=792) N/A N/A 1.14 (0.82, 1.59) 
Korean War (n=1082) N/A N/A 1.39 (1.05, 1.85) 
Vietnam conflict (n=704) N/A N/A 0.96 (0.63, 1.47) 
CONTINUOUS CIMT (µm) 
   
Mean CIMT in µm (RD (95% CI)) † 
   
Total (n=5347) 12.48 (2.64, 22.32) 57.16 (45.11, 69.21) 44.68 (32.47, 56.89) 
African-Americans (n=1076) 16.03 (-5.31, 37.37) 29.15 (2.45, 55.85) 13.12 (-18.95, 45.19) 
Caucasians (n=4271) 12.10 (0.65, 23.55) 61.43 (47.51, 75.35) 49.33 (36.16, 62.50) 
World War II (n=792) N/A N/A 27.27 (-0.74, 55.28) 
Korean War (n=1082) N/A N/A 19.51 (-1.58, 40.60) 
Vietnam conflict (n=704) N/A N/A -2.07 (-22.22, 18.08) 
Deviation from age-adjusted CIMT in µm (RD (95% CI)) * 
  
Total (n=5347) -9.69 (-20.23, 0.85) 5.23 (-7.26, 17.72) 14.92 (2.06, 27.78) 
African-Americans (n=1076) -2.89 (-25.33, 19.55) -8.59 (-36.40, 19.22) -5.70 (-38.45, 27.05) 
Caucasians (n=4271) -10.87 (-23.12, 1.38) 7.05 (-7.26, 21.36) 17.92 (4.00, 31.84) 
World War II (n=792) N/A N/A 16.37 (-13.13, 45.87) 
Korean War (n=1082) N/A N/A 21.04 (-3.36, 45.44) 
Vietnam conflict (n=704) N/A N/A 12.43 (-9.35, 34.21) 
Because of missing data, N differs in some variables. 
* Combat Veterans are identified by a summary variable based on whether or not the individual served in the 
military and, if so, whether he (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw 
wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans reported 
military service but no combat exposures (1-4). 
†
 Average far wall imputed CIMT over ARIC Visits 1 and 2 
‡ Average far wall imputed CIMT over ARIC Visits 1 and 2; 85th percentile of CIMT for all African-American or 
Caucasian male ARIC participants; four separate age and race-specific 85th percentile cutpoints were used: 
Black men ages 45-54, Black men ages 55-65, White men ages 45-54 and White men ages 55-65. 
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Discussion 
Men with distant military service, particularly when it included combat exposure, are 
more likely to have carotid plaque and increased CIMT than their non-veteran counterparts. 
These effects remain after age and race are taken into account. No prior studies have assessed 
the relationship between military or combat exposure and clinical or subclinical 
atherosclerosis. However, our findings are consistent with earlier studies that reported that 
combat veterans with post-traumatic stress disorder (PTSD) were more likely to have 
increased chronic cardiovascular arousal,700 higher circulating catecholamines and other 
neuroendocrine agents implicated in arterial damage and a higher frequency of abnormal 
ECG readings.151 In contrast to most previous studies, the current study investigated the 
effects of combat, rather than the clinically-defined chronic stress reaction (CSR) or PTSD 
diagnosis and incorporates both non-combat veteran and non-veteran “control” groups. 
One possible explanation for our findings of higher rates of subclinical 
atherosclerosis in combat veterans is that the extreme trauma experienced set into motion a 
chronic stress response and a resultant inflammatory, atherosclerotic process that initiated the 
formation of plaque and the thickening of the arterial wall. Although the link between 
psychosocial stress and coronary events is well-established, 1 ,2 , 3 the mechanisms underlying 
these associations are not well understood. Specifically, the association between psychosocial 
stress and with subclinical atherosclerosis is not yet clear.701 However, this theory is 
supported by findings in the ARIC study: lower SES, both early in life and cumulatively 
across the life course, is associated with elevated levels of inflammatory markers such as C-
reactive protein, fibrinogen, white blood cell count and von Willebrand factor later in 
life.702,703 Similarly, a small study of Croatian combat veterans with PTSD found that combat 
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veterans had higher lymphocyte counts than civilian controls, suggesting that the immune 
system was affected in the course of chronic PTSD.704 
Both combat and non-combat veterans were more likely to be current drinkers and 
heavy smokers than non-veterans but less likely to be current smokers and physically 
inactive. Other studies have found that although men and women are selectively accepted 
into the military based on their good physical health, they tend to have higher alcohol and 
tobacco usage rates after participation in the military compared to the general 
population.705,706,707 Given the strong link between smoking and atherosclerosis, smoking 
may be acting as a mediator in the effects found in this study. However, studies of veterans 
with and without combat-related PTSD have found that the association between PTSD and 
poor physical health persists even after controlling for smoking and alcohol 
consumption,407,708 suggesting a more direct link between traumatic stress and subclinical 
disease or a role of psychological factors as mediators.  
Psychological conditions such as CSR and PTSD have been associated with an 
increased burden of cardiovascular morbidity and mortality.182,709 While it would have been 
of interest to provide results stratified on CSR or PTSD status, this information was not 
queried in the LC-SES interview. Psychological status would have been assessed as a 
potential effect measure modifier rather than as a confounder; consequently its exclusion 
does not detract from our findings. Our results support the conclusion that the effects of 
combat exposure extend beyond the narrow scope of these clinical diagnoses..594,700,710 
The association between combat-related stress and subclinical atherosclerosis may 
also differ by current and past social, educational and economic environments and 
opportunities. Inverse associations between SES and CVD as well as mortality from other 
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health related outcomes have been demonstrated repeatedly511,512 and may work through a 
number of mechanisms. Lower individual SES is associated with increased risk of smoking, 
less healthy diet, increased obesity, and reduced physical activity523,524 as well as lower self-
reported social mobility, increased financial strain and more stressful life events.709 SES may 
differentially affect how an individual responds psychologically and physically to other 
meaningful life events and stressors such as exposure to combat, both psychologically and 
physically, with higher SES providing protection.22,567  In the current study, while non-
combat veterans consistently have the most favorable SES profiles overall, combat veterans 
have more favorable levels of education and family income but less favorable early life SES 
(i.e., father’s education and occupation) than did non-veterans. These differences may reflect 
the different age distributions in each exposure group, as the socioeconomic position of 
veterans has increased over time.582 Alternatively, it may reflect the economic and 
educational opportunities such as the Montgomery GI Bill that have enabled veterans to keep 
pace with, though not exceed, non-veterans in terms of educational attainment.647,572 
Because the combat exposure variables are based on self-report, recall bias may also 
affect results, such that men in worse health may differentially recall their military 
experiences. Although our outcome was subclinical disease, the status of which was likely 
unknown to participants at the time, combat veterans were more likely to have other known 
indicators of poor health such as hypertension, high cholesterol and CHD. Use of recalled 
combat exposures has precedent676,677,678 and has high validity and reliability;679 thus it is 
unlikely that differential recollection of past military experiences based on current health 
status was significant.  
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Age is a potent predictor of subclinical atherosclerosis; however, because age was not 
associated with the exposure in this study population, as evidenced by the similarities in the 
age at induction into the military, it could not be treated as a confounder in analysis. Still, 
participants’ mean age at the time when CIMT and carotid plaque were measured differed 
sufficiently among the three exposure groups – with combat veterans averaging three years 
older than non-combat veterans and five years older than non-veterans – to raise the potential 
concern that age may be affecting results.  Therefore, age was taken into consideration by 
assessing age and race-specific percentiles of carotid intima-media thickness. Although this 
data-driven method not ideal, it is a meaningful way of reflecting the age-dependent slope of 
vasculature. Even after using this method to consider age and race, combat veterans still had 
the highest risk of having carotid plaque and thickened carotid arterial walls.  
The distribution of veterans by era of conflict differed substantially between combat 
and non-combat veterans. Combat veterans were more likely to serve during World War II 
and least likely to serve during the Vietnam Conflict, while non-combat veterans were most 
likely to serve during the Korean War and least likely to serve during World War II. Profiles 
of veterans from each era of service differ on factors such as age at entry, race, SES, type, 
duration and intensity of combat experienced and the sociopolitical atmosphere surrounding 
the conflict. Our results suggest heterogeneity in the effect of combat by era of service. In 
contrast to the higher prevalence of carotid plaque and thickened arterial walls among 
combat veterans compared to non-combat veterans of the World War II and Korean War 
eras, associations were weaker or even reversed among those who served during the era of 
the Vietnam Conflict.   
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The type and nature of combat experienced during each of these conflicts, as well as 
the social and political context surrounding them, differed.585 Reports suggest that Vietnam 
veterans were subjected to unusually high levels of “barbarity and moral ambiguity” as well 
as chronic exposure to unpredictable and dangerous warfare environments, and were more 
likely to have witnessed abusive violence or killings compared to veterans of World War II 
and the Korean War.711,712 Further, Vietnam veterans returned home to a social and political 
environment that was unsupportive of the US involvement in the conflict.588 In contrast, 
World War II was a war with a clearly identified enemy, and returning soldiers had the 
overwhelming support of the American public.595 Like World War II, the Korean War was 
fought by defined armies for territory; however, soldiers lost support from the American 
public over the course of the war. The manner in which soldiers were received at 
homecoming has been found to have a significant effect on the risk of developing PTSD and 
other psychiatric symptoms later in life.596 The confluence of divergent factors such as the 
clarity of identification of the enemy, involvement of civilians in combat, transparency of the 
purported goals of the war, and level of public support could explain the different 
associations between combat-related stress and health among men from different eras. Given 
the particularly brutal nature of combat experienced during the Vietnam Conflict,677 we might 
expect the effects of combat to be most pronounced among these veterans. Conversely, the 
negative sociopolitical atmosphere surrounding the Vietnam Conflict may have acted as a 
stressor among both combat and non-combat soldiers upon homecoming, attenuating 
differences.  
The different demographic profile of the Vietnam Conflict cohort may also have 
contributed to differences in the effect of combat in this study. Members of this cohort tended 
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to be inducted into the military at a slightly older age and served for a longer period of time 
compared to those who served during the World War II or Korean War eras. They also 
tended to be of higher socioeconomic position, which, according to current theory, tends to 
be protective against the effects of traumatic stress.22,511 Both older average age at induction 
and higher average SES among men in this cohort may be a reflection of secular trends in 
education or in the ability of affluent Vietnam draftees to postpone induction by enrolling in 
school and obtaining educational deferment.713 Finally, the younger age at which Vietnam 
Conflict era veterans’ outcomes were assessed in this study – an average of ten years younger 
than non-combat veterans and seventeen years younger than non-veterans – also may have 
contributed to the apparently weaker effect of combat exposure among these participants. 
Heterogeneous behavioral and physical risk factor profiles among veterans by era 
may also have contributed to differences in effect by era of service. In line with results of a 
higher prevalence of carotid plaque and thickened arterial walls among combat veterans 
among World War II and Korean War era veterans but not Vietnam Conflict era veterans, 
results showed combat exposure was associated with higher rates of heavy lifetime smoking 
among World War II and Korean War era veterans, but not among Vietnam Conflict era 
veterans. However, combat exposure was associated with higher rates of diabetes, higher 
waist circumference and higher triglycerides only among veterans of the Korean War and 
Vietnam Conflict. Higher SBP and higher rates of CHD were found only among combat 
veterans who served during the era of the Korean War.  
The effects of combat on subclinical atherosclerosis vary by race, consistent with 
other studies that have found that the composition and morphology of atherosclerotic plaque 
vary by ethnic and racial groups.714,715 Whites tend to have plaque in larger arteries such as 
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the coronary arteries investigated in the present study, blacks typically develop plaques in 
smaller and more distal arteries.716 Our results were in line with these findings, with a higher 
proportion of white men showing carotid plaque and a higher average carotid intima-media 
thickness measured at Visits 1 or 2 compared to black men, in each of the three exposure 
groups. These racial differences are consistent with our findings that the effect of combat on 
carotid plaque or CIMT was limited to white men. Combat-related effects noted in white but 
not black men may also be related to differences in baseline risk factor profiles. Most 
notably, white but not black combat veterans were most likely to be heavy smokers, a major 
risk factor for the development of subclinical atherosclerosis. Alternatively, the low sample 
size of black men may have masked an effect.  
This study provided a rare opportunity to investigate the long-term association of 
combat exposure on levels of atherosclerosis and cardiovascular risk in a large community-
based cohort. Average follow-up time was long and participants were of an age (60 to 80 
years) where CHD is most likely manifest. Among veterans,  periods of military service 
spanned from World War II through the Vietnam Conflict and includes measures of specific 
combat exposures and both military and civilian controls. Most previous studies have been 
based on retrospective cohorts and have investigated differences in CVD mortality 
comparing war theater veterans and non-theater veterans of the same era. Also a particular 
strength, this study included objective, standardized measures of cardiovascular outcomes. 
The wide range of physical and behavioral risk factor measures also allowed for a more 
extensive examination of the intermediate mechanisms through which the combat-subclinical 
atherosclerosis association potentially works. The availability of socioeconomic measures 
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from various life epochs further offered an unusual opportunity to investigate the role of SES 
in combat-cardiovascular associations.   
As previously discussed, the use of self-reported combat exposures presents 
challenges. Although recalled exposure status is not ideal, to our knowledge, no cohorts exist 
that collected combat exposure during military service and included long-term follow-up 
with a rigorous measurement of cardiovascular outcomes. Further, defining combat as the 
exposure to one or more specific combat experiences can be viewed as a strength, as it is a 
more specific and meaningful definition than simply separating exposure groups into theater 
and non-theater veterans who served during the same era.  
Combat exposure was not assessed until 12-14 years after baseline, at which time 
17% of male baseline participants had expired. Thus, it is possible that selective survival may 
have biased our findings. We took two steps to address this concern. First, we conducted a 
pilot study on a subset of decedents from North Carolina for whom veteran status was 
recorded on death certificates. Briefly, we found a small (2%) but not statistically significant 
excess mortality among veterans, even after adjustment for age, race and education. Second, 
we conducted a sensitivity analysis to estimate the extent to which differential survival, if 
extant, may have influenced observed results by comparing observed RRs with those 
corrected for selection bias.718 We applied the adjusted mortality rates obtained from the pilot 
study to hypothetical data with incident CHD as the outcome. Assuming that those who 
eventually had a CHD event were 1.5 times more likely to die before providing data on 
military history than those who did not go on to develop CHD, our odds ratio was 
underestimated by only 1.5%.  Even under a more extreme scenario – where the difference in 
mortality was assumed to be higher than what we found in the pilot study (e.g., 14% for non-
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veterans and 18% for veterans – a 29% difference in mortality) and assuming those who 
eventually go on to develop CHD were two times more likely to die prior to providing their 
military history – our observed effect estimate would still only differ from the corrected 
estimate by 7%. These results are reassuring as they suggest that both the potential 
magnitude of survivorship bias, if extant, would have been small in these data.  
Finally, although this study includes a large population of men, it does not have 
adequate statistical power to formally address hypotheses about potential effect measure 
modification. In addition to era of service and race, of particular interest would be to see if 
there is interaction by age at entry, duration of service, psychological status and type of 
combat exposure.  
Older male participants of the ARIC Study with a history of distant military and 
combat exposure had a higher burden of subclinical atherosclerosis than those not reporting 
military service. Thus, combat exposure may exert long-term adverse effects on subclinical 
atherosclerosis. A challenge for future studies is to elucidate the possible mechanisms 
through which stress can place an individual at long-term risk for atherosclerosis and CHD. 
With a focus on finding pathways for prevention, subsequent studies should assess whether 
psychosocial stress acts through mediational biological processes such as inflammatory 
markers as well as through psychological, behavioral or lifestyle changes. In addition, studies 
with larger sample sizes could better evaluate the potential role of service era, race, SES and 
other important modifiers of the association between combat and cardiovascular risk can be 
clarified. Ideally, studies should be population-based, so as to include both veteran and non-
veteran controls. The findings in this study, if confirmed, have implications for our 
understanding of the lasting effects of traumatic stress on long-term cardiovascular health.  
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Manuscript 2: Military Combat and Risk of Coronary Heart Disease and Ischemic 
Stroke in Aging Men: the Atherosclerosis Risk in Communities (ARIC) Study 
 
Abstract 
Studies of the long-term cardiovascular consequences of combat stress are few and 
inconclusive. The association between remote exposure to military combat and the risk of 
cardiovascular disease was assessed among 4,620 men in the Atherosclerosis Risk in 
Communities study. Predicted and observed risk of coronary heart disease (CHD) and 
ischemic stroke (IS), as well as key risk factors were compared between non-veterans and 
veterans with and without one or more self-reported combat exposures. Outcomes were 
assessed an average of 36 years after entry into military service during the eras of World War 
II, the Korean War and the Vietnam conflict.  Veterans tended to be older, white and of 
higher socioeconomic status than non-veterans. Veterans were less likely to be current 
smokers than non-veterans. Combat veterans had higher average systolic blood pressure, 
lower average high density lipoprotein cholesterol and were more likely to be on 
hypertension medications and have prevalent CHD than either non-veterans or non-combat 
veterans. Combat veterans had higher CHD and IS incidence rates than non-combat veterans 
or non-veterans of the Korean War era; however, they had lower incidence rates than either 
comparison group for cohort members of World War II and the Vietnam Conflict eras. 
Incidence rate ratios (IRR) were statistically significant only in comparisons between combat 
and non-combat veterans for CHD (IRR=1.46; 95% CI=1.02, 2.07) and IS (IRR=1.81; 95% 
CI=1.01, 3.23).  Results do not suggest that combat exposure exerts long-term adverse effects 
on cardiovascular risk among men; however, effects may differ by military conflict.   
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Introduction 
Exposure to military service can have positive as well as negative consequences9,10 
and can have both short-term and long-term effects.11,12 The psychosocial stress experienced 
by veterans who have engaged in active combat is a uniquely traumatic stressor that includes 
both psychological and physical components.13,112 The effects of military service in general 
and military combat in particular are so pervasive yet so little studied that they have been 
termed the “hidden variable” in the aging of older American men.10,13 Approximately 65% of 
American men over the age of 55 served in World War II or the Korean conflict. Further, 
about one quarter of all older American men were exposed to military combat at some time 
in their lives.11,116 
Studies report higher rates of adverse behavioral risk profiles,125 psychological 
conditions128 and self-reported health conditions130,131 among those exposed to military 
combat. However, studies of the long-term cardiovascular consequences of combat stress are 
limited, and to date have been inconclusive.13,137 We report on the long term association 
between exposure to military combat and the incidence of coronary heart disease (CHD) and 
ischemic stroke (IS) in a large, community-based sample of men whose military service 
spanned the eras of World War II, the Korean War and the Vietnam Conflict. 
 
Methods 
Data for this investigation were collected in the cohort component of the 
Atherosclerosis Risk in Communities (ARIC) Study, a prospective, community-based study 
designed to investigate the etiology and natural history of cardiovascular disease (CVD) and 
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atherosclerosis. At baseline (1987-1989), the cohort included 15,792 African-American and 
Caucasian men and women between the ages of 45 and 64 years, sampled from four U.S. 
communities: Minneapolis, MN; Washington County, MD; Jackson, MS; and Forsyth 
County, NC. Participants from MN and MD were Caucasian, while African-American 
participants were sampled exclusively in MS. The NC center included both African-
American and Caucasian participants with an over-sampling of African-Americans. At 
baseline, standardized interviews were conducted to establish health history and to obtain 
demographic, socioeconomic and behavioral risk data. Using standard protocols, trained and 
certified technicians performed physical exams and subclinical CVD procedures and 
collected fasting blood samples. A detailed account of the design and procedures has been 
published,652,653 and the study protocols and information on quality control and assurance can 
be found on the ARIC website (http://www.cscc.unc.edu/aric). After baseline, three triennial 
examinations were given, the last of which occurred in 1997-1999. In addition, 
approximately 94% of cohort survivors are successfully contacted and interviewed annually 
to ascertain vital status, health status and hospitalizations. 
An ancillary study to ARIC, the Life Course Socioeconomic Status, Social Context 
and Cardiovascular Disease (LC-SES) Study was initiated in 2001 to examine the association 
between SES across the life course and adult cardiovascular conditions. Additional details 
about its design and procedures are published654 and are available on the LC-SES website 
(http://www.lifecourseepi.info). After an average of fifteen years of follow-up, the ages of 
cohort participants ranged from 57 to 79 years. During the LC-SES interview, 12,716 or 81% 
of the baseline ARIC participants (91% of cohort survivors) were queried about 
socioeconomic information, military service and combat exposures.  
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Because only 49 women who participated in the LC-SES Survey reported that they 
had served in the armed services, the current study was limited to men. Also, because their 
numbers were insufficient for analysis, men with self-reported race other than African-
American or Caucasian (n=14) and African-Americans from Washington County or 
Minneapolis (n=21) were excluded. Further excluded were 53 men who had missing or 
unknown military service status and 727 men who served outside the defined periods of 
conflict for World War II (1941-1945), the Korean War (1950-1953) and the Vietnam 
Conflict (1961-1975). After these exclusions, the study population included 4,620 men for 
analyses.  
Military service status is based on self-report during the LC-SES follow-up interview. 
Participants who reported that they had served in the military were further asked a series of 
questions detailing military experience, including: (1) age at entry into the service, (2) length 
of service, and whether they (4) served in a combat zone, (5) were ever under fire or fired at 
the enemy, (6) saw others wounded or killed or (7) were ever wounded or missing in 
action.675 A three-level exposure variable was derived: no history of military service (non-
veterans), history of military service without exposure to combat stress (non-combat 
veterans) and history of military service with exposure to combat stress (combat veterans). 
While history of military service was directly queried, exposure to combat was established 
based on a positive response to one or more of questions 4-7 above. Throughout the analyses, 
combat veterans and non-combat veterans are treated as two levels of exposure and are 
compared separately to non-veteran “controls.”  
Era of military service was determined using information provided on age at entry 
into the military and duration of service. Veterans served during the eras of World War II, the 
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Korean War and the Vietnam Conflict. Veterans who served during multiple conflict eras 
(e.g., both World War II and the Korean War or both the Korean War and the Vietnam 
Conflict) were categorized according to their first era of service, as this was their initial 
military experience. Veterans who served between periods of defined conflict were excluded 
from analysis, as they were deemed too heterogeneous to provide results from which 
meaningful conclusions could be drawn. Non-veterans were placed into era of service 
categories according to the chronological age category into which they fell at Visit 1 (<52, 
52-59 and 60+ years). These age categories matched up closely with era of service categories 
in this study population, with 94% of World War II era veterans ages 60 years and greater, 
89% of Korean War era veterans ages 52-59 years and 91% of Vietnam era veterans under 
the age of 52 years.  
Differences in the age-adjusted distribution of established biological and behavioral 
cardiovascular risk factors measured at the baseline assessment (Visit 1; 1987-1989) among 
each of the three exposure groups were examined individually. Risk factors include current 
smoking status, total cholesterol, high density lipoprotein cholesterol (HDL), systolic blood 
pressure (SBP), prevalent left ventricular hypertrophy (LVH), prevalent diabetes mellitus, 
prevalent CHD, and blood pressure medication use. Current cigarette smoking is defined as 
self-report of smoking one or more cigarettes per year at baseline (vs. former or never 
smoker). Plasma total cholesterol (mg/dL) was measured using an established enzymatic 
method,684 and HDL cholesterol (mg/dL) was measured after dextran-magnesium 
precipitation of non-high density lipoproteins.685 For SBP measurements, three seated blood 
pressure measurements were taken with a random-zero sphygmomanometer, and the last two 
measurements were averaged. Prevalent left ventricular hypertrophy was defined according 
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to the Cornell definition. Diabetes was defined as having a fasting glucose level of 126 
mg/dL or higher, a non-fasting glucose level of 200 mg/dL or higher, or a self-reported 
diagnosis of diabetes or use of diabetic medication. Prevalent CHD was defined as history of 
a myocardial infarction (MI), presence of an MI from adjudicated Visit 1 
electrocardiographic (ECG) data, or history of heart or arterial surgery, coronary bypass 
surgery, balloon angioplasty or angioplasty of one or more coronary arteries. Blood pressure 
medication use was defined as self-reported use in the previous two weeks. Additional details 
of the procedures used to obtain the risk factor data as well as the quality assurance 
procedures are published652,653 and are detailed at http://www.cscc.unc.edu/aric.  
An overall measure of predicted risk, composite CHD and IS risk scores optimized 
for race-gender groups within the ARIC population were also calculated using the ARIC risk 
equations. Methods for calculating these risk scores and the parameter estimates used have 
been published.668,669 The use of risk prediction equations has become increasingly common 
in both research and clinical applications.690,691,692 Predicted CHD risk scores for men are 
stratified by race and incorporate baseline values for age in years, total and HDL cholesterol, 
SBP, prevalent diabetes, current smoking status and blood pressure medication use. Predicted 
IS risk scores incorporate age, race, current smoking status, SBP, prevalent diabetes, blood 
pressure medication use, LVH and prevalent CHD. 
Detailed descriptions of the methods of ascertainment of incident CHD and IS events 
have been provided in previous work.668,669 Briefly, CHD and IS incidence were ascertained 
by annual follow-up interview and validated by review of hospital discharge records and 
death certificates.665,671,672 Out-of-hospital deaths were ascertained through death certificates 
and, when available, coroner or autopsy reports. In the majority of out-of-hospital deaths, 
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cause of death was further validated by an interview with one or more next of kin as well as 
by a questionnaire completed by the patient’s treating physician. Incident events were 
included from enrollment in ARIC until December 31, 2002. 
An incident CHD event was defined as: (a.) a validated definite or probable 
hospitalized myocardial infarction (based on a combination of chest pain symptoms, ECG 
changes, and cardiac enzyme levels); (b.) a definite CHD death (based on chest pain 
symptoms, underlying cause of death from death certificate, and other information from the 
hospital chart, medical history or ARIC visit); or (c.) an unrecognized MI identified by ECG 
readings at one or more of the ARIC examinations (based on ECG readings with a major Q-
wave or a minor Q-wave with ischemic ST-T changes, or an MI by computerized NOVA-
CODE criteria confirmed by a side-by-side visual comparison of baseline and follow-up 
ECGs).  
An incident IS event was defined as a validated definite or probable hospitalized 
embolic or thrombotic stroke, classified according to symptom type, duration and severity as 
well as results of neuroimaging and other diagnostic procedures and autopsy evidence, when 
available.671,674 
SAS statistical software Version 8.02 was used for all analyses.693 Descriptive 
statistics were calculated for baseline distributions of sociodemographic characteristics and 
military and combat exposures. Ten-year predicted risks of CHD and IS associated with 
exposure to military service with and without combat were calculated independently using 
linear regression using published sex and race-specific parameter estimates. 668,669 
Incidence rates (IR) were calculated by dividing the number of events by the total 
time experienced for the participants followed. Incidence rate ratios (IRR) and 95% 
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confidence intervals (CI) were calculated using Poisson regression697 using PROC 
GENMOD with the log link and Poisson distribution options. In this way, CHD and stroke 
event rates were modeled on a logarithmic scale as a function of military and combat 
exposure status, and residuals followed a Poisson distribution. Combat veterans and non-
combat veterans were compared separately with non-combat “controls,” and the two veteran 
groups—combat veterans and non-combat veterans—were also compared with one another. 
Results were stratified according to era of service (World War II, the Korean War or 
the Vietnam Conflict) in order to assess potentially important heterogeneity in effects. Non-
veterans were grouped into three age categories (<52, 52-59, 60+ years) that most closely 
mirrored the age categories of veterans who served during the eras of World War II, the 
Korean War and the Vietnam Conflict, respectively. Interaction by era was assessed using 
Wald chi-square tests for homogeneity of IRR using an a priori rejection level of 0.05. 
Although insufficient sample size prohibited further stratification by race, descriptive 
military, combat and sociodemographic were presented in order to highlight differences 
among the three eras of service investigated.  
 
Results  
A total of 4,620 men were included in this study: 2042 non-veterans, 1495 non-
combat veterans and 1083 combat veterans. Among veterans, the most common period of 
service was during the Korean War (42%), and approximately equal proportions of veterans 
participated in World War II (31%) or the Vietnam conflict (27%) (Table 16). Combat 
veterans were more likely to have served during World War II and less likely to have served 
during the Vietnam conflict, compared to non-combat veterans. The mean age at induction 
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into the military was approximately one year younger for combat veterans compared to non-
combat veterans, and the duration of service was approximately 1.5 years longer. Terms of 
service were longest for combat veterans who served during the Vietnam Conflict. The 
average time elapsed between induction into the military and enrollment in the ARIC study 
was 39 years among combat veterans and 35 years among non-combat veterans. Among 
combat veterans, service in a combat zone was the most commonly reported combat 
exposure, followed by having seen others wounded or killed during the war, and having been 
under fire or fired at the enemy. Only 14% of combat veterans reported having been 
wounded or missing during war. World War II era veterans were most likely to report each of 
the combat exposures assessed, while Vietnam Conflict era veterans were the least likely. 
Veterans tended to be older, white and of higher SES compared to non-veterans 
(Table 17). A larger proportion of Vietnam Conflict era veterans were black (20%), 
compared to combat veterans of the World War II (9%) or Korean War eras (15%). Veterans 
consistently had more favorable socioeconomic profiles that non-veterans, with Vietnam 
veterans having the highest education, income and occupation levels.  
When profiles were further broken down by race, a number of differences were noted 
among the three eras of service investigated (Table 18). White men were more likely to have 
served in the military than black men in each of the conflicts, although these differences were 
largest for the World War II era (83% vs. 55%) and smallest for the Vietnam Conflict era 
(44% vs. 42%). White veterans were more likely than black veterans to see combat during 
the World War II era, and less likely during the eras of the Korean War and the Vietnam 
Conflict.  For each era of service investigated, black veterans served longer terms than their 
white counterparts. Black and white men differed little in their age at baseline. Black men 
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had lower adult SES, as measured by education, income and occupation at each combat level 
and during each era of service. However, measured by father’s education level, childhood 
SES was higher for black men than white men during the World War II and Korean War eras 
and reversed for the era of the Vietnam Conflict. 
 Overall, veterans were less likely to be current smokers than non-veterans (Table 19). 
Combat veterans had higher average SBP, lower average HDL, and were more likely to be 
on hypertension medications and have prevalent CHD than either non-veterans or non-
combat veterans (Tables 4 and 5). Non-combat veterans had the lowest prevalence of 
diabetes and the lowest average total cholesterol. When overall CHD and IS risk scores were 
calculated, the 10-year predicted CHD and stroke risk was highest for combat veterans and 
lowest for non-veterans. Current smoking rates were highest among Vietnam era men and 
lowest among World War II era men, while the reverse was true for hypertension medication 
use, LVH, CHD and diabetes rates. Similarly, men from the era of the Vietnam Conflict were 
most likely to have the lowest SBP, total cholesterol and predicted risks of CHD and IS. The 
association between combat and risk factors differed by era of service as well. In particular, 
among World War II era veterans, those exposed to combat were less likely to have prevalent 
diabetes or CHD compared to non-combat veterans. Among Korean War veterans, combat 
veterans were more likely to be current smokers and more likely to have diabetes or CHD 
and higher SBP compared to non-combat veterans. Among veterans of the Vietnam Conflict, 
those exposed to combat were less likely to be current smokers but more likely to have 
diabetes than non-veterans. 
  A total of 813 CHD events and 173 IS events occurred in this study population by 
December 31, 2002 (Table 21). Statistical interaction by era of service was detected on the 
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IRR scale (Wald chi-square p<0.05), supporting stratification of results into eras of service.  
Inter-era differences in the association between combat and the incidence of CHD and IS 
were notable. While combat veterans had higher CHD and IS incidence rates than either non-
combat veterans or non-veterans for cohort members of the Korean War era, they had lower 
incidence rates than either comparison group for cohort members of World War II and the 
Vietnam Conflict eras. Even for cohort members of the Korean War era, however, IRRs were 
statistically significant only in comparison of rates between combat and non-combat 
veterans, both for CHD (IRR=1.46; 95% CI=1.02, 2.07) and IS (IRR=1.81; 95% CI=1.01, 
3.23). 
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Table 16: Profile of Recalled Military Service and Combat History Reported During the LC-SES 
Interview, by War/Conflict Era. 
 
Non-Combat  
Veteran 1 
Combat  
Veteran 
N    
World War II  314 478 
Korean War  675 407 
Vietnam Conflict  506 198 
Mean (SD) Age at induction into service (years)   
World War II  17.9 (0.9) 18.0 (1.0) 
Korean War  19.7 (1.9) 19.4 (1.9) 
Vietnam Conflict  21.2 (2.8) 20.9 (3.3) 
Mean (SD) Duration of service (years)   
World War II  2.5 (2.2) 4.2 (4.5) 
Korean War  3.5 (3.7) 5.2 (6.1) 
Vietnam Conflict  4.0 (4.4) 7.2 (7.2) 
Mean (SD) Elapsed time since age at induction into service (years) 2  
World War II  43.6 (1.3) 44.5 (1.3) 
Korean War  36.6 (2.0) 37.3 (2.0) 
Vietnam Conflict  27.0 (3.0) 26.7 (3.7) 
n (%) Served in combat zone   
World War II  0 430 (90.0) 
Korean War  0 339 (83.3) 
Vietnam Conflict  0 163 (82.3) 
n (%) Under enemy fire or fired at enemy 
 
 
World War II  0 337 (70.7) 
Korean War  0 229 (56.8) 
Vietnam Conflict  0 110 (55.6) 
n (%) Saw wounded or killed during war   
World War II  0 357 (74.8) 
Korean War  0 294 (73.0) 
Vietnam Conflict  0 139 (70.2) 
n (%) Ever wounded or missing during war   
World War II  0 76 (15.9) 
Korean War  0 57 (14.1) 
Vietnam Conflict  0 18 (9.1) 
1 Combat Veterans are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans are defined as those who served in the military but did not report 
any combat exposures (1-4).  
2 Age at Visit 1 – self-reported age at entry into the military
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Table 17: Sociodemographic Profile of Black and White Men at ARIC Baseline Examination 
(1987-1989): LC-SES Participants (Overall and by Military/Combat Exposure), by Era of 
Service. 
 
Non-
Veteran 
Non-Combat  
Veteran 1 
Combat  
Veteran  
N    
World War II  217 314 478 
Korean War  695 675 407 
Vietnam Conflict  1130 506 198 
Mean (SD) Age at Baseline ARIC Visit in years    
World War II  61.9 (1.5) 61.5 (1.6) 62.5 (1.5) 
Korean War  54.9 (2.3) 56.3 (2.4) 56.7 (2.2) 
Vietnam Conflict  47.9 (2.0) 48.2 (2.5) 47.6 (2.6) 
n (%) Black     
World War II  68 (31.3) 37 (11.8) 45 (9.4) 
Korean War  204 (29.4) 88 (13.0) 60 (14.7) 
Vietnam Conflict  371 (32.8) 75 (14.8) 39 (19.7) 
n (%) Education <High School 
   
World War II  113 (52.3) 77 (24.5) 112 (23.4) 
Korean War  280 (40.4) 94 (14.0) 67 (16.5) 
Vietnam Conflict  232 (20.6) 20 (4.0) 8 (4.1) 
n (%) Father’s Education <High School 2    
World War II  108 (62.8) 178 (63.1) 282 (64.7) 
Korean War  355 (63.6) 374 (64.0) 229 (65.4) 
Vietnam Conflict  547 (59.1) 219 (50.9) 79 (48.2) 
n (%) Combined Family Income <$25,000 3 
   
World War II  129 (62.3) 81 (26.8) 163 (35.8) 
Korean War  229 (34.9) 135 (20.6) 74 (19.2) 
Vietnam Conflict  267 (25.2) 63 (12.9) 26 (13.7) 
n (%) Occupation Non-Managerial/Professional 
   
World War II  196 (90.3) 245 (78.0) 412 (86.2) 
Korean War  512 (73.9) 446 (66.1) 290 (71.3) 
Vietnam Conflict  738 (65.3) 302 (59.7) 132 (66.7) 
Note: columns may not sum to 100% due to rounding 
1 Combat Veterans are identified by a summary variable based on whether or not the individual served 
in the military and, if so, whether the individual (1) served in a combat zone, (2) was under enemy fire 
or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; 
Non-Combat Veterans are defined as those who served in the military but did not report any combat 
exposures (1-4).  
2
 718 values missing information on natural father’s education; Measured during LCSES Interview 
(2001-2002) and therefore not available on entire ARIC Study population. 
3 220 values missing information on combined family income.  
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Table 18:  Military, Combat and Sociodemographic Profile of Black and White Male LC-SES Participants (Overall and by Military/Combat 
Exposure), by Race and Era of Service. 
Note: columns may not sum to 100% due to rounding 
1Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the individual (1) served 
in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat 
Veterans are defined as those who served in the military but did not report any combat exposures (1-4).  
2
 718 values missing on natural father’s education;  220 values missing information on combined family income.  
 
Black 
 
White 
 
Non- 
Veteran 
Non-Combat 
Veteran 1 
Combat 
Veteran  
Non- 
Veteran 
Non-Combat 
Veteran  
Combat 
Veteran  
N (%) Military/combat status 
      
World War II  68 (45.3) 37 (24.7) 45 (30.0) 149 (17.4) 277 (32.3) 433 (50.4) 
Korean War  204 (58.0) 88 (25.0) 60 (17.1) 491 (34.5) 587 (41.2) 347 (24.4) 
Vietnam Conflict  371 (57.7) 75 (37.5) 39 (27.1) 759 (56.3) 431 (32.0) 159  (11.8) 
Mean (SD) Duration of Service i 
      
World War II  0 2.9 (3.3) 6.3 (7.5) 0 2.5 (2.0) 4.0 (4.1) 
Korean War  0 3.8 (4.4) 5.6 (6.8) 0 3.5 (3.5) 5.2 (6.0) 
Vietnam Conflict  0 5.5 (6.8) 8.5 (8.2) 0 3.7 (3.7) 6.9 (6.9) 
Mean (SD) Age at Baseline in years 
      
World War II  62.0 (1.6) 62.6 (1.2) 62.8 (1.5) 61.9 (1.5) 61.3 (1.6) 62.5 (1.5) 
Korean War  54.8 (2.4) 56.8 (2.4) 57.1 (2.7) 55.0 (2.3) 56.3 (2.4) 56.6 (2.1) 
Vietnam Conflict  47.8 (2.0) 47.7 (2.4) 47.5 (3.0) 48.0 (2.0) 48.3 (2.5) 47.6 (2.5) 
n (%) Education <High School 
      
World War II  58 (85.3) 18 (48.7) 14 (31.1) 55 (37.2) 59 (21.3) 98 (22.6) 
Korean War  147 (72.4) 15 (17.1) 9 (15.0) 133 (27.1) 79 (13.5) 58 (16.8) 
Vietnam Conflict  134 (36.3) 4 (5.33) 2 (5.1) 98 (12.9) 16 (3.7) 6 (3.8) 
n (%) Father’s Education <High School 2 
      
World War II  22 (51.2) 17 (58.6) 22 (64.7) 86 (66.7) 161 (63.6) 260 (64.7) 
Korean War  76 (55.5) 40 (64.5) 38 (77.6) 279 (66.3) 334 (64.0) 191 (63.5) 
Vietnam Conflict  173 (66.0) 34 (58.6) 19 (65.5) 374 (56.3) 185 (49.7) 60 (44.4) 
n (%) Combined Family Income <$25,000 2 
      
World War II  59 (93.7) 21 (65.6) 28 (70.0) 70 (48.6) 60 (22.2) 135 (32.5) 
Korean War  134 (71.7) 38 (46.3) 23 (44.2) 95 (20.2) 97 (16.9) 51 (15.3) 
Vietnam Conflict  172 (53.4) 21 (31.3) 12 (34.3) 95 (12.9) 42 (10.0) 14 (9.0) 
n (%) Occupation Non-Managerial/Professional 
      
World War II  67 (98.5) 30 (81.1) 41 (91.1) 129 (86.6) 215 (77.6) 371 (85.7) 
Korean War  185 (90.7) 61 (69.3) 41 (68.3) 327 (66.9) 385 (65.6) 249 (71.8) 
Vietnam Conflict  280 (75.5) 53 (70.7) 29 (74.4) 458 (60.3) 249 (57.8) 103 (64.8) 
150 
 150 
Table 19: Risk Factor Profile of Black and White Men at ARIC Baseline Examination (1987-
1989): LC-SES Participants (Overall and by Military/Combat Exposure), by Era of Service 
(Dichotomous Variables). 
 
Non-Veteran Non-Combat  
Veteran 1 
Combat  
Veteran  
N    
World War II  217 314 478 
Korean War  695 675 407 
Vietnam Conflict  1130 506 198 
n (%) Current cigarette smoking status 2    
World War II  42 (19.4) 44 (14.0) 70 (14.6) 
Korean War  183 (26.4) 139 (20.6) 108 (26.6) 
Vietnam Conflict  316 (28.0) 136 (26.9) 44 (22.2) 
n (%) Used blood pressure-lowering 
medications in past 2 weeks 
   
World War II  77 (35.5) 118 (37.6) 139 (29.1) 
Korean War  204 (29.4) 175 (25.9) 113 (27.9) 
Vietnam Conflict  212 (18.8) 78 (15.4) 28 (14.1) 
n (%) Prevalent left ventricular hypertrophy 3 
   
World War II  8 (3.8) 10 (3.3) 7 (1.5) 
Korean War  22 (3.3) 5 (0.8) 8 (2.0) 
Vietnam Conflict  18 (1.6) 4 (0.8) 1 (0.5) 
n (%) Prevalent diabetes  
   
World War II  36 (16.7) 40 (12.7) 56 (11.8) 
Korean War  69 (10.1) 55 (8.2) 36 (8.9) 
Vietnam Conflict  108 (9.7) 29 (5.8) 17 (8.6) 
n (%) Prevalent coronary heart disease  
   
World War II  18 (8.5) 36 (11.6) 45 (9.6) 
Korean War  45 (6.6) 42 (6.4) 37 (9.3) 
Vietnam Conflict  42 (3.8) 12 (2.4) 4 (2.0) 
Because of missing data, N differs for some variables. 
Some columns may not sum to 100% due to rounding. 
1 Combat Veterans are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans are defined as those who served in the military but did not report 
any combat exposures (1-4).  
2 Current cigarette smoking is defined as self-report of smoking one or more cigarettes per year at 
baseline; Heavy cigarette years of smoking is calculated by multiplying the number of cigarettes 
smoked per year by the number of years the individual has been smoking and is defined as having 
smoked 660 or more cigarettes; Physical inactivity is defined as having a sports activity index score 
less than 2.0.  
3 Presence of left ventricular hypertrophy was determined electrocardiographically using the Cornell 
criteria.
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Table 20: Risk Factor Profile of Black and White Men at ARIC Baseline Examination (1987-
1989): LC-SES Participants (Overall and by Military/Combat Exposure), by Era of Service 
(Continuous Variables). 
 
Non-Veteran Non-Combat  
Veteran 1 
Combat  
Veteran  
N    
World War II  217 314 478 
Korean War  695 675 407 
Vietnam Conflict  1130 506 198 
Mean (SD) Systolic BP (mmHg) 
   
World War II  127.7 (20.5) 125.7 (18.9) 125.6 (17.3) 
Korean War  123.5 (17.8) 120.8 (16.3) 122.5 (16.0) 
Vietnam Conflict  119.5 (16.4) 116.1 (14.6) 116.6 (14.5) 
Mean (SD) Total cholesterol (mg/dL) 
   
World War II  212.4 (38.8) 212.0 (37.9) 214.3 (38.0) 
Korean War  212.6 (40.4) 212.5 (37.3) 214.6 (42.6) 
Vietnam Conflict  207.4 (39.5) 205.9 (39.0) 207.7 (41.0) 
Mean (SD) HDL cholesterol (mg/dL) 
   
World War II  46.7 (13.9) 44.7 (14.1) 44.1 (12.2) 
Korean War  44.6 (13.5) 43.9 (12.8) 43.3 (13.2) 
Vietnam Conflict  44.6 (13.5) 43.9 (13.0) 43.6 (13.1) 
Mean (SD) 10-year predicted risk of 
coronary heart disease 2 
   
World War II  0.1567 (0.0997) 0.1593 (0.0962) 0.1567 (0.0845) 
Korean War  0.1283 (0.0797) 0.1325 (0.0792) 0.1456 (0.0853) 
Vietnam Conflict  0.0788 (0.0561) 0.0805 (0.0589) 0.0766 (0.0491) 
Mean (SD) 10-year predicted risk of 
ischemic stroke 2 
   
World War II  0.0626 (0.0659) 0.0506 (0.0511) 0.0469 (0.0409) 
Korean War  0.0299 (0.0308) 0.0275 (0.0292) 0.0316 (0.0293) 
Vietnam Conflict  0.0149 (0.0155) 0.0117 (0.0100) 0.0114 (0.0102) 
Because of missing data, N differs for some variables. 
1 Combat Veterans are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans are defined as those who served in the military but did not report 
any combat exposures (1-4).  
2 Components of 10-year predicted risk score described in detail in Methods section; age is included 
in the risk prediction model and is centered at 55 years
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Table 21: Observed Cumulative Incidence of Coronary Heart Disease (CHD) and Ischemic 
Stroke through 2002 by Military Service and Combat History.   
 Non- 
Veteran 
Non-Combat  
Veteran 1 
Combat  
Veteran 
N    
World War II  217 314 478 
Korean War  695 675 407 
Vietnam Conflict  1130 506 198 
    
CHD 
   
n (%) Events    
World War II  60 (27.7) 72 (22.9) 102 (21.3) 
Korean War  123 (17.7) 135 (20.0) 88 (21.6) 
Vietnam Conflict  147 (13.0) 64 (12.7) 22 (11.1) 
Incidence rate (incident events  
         per 10,000 person-years)    
World War II  38.9 32.5 29.6 
Korean War  27.4 30.3 32.7 
Vietnam Conflict  22.4 21.7 19.2 
Incidence rate ratio (95% CI)     
World War II  REF 0.83 (0.59, 1.17) 0.77 (0.56, 1.06) 
Korean War  REF 1.13 (0.89, 1.44) 1.22 (0.93, 1.61) 
Vietnam Conflict  REF 0.97 (0.73, 1.30) 0.85 (0.55, 1.34) 
Incidence rate ratio (95% CI)     
World War II   REF 0.93 (0.69, 1.26) 
Korean War   REF 1.08 (0.83, 1.41) 
Vietnam Conflict   REF 0.88 (0.54, 1.43) 
    
ISCHEMIC STROKE 
   
n (%) Events    
World War II  11 (5.1) 19 (6.1) 24 (5.0) 
Korean War  29 (4.2) 22 (3.3) 24 (5.9) 
Vietnam Conflict  31 (2.7) 11 (2.2) 24 (1.0) 
Incidence rate (incident events  
         per 10,000 person-years)    
World War II  6.7 8.0 6.5 
Korean War  6.0 4.0 8.3 
Vietnam Conflict  4.4 3.5 1.6 
Incidence rate ratio (95% CI)     
World War II  REF 1.19 (0.57, 2.51) 0.99 (0.49, 2.02) 
Korean War  REF 0.78 (0.45, 1.36) 1.41 (0.82, 2.43) 
Vietnam Conflict  REF 0.79 (0.40, 1.58) 0.37 (0.09, 1.54) 
Incidence rate ratio (95% CI)    
World War II  
 
REF 0.83 (0.45, 1.51) 
Korean War  
 
REF 1.81 (1.01,  3.23) 
Vietnam Conflict   REF 0.46 (0.10, 2.10) 
1 Combat Veterans are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans are defined as those who served in the military but did not 
report any combat exposures (1-4).  
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Discussion 
This prospective study of aging men found that the association between exposure to 
military combat on the rate of CHD and IS later in life may not be consistent across military 
conflicts. While combat may be associated with increased CHD and IS rates among men who 
served during the era of the Korean War, combat exposure appears to have no effect or even 
a protective effect among men who served during the eras of World War II and the Vietnam 
Conflict.  
To our knowledge, an association between exposure to military combat and incident 
CHD and IS has not previously been reported. However, our findings were in line with those 
from previous studies of veterans who served during the Vietnam Conflict that compared 
theater veterans to their non-theater veteran counterparts. These studies found no significant 
differences in all-cause or circulatory disorder mortality rates 20-30 years after participation 
in the military154,157,158,194 or in relative risks of circulatory disease 16 after military service.193 
Although more limited, research on the long-term health effects of combat exposure among 
World War II and Korean War veterans parallels our findings for Korean War era veterans 
but not World War II era veterans. A study of former prisoners of war (POWs) of World War 
II and the Korean War reported higher risk of heart disease and stroke mortality among 
POWs compared to both non-POW veteran controls and US population controls 50 years 
after exiting the military.147 Similarly, a study of World War II veterans found that combat 
was associated with higher prevalence of chronic illness and all-cause mortality 15 years 
after the end of the conflict175 and all-cause mortality 50 years after exiting the military.710 
Heterogeneity in the effect of combat on carotid plaque and carotid artery wall thickness by 
era of service was noted in a previous analysis of ARIC men, which reported stronger 
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associations between combat and subclinical atherosclerosis among veterans of the World 
War II and Korean War eras than those who served during the era of the Vietnam Conflict.717 
Findings from this study are congruent with those from the present study for veterans of the 
eras of the Korean War and the Vietnam Conflict but not for those from World War II.  The 
apparent disagreement of results among World War II era veterans—that combat is 
associated with higher rates of subclinical atherosclerosis but not CHD and stroke events—
may be a result of the time that outcomes were measured, such that in this older cohort the 
majority of events may have already taken place regardless of combat or veteran status, 
masking differences. 
Age is a potent predictor of CHD and stroke; however, because age was not 
associated with the exposure in this study population, as evidenced by the similarities in the 
age at induction into the military, it could not be treated as a confounder in analysis. Still, 
participants’ mean age at the time when CIMT and carotid plaque were measured differed 
sufficiently among the three exposure groups – with combat veterans averaging three years 
older than non-combat veterans and five years older than non-veterans – to raise the potential 
concern that age may be affecting results.  Although stratification of results by era of service 
limited the effects of age in these analyses, residual differences in age may still be playing a 
role in inter-era differences in effect. The older age of World War II era participants may 
mask effects in that the majority of events may have already taken place by the time that 
events were measured. Reciprocally, the younger age at which Vietnam Conflict era 
participants’ outcomes were assessed in this study may have contributed to the apparently 
weaker effect of combat exposure among these participants,  
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Heterogeneous behavioral and physical risk factor profiles among veterans by era 
may also contribute to the apparent inter-era differences in the effect of combat. The finding 
of associations between combat and CVD among Korean War era veterans but not World 
War II and Vietnam Conflict era veterans mirrors findings that combat veterans were more 
likely to have higher rates of diabetes, higher waist circumference and higher triglycerides 
during the eras of the Korean War and Vietnam Conflict but not the World War II era, and 
that higher SBP and higher rates of CHD were found only among combat veterans who 
served during the era of the Korean War. Similarly, differences in the composite CHD and IS 
risk scores are in line with differences in the observed incidence rates of CHD and IS; the 
ten-year predicted risks of CHD and IS were highest for combat veterans during the Korean 
War era but not during the eras of World War II or the Vietnam Conflict. Some risk factor 
differences may be attributed, at least in part, to differences in the age at which risk factors 
were measured. The finding that Vietnam era men had higher smoking rates and lower 
hypertension medication use, SBP, total cholesterol, LVH, CHD and diabetes rates than 
members of the World War II and Korean War era cohorts is likely age-related, such that 
older men are more likely to have been diagnosed with health problems such as LVH, CHD, 
diabetes, high BP and high cholesterol that required them to quit smoking and be placed on 
hypertension medications.   
Unmeasured psychological disorders such as post-traumatic stress disorder (PTSD) 
may also have acted as a mediator in the relationship between combat and cardiovascular 
morbidity and mortality.182,709 The development and persistence of PTSD has been found to 
be directly associated with exposure to combat among veterans of all three conflicts,10,595,710 
as well as with plasma cortisol and other inflammatory markers150,164 and circulatory 
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prevalence rates408 among veterans of the Vietnam Conflict. While it would have been of 
interest to provide results stratified on PTSD status, this information was not queried in the 
LC-SES interview. Because PTSD status would have been assessed as a modifier rather than 
as a confounder, its exclusion does not detract from our findings. Our results support the 
conclusion that the effects of combat exposure extend beyond the narrow scope of these 
clinical diagnoses.9,700,710 
The association between combat and CHD and IS may also differ by current and past 
socioeconomic environments and opportunities. Inverse associations between SES and CVD 
have been demonstrated repeatedly.511,512 Lower individual SES is associated with increased 
rates of smoking, obesity and physical inactivity523,524,525 as well as lower self-reported social 
mobility, increased financial strain and more stressful life events.512 SES may differentially 
affect how an individual responds psychologically and physically to life events and stressors 
such as exposure to combat, both psychologically and physically, with higher SES providing 
protection.567  In the current study, veterans consistently had the most favorable SES profiles 
overall, with Vietnam veterans having the highest education, income and occupation levels. 
Such differences may reflect the different age distributions in each exposure group, as the 
socioeconomic position of veterans has increased over time.582 This finding is also likely a 
reflection of secular trends in education or in the ability of affluent Vietnam draftees to 
postpone induction by enrolling in school and obtaining educational deferment.713 
Alternatively, it may reflect the economic and educational opportunities such as the 
Montgomery GI Bill has enabled veterans to keep pace with, though not exceed, non-
veterans in terms of educational attainment.172,572  
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Inter-era differences in the association between military and combat exposures with 
CHD and IS rates may also reflect differences in the type and nature of combat experienced 
during each of these conflicts as well as the social and political context surrounding them.585 
Although in the current analyses Vietnam Conflict era veterans were less likely to report 
combat exposure than other veterans, they served longer average terms, and the nature of the 
combat experienced may have differed. Reports suggest that Vietnam veterans were 
subjected to unusually high levels of “barbarity and moral ambiguity” as well as chronic 
exposure to unpredictable and dangerous warfare environments and were more likely to have 
witnessed abusive violence or killings compared to veterans of World War II.711,712 Further, 
inter-era variations may also reflect differences in the social and political context surrounding 
the conflicts.585 Vietnam veterans returned home to a social and political environment that 
was unsupportive of the US involvement in the conflict.588 In contrast, World War II was a 
war with a clearly identified enemy, and returning soldiers had the overwhelming support of 
the American public.595 Although the Korean War was fought by defined armies for territory, 
there were heavy military and civilian casualties, similar to the Vietnam Conflict. Further, 
soldiers left the war with no clear victor and little support or recognition and even 
condemnation from the American public, leading them to be known as the “forgotten” 
veterans.727 The manner in which soldiers were received at homecoming has been found to 
have a significant effect on the risk of developing PTSD and other psychiatric symptoms 
later in life.726 The confluence of divergent factors such as the clarity of identification of the 
enemy, involvement of civilians in combat, transparency of the purported goals of the war, 
and level of public support could explain the different associations between combat-related 
stress and health among men from different eras.  
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Given the particularly brutal nature of combat experienced during the Vietnam 
Conflict and the Korean War and the sociopolitical context in which their homecoming 
occurred,588 we might expect the effects of combat to be most pronounced among these 
veterans. In fact, studies comparing postwar readjustment and psychological health among 
veterans of World War II, the Korean War and the Vietnam Conflict have found the highest 
rates of PTSD among Korean War and Vietnam Conflict veterans and the lowest among 
World War II veterans.724 Once factors such as age, race, education and combat exposure 
were taken into account, symptoms of PTSD and psychiatric distress were found to be higher 
among Korean War Veterans than among either World War II or Vietnam Conflict 
veterans.595,725 The stronger associations found in the present study between combat and 
cardiovascular morbidity and mortality are in line with such findings, in that the way that 
combat affected veterans was likely not the same in each conflict, and that the long-term 
psychological and physical health effects of such exposures may have been most damaging 
among veterans of the Korean War.  
Inter-era differences in the effect of combat may also reflect differences in the racial 
composition of era of service cohorts. PTSD research suggests that different race groups may 
respond psychologically to combat in different ways. 142,617,619 Previous ARIC study results 
suggest modification by race, as an association between combat and subclinical 
atherosclerosis was noted in white but not black men.717 However, these differences may 
have been attributable to differences in baseline risk factor profiles—white but not black 
combat veterans were most likely to be heavy smokers, a major risk factor for subclinical 
atherosclerosis—and the low sample size of black men may have masked an effect in this 
group. In the present study, a higher proportion of Vietnam Conflict era veterans were black 
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compared to those of the World War II or Korean War eras. Further, compared to black 
Korean War or Vietnam Conflict era veterans, black Vietnam Conflict era veterans were 
more likely to be involved in combat.  Given these inter-era differences in racial 
composition, and because black men in the general population tend to have higher rates of 
both CHD and IS than white men, we might expect observed effects among the Vietnam era 
cohort to be inflated for CHD and IS.  However, it is also foreseeable that the effect of race 
in the combat-CVD association may differ by era, as sociopolitical factors affecting 
participation of black men in the military and, specifically in combat, differed during the 
different eras of service investigated. Finally, racial differences are often difficult to 
disentangle from differences in SES. In the present study, black men had lower adult SES, as 
measured by education, income and occupation at each combat level and during each era of 
service.  In previous studies, the effect of combat and other traumatic stressors on chronic 
disease and mortality has been found to be highest among low SES individuals, as these 
groups tend to have a higher overall stress burden as well as fewer skills and resources to 
cope with such stress.10,135 Given these findings, we might expect the combat-CVD 
association to be higher among black men than white men. Future studies would benefit from 
large enough sample size to stratify results by both era and race.  
This study provided a rare opportunity to investigate the long-term association of 
combat exposure on levels of cardiovascular risk in a large community-based cohort. 
Average follow-up time was long and participants were of an age (60 to 80 years) where 
CHD is most likely manifest. Among veterans,  periods of military service spanned from 
World War II through the Vietnam Conflict and includes measures of specific combat 
exposures and both military and civilian controls. Most previous studies have been based on 
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retrospective cohorts and have investigated differences in CVD mortality comparing war 
theater veterans and non-theater veterans of the same era. Also a particular strength, this 
study included objective, standardized measures of cardiovascular outcomes and a wide 
range of physical and behavioral risk factor measures. The availability of socioeconomic 
measures from various life epochs further offered an unusual opportunity to investigate the 
role of SES in combat-cardiovascular associations.   
The use of self-reported combat exposures presents challenges. Because the combat 
exposure variable used in this study is based on self-reported information, recall bias may 
affect results, such that men in worse health may differentially recall their military 
experiences. Even for participants whose CHD and stroke status was unknown at the time 
that military exposures were queried, participants may have been aware of their status on 
other health indicators such as hypertension and high cholesterol status. Although recalled 
exposure status is not ideal, to our knowledge, no cohorts exist that collected combat 
exposure during military service and included long-term follow-up with a rigorous 
measurement of cardiovascular outcomes. Further, defining combat as the exposure to one or 
more specific use of recalled combat exposures has precedent676,677,678 and has high validity 
and reliability.722,723 Therefore, it is unlikely that differential recollection of past military 
experiences based on current health status was significant. In fact, use of recalled combat 
experiences can be viewed as a strength, as it is a more specific and meaningful definition 
than simply separating exposure groups into theater and non-theater veterans who served 
during the same era.  
As discussed in a previous study of combat veterans in the ARIC Study, men that 
participated in the LC-SES survey had slightly more favorable behavioral and physical risk 
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factor profiles at Visit 1 than the larger ARIC cohort from which they were drawn.717 Combat 
exposure was not assessed until 12-14 years after baseline, at which time 17% of male 
baseline participants had expired. Thus, it is possible that selective survival may have biased 
our findings. We took two steps to address this concern. First, we conducted a pilot study on 
a subset of decedents from North Carolina for whom veteran status was recorded on death 
certificates. Briefly, we found a small (2%) but not statistically significant excess mortality 
among veterans, even after adjustment for age, race and education. Second, we conducted a 
sensitivity analysis to estimate the extent to which differential survival, if extant, may have 
influenced observed results by comparing observed RRs with those corrected for selection 
bias.718 We applied the adjusted mortality rates obtained from the pilot study to hypothetical 
data with incident CHD as the outcome. Assuming that those who eventually had a CHD 
event were 1.5 times more likely to die before providing data on military history than those 
who did not go on to develop CHD, our odds ratio was underestimated by only 1.5%.  Even 
under a more extreme scenario – where the difference in mortality was assumed to be higher 
than what we found in the pilot study (e.g., 14% for non-veterans and 18% for veterans – a 
29% difference in mortality) and assuming those who eventually go on to develop CHD were 
two times more likely to die prior to providing their military history – our observed effect 
estimate would still only differ from the corrected estimate by 7%. These results are 
reassuring as they suggest that both the potential magnitude of survivorship bias, if extant, 
would have been small in these data.  
Finally, although this study includes a large population of men, it does not have 
adequate statistical power to formally address hypotheses about potential effect measure 
modification. In addition to era of service and race, of particular interest would be to see if 
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there is interaction by age at entry, duration of service, psychological status and type of 
combat exposure.  
 
Conclusions  
These findings do not support the hypothesis that middle-aged men with a history of 
distant military and combat exposure are at increased long-term cardiovascular risk; 
however, effects may not be consistent across military conflicts.  Specifically, combat 
veterans from the Korean War era—but not the eras of World War II or the Vietnam 
Conflict—had a higher risk of cardiovascular disease, primarily IS, than did those who did 
not report serving in this conflict. Given the inter-era differences noted, future studies should 
focus on which aspects of combat might help explain these differences would also be of 
benefit, including the role of specific combat exposures and other military factors as well as 
socio-political factors and homecoming experiences. Further, future studies should focus on 
elucidating possible mechanisms through which psychosocial stress can place an individual 
at long-term risk for CVD. In addition, studies with larger sample sizes could better evaluate 
the potential role of service era, race, SES and other important modifiers of the association 
between combat and cardiovascular risk can be clarified. Ideally, studies should be 
population-based, so as to include both veteran and non-veteran controls. The findings in this 
study, if confirmed, have implications for our understanding of the lasting effects of 
traumatic stress on long-term cardiovascular health.  
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CHAPTER 6 
 CONCLUSIONS 
 
Summary of Results 
In this study we reported on the long term association between exposure to military 
combat and the burden of subclinical atherosclerosis (measured by carotid plaque and CIMT) 
as well as the incidence of CHD and IS in a large, community-based sample of men whose 
military service spanned the eras of World War II, the Korean War and the Vietnam Conflict. 
Those with a history of military service who reported one or more combat-related stressors 
(combat veterans) were contrasted to those without a history of military service (non-
veterans) as well as to those with a history of military service without combat (non-combat 
veterans). Results were stratified by race as well as by era of service to detect differences in 
effect among veterans of different birth and service cohorts. We also examined the extent to 
which differences by combat exposure status, if extant, vary by differences in 
sociodemographic and cardiovascular risk factor profiles.  
In the first manuscript we reported that men with distant military service, particularly 
when it included combat exposure, were more likely to have carotid plaque and increased 
CIMT than their non-veteran counterparts. These effects remained after age was taken into 
account. Overall, findings held true for veterans of the World War II and Korean War eras 
but were attenuated for those from the Vietnam Conflict era. Results for white men were 
similar to overall results, while results for black men were weaker or absent.  
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In the second manuscript we did not find the hypothesized association between 
combat exposure and risk of CHD or IS later in life; however, the effect of military combat 
on cardiovascular risk may not be consistent across military conflicts. Specifically, while 
modest associations were reported between combat exposure and increased CHD and IS rates 
among men who served during the era of the Korean War, combat exposure appeared to have 
no effect or even a protective effect among men who served during the eras of World War II 
and the Vietnam Conflict. 
Sociodemographic and cardiovascular risk factor profiles were assessed in both 
manuscripts, with notable differences seen by combat exposure status.  Veterans were more 
likely to be older and white compared to non-veterans, and veterans consistently had more 
favorable socioeconomic profiles than non-veterans, with Vietnam Conflict era veterans 
having the highest education, income and occupation levels. Combat and non-combat 
veterans were more likely to be current drinkers and heavy smokers than non-veterans but 
less likely to be current smokers and physically inactive. Combat veterans and non-veterans 
were more likely than non-veterans to have prevalent diabetes, but compared to either 
comparison group, combat veterans were most likely to have prevalent CHD, to be on 
hypertension medications and to have higher average SBP, total cholesterol and triglycerides 
and lower average HDL. When overall predicted CHD and IS risk scores were calculated, the 
10-year predicted CHD and stroke risk was highest for combat veterans and lowest for non-
veterans.  
 
 
 
 166 
Overall Conclusions  
To our knowledge, no prior studies have assessed the relationship between combat 
exposure and clinical or subclinical atherosclerosis or the relationship between combat 
exposure and incident CHD and IS. Our finding that combat is associated with carotid plaque 
and CIMT is consistent with earlier studies that reported that combat veterans with PTSD 
were more likely to have increased chronic cardiovascular arousal, higher circulating 
catecholamines and other neuroendocrine agents implicated in arterial damage and a higher 
frequency of abnormal ECG readings.  Similarly, our finding of a lack of association between 
combat exposure and rates of CHD and IS are in line findings from previous studies 
comparing theater and non-theater Vietnam veterans that found no significant differences in 
all-cause or circulatory disorder mortality rates 20-30 years after participation in the military 
or in relative risks of circulatory disease 16 after military service.  Our finding of 
heterogeneity in effect by era of service is also consistent with the current literature. 
Although more limited, research on the long-term health effects of combat exposure among 
World War II and Korean War veterans parallels our findings for Korean War era veterans 
but not World War II era veterans. A study of former POWs of World War II and the Korean 
War reported higher risk of heart disease and stroke mortality among POWs compared to 
both non-POW veteran controls and US population controls 50 years after exiting the 
military.  Similarly, a study of World War II veterans found that combat was associated with 
higher prevalence of chronic illness and all-cause mortality 15 years after the end of the 
conflict and all-cause mortality 50 years after exiting the military.   
As discussed in the Introduction, exposure to traumatic stress may affect 
cardiovascular processes through a variety of mechanisms.  Although the link between 
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psychosocial stress and coronary events is well-established, the mechanisms underlying these 
associations are not well understood. One possible explanation for our findings of higher 
rates of subclinical atherosclerosis in combat veterans is that the extreme trauma experienced 
set into motion a chronic stress response and a resultant inflammatory, atherosclerotic 
process that initiated the formation of plaque and the thickening of the arterial wall. This 
theory is supported by ARIC study findings that lower SES, both early in life and 
cumulatively across the life course, is associated with elevated levels of inflammatory 
markers such as C-reactive protein, fibrinogen, white blood cell count and von Willebrand 
factor later in life.  Similarly, a small-sample Croatian study found that combat veterans with 
PTSD had higher lymphocyte counts than civilian controls, suggesting that the immune 
system was affected in the course of chronic PTSD.   
Our failure to find an association between combat exposure and rates of CHD and IS 
does not negate the possibility that combat stress causes a direct physiologic cardiovascular 
response; it may be that while differences are detectable at the subclinical level, they are not 
yet manifest at the level of symptomatic disease. The possibility that selection bias played a 
role in this discrepancy in results was also assessed. Men that participated in the LC-SES 
survey had slightly more favorable behavioral and physical risk factor profiles at Visit 1 than 
the larger ARIC cohort from which they were drawn.717 Combat exposure was not assessed 
until 12-14 years after baseline, at which time 17% of male baseline participants had expired. 
Thus, it is possible that selective survival may have biased our findings. We took two steps to 
address this concern. First, we conducted a pilot study on a subset of decedents from North 
Carolina for whom veteran status was recorded on death certificates. Briefly, we found a 
small (2%) but not statistically significant excess mortality among veterans, even after 
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adjustment for age, race and education. Second, we conducted a sensitivity analysis to 
estimate the extent to which differential survival, if extant, may have influenced observed 
results by comparing observed RRs with those corrected for selection bias.718 We applied the 
adjusted mortality rates obtained from the pilot study to hypothetical data with incident CHD 
as the outcome. Assuming that those who eventually had a CHD event were 1.5 times more 
likely to die before providing data on military history than those who did not go on to 
develop CHD, our odds ratio was underestimated by only 1.5%.  Even under a more extreme 
scenario – where the difference in mortality was assumed to be higher than what we found in 
the pilot study (e.g., 14% for non-veterans and 18% for veterans – a 29% difference in 
mortality) and assuming those who eventually go on to develop CHD were two times more 
likely to die prior to providing their military history – our observed effect estimate would still 
only differ from the corrected estimate by 7%. These results are reassuring as they suggest 
that both the potential magnitude of survivorship bias, if extant, would have been small in 
these data.  
Behavioral mechanisms may also be at work. Both combat and non-combat veterans 
were more likely to be current drinkers and heavy smokers than non-veterans but less likely 
to be current smokers and physically inactive. Given the strong link between smoking and 
atherosclerosis, smoking may be acting as a mediator in the effects found in this study. Still, 
studies of veterans with and without combat-related PTSD have found that the association 
between PTSD and poor physical health persists even after controlling for smoking and 
alcohol consumption.  
Heterogeneous physical risk factor profiles among veterans by era may also act as 
mediators in the combat-CVD association and contribute to inter-era differences. In the study 
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of subclinical disease, associations were strongest among men who served during the World 
War II and Korean War eras and weakest among those who served during the era of the 
Vietnam Conflict.  In the study of CHD and IS events, associations were present, though 
modest, among men from the Korean War era but not the eras of World War II or the 
Vietnam Conflict. These findings are compatible with those that found combat veterans more 
likely to have higher rates of diabetes, higher waist circumference and higher triglycerides 
during the eras of the Korean War and Vietnam Conflict but not the World War II era, and 
that higher SBP and higher rates of prevalent CHD were found only among combat veterans 
who served during the era of the Korean War. Similarly, differences in the composite CHD 
and IS risk scores are in line with inter-era differences in the effect of combat; the ten-year 
predicted risks of CHD and IS were highest for combat veterans during the Korean War era 
but not during the eras of World War II or the Vietnam Conflict.  
The different social, educational and economic environments and opportunities to 
which combat veterans, non-combat veterans and non-veterans were exposed may also 
contribute to differences noted in the effect of combat on cardiovascular health. In the current 
study, while non-combat veterans consistently had the most favorable SES profiles overall, 
combat veterans had more favorable adult SES profiles but less favorable early life SES 
profiles than non-veterans.  These differences may reflect the different age distributions in 
each exposure group, as the socioeconomic position of veterans has increased over time.  
Alternatively, they may reflect the economic and educational opportunities opened to 
servicemen through programs such as the Montgomery GI Bill. Given the inverse association 
between SES and CVD, the more favorable SES profiles of veterans in this study population 
may attenuate effect estimates if combat does, indeed, adversely affect cardiovascular health. 
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Reflecting secular trends, Vietnam veterans consistently had the highest education, income 
and occupation levels in each exposure group. 
 
Interaction by Era of Service 
As discussed in the manuscripts, inter-era differences in the association between 
military and combat exposures with CHD and IS rates may also reflect differences in the type 
and nature of combat experienced during each of these conflicts as well as the social and 
political context surrounding them.  Given the particularly brutal nature of combat 
experienced during the Vietnam Conflict and the Korean War and the unfavorable 
sociopolitical context in which their homecoming occurred, we might expect the effects of 
combat to be most pronounced among these veterans. In fact, studies comparing postwar 
readjustment and psychological health among veterans of World War II, the Korean War and 
the Vietnam Conflict have found the highest rates of PTSD among Korean War and Vietnam 
Conflict veterans and the lowest among World War II veterans.  In line with these findings, 
the manuscript investigating the association between combat and CHD and IS events 
reported that associations were present, though modest, among men from the Korean War era 
but not the eras of World War II or the Vietnam Conflict. While the study investigating the 
association between combat and subclinical disease also reported associations among men 
from the Korean War era, associations were also present among those who served during the 
World War II era but not the Vietnam Conflict era. The apparent disagreement of results 
among World War II era veterans—that combat is associated with higher rates of subclinical 
atherosclerosis but not CHD and stroke events—may be a result of differential survival, such 
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that in this older cohort the majority of events may have already taken place regardless of 
combat or veteran status, masking differences.  
The lack of a finding of an effect of combat in either manuscript among men from the 
Vietnam Conflict era may reflect a number of factors. The negative sociopolitical atmosphere 
surrounding the Vietnam Conflict may have acted as a stressor among both combat and non-
combat soldiers upon homecoming, attenuating differences. The different demographic 
profile of the Vietnam Conflict cohort may also have contributed to differences in the effect 
of combat in this study. Members of this cohort tended to be inducted into the military at a 
slightly older age than those who served during the World War II or Korean War eras and 
tended to be of higher socioeconomic position, which, according to current theory, tends to 
be protective against the effects of traumatic stress. Both older average age at induction and 
higher average SES among men in this cohort may be a reflection of secular trends in 
education or in the ability of affluent Vietnam draftees to postpone induction by enrolling in 
school and obtaining educational deferment.  Finally, the younger age at which Vietnam 
Conflict era veterans’ outcomes were assessed in this study, an average of 48 years old, was 
approximately ten years younger than Korean War era veterans and seventeen years younger 
than World War II era veterans, which may have contributed to the apparently weaker effect 
of combat exposure among these participants.  
 
Interaction by Race 
The effect of race on the combat-CVD association was assessed in both 
manuscripts—through stratification of results in the manuscript investigating subclinical 
disease and descriptively in the manuscript investigating CHD and IS. Consistent with 
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previous studies that have found that the topographic distribution of atherosclerotic plaque 
vary by ethnic and racial groups, the present study reported that the association between 
combat and subclinical atherosclerosis varied by race.   Combat-related effects noted in white 
but not black men may also be related to differences in baseline risk factor profiles. Most 
notably, white but not black combat veterans were most likely to be heavy smokers, a major 
risk factor for the development of subclinical atherosclerosis. Alternatively, the low sample 
size of black men may have masked an effect. 
Although results in the manuscript studying the association between combat and 
CHD and IS events were not stratified, demographic and risk factor profiles were created 
separately for black and white men. Because black men in the general population tend to 
have higher rates of CHD and IS than white men, given the larger proportion of black men 
that participated in the military in the Vietnam Conflict era, we might expect observed effects 
among the Vietnam Conflict era cohort to be inflated for CHD and IS.  However, it is also 
foreseeable that the effect of race in the combat-CVD association may not be consistent 
across eras of service, as sociopolitical factors affecting participation of black men in the 
military and, specifically in combat, differed during the different eras of service investigated. 
Finally, racial differences are often difficult to disentangle from differences in SES. In the 
present study, black men had lower adult SES, as measured by education, income and 
occupation at each combat level and during each era of service. Thus, we might expect the 
association between combat and CHD and IS event rates to be higher among black men.  
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Strengths and Limitations 
This study provided a rare opportunity to investigate the long-term association of 
combat exposure on levels of cardiovascular risk in a large community-based cohort. 
Average follow-up time was long and participants were of an age (60 to 80 years) where 
CHD is most likely manifest. Among veterans,  periods of military service spanned from 
World War II through the Vietnam Conflict and includes measures of specific combat 
exposures and both military and civilian controls. Most previous studies have been based on 
retrospective cohorts and have investigated differences in CVD mortality comparing war 
theater veterans and non-theater veterans of the same era. Also a particular strength, this 
study included objective, standardized measures of cardiovascular outcomes and a wide 
range of physical and behavioral risk factor measures. The availability of socioeconomic 
measures from various life epochs further offered an unusual opportunity to investigate the 
role of SES in combat-cardiovascular associations.   
The use of self-reported combat exposures presents challenges. Because the combat 
exposure variable used in this study is based on self-reported information, recall bias may 
affect results, such that men in worse health may differentially recall their military 
experiences. Even for participants whose CHD and stroke status was unknown at the time 
that military exposures were queried, participants may have been aware of their status on 
other health indicators such as hypertension and high cholesterol status. Although recalled 
exposure status is not ideal, to our knowledge, no cohorts exist that collected combat 
exposure during military service and included long-term follow-up with a rigorous 
measurement of cardiovascular outcomes. Further, defining combat as the exposure to one or 
more specific use of recalled combat exposures has precedent719,720, 721 and has high validity 
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and reliability.722, 723 Therefore, it is unlikely that differential recollection of past military 
experiences based on current health status was significant. In fact, use of recalled combat 
experiences can be viewed as a strength, as it is a more specific and meaningful definition 
than simply separating exposure groups into theater and non-theater veterans who served 
during the same era.  
As discussed in both manuscripts, we were not able to assess the role of 
psychological mediators in the associations investigated. While it would have been of interest 
to provide results stratified on CSR or PTSD status, this information was not queried in the 
LC-SES interview.724,725 Psychological status would have been assessed as a potential effect 
measure modifier rather than as a confounder; consequently its exclusion does not detract 
from our findings. Our results support the conclusion that the effects of combat exposure 
extend beyond the narrow scope of these clinical diagnoses. 
Finally, although this study includes a large population of men, it does not have 
adequate statistical power to formally address hypotheses about potential effect measure 
modification for all of the outcomes assessed. In addition to era of service and race, of 
particular interest would be to see if there is interaction by age at entry, duration of service, 
psychological status and type of combat exposure.  
 
Future Directions 
Because this study is the first, to of our knowledge, to assess the relationship between 
combat exposure and clinical or subclinical atherosclerosis or the relationship between 
combat exposure and incident CHD and IS, the long-term effects of combat on 
cardiovascular health should be examined in other populations. Ideally, studies would be 
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population-based, so as to include both veteran and non-veteran controls, and would not 
include a gap in data collection between the time of exposure and the time of outcome 
assessment in order to minimize the potential impact of selective survival. Although this 
study offered a more meaningful measure of exposure than most studies of combat in the 
published literature, more information about the specific nature, duration and severity of 
combat would be of benefit in order to have a richer measure of exposure. If the association 
between combat and subclinical atherosclerosis is confirmed in other studies, whether this 
carries over into an increased risk of clinical disease and mortality should be investigated. 
Further, given the inter-era differences noted, future studies should focus on which aspects of 
combat might help explain these differences, including the role of specific combat exposures 
and other military factors as well as socio-political factors and homecoming 
experiences.726,727 
If future studies support a connection between combat and CVD, an additional 
challenge will be to elucidate the possible mechanisms through which stress can place an 
individual at long-term risk for CVD. With a focus on finding pathways for prevention, 
subsequent studies should assess whether psychosocial stress acts through mediational 
biological processes such as inflammatory markers as well as through psychological, 
behavioral or lifestyle changes. In addition, studies with larger sample sizes could better 
evaluate the potential role of race, SES, pre- and post-military psychological status and other 
potentially important modifiers of the association between combat and cardiovascular risk. 
The findings in this study provide key groundwork for future opportunities into an important 
area of study that have implications for our understanding of the lasting effects of traumatic 
stress on long-term cardiovascular health.  
 176 
APPENDICES 
A. Institutional Review Board Certification. 
 
Date: Fri, 15 Jun 2007 10:17:40 (EDT) 
FROM: UNC-CH IRB 
TO: Anne-Marie Johnson 
SUBJECT: IRB Notice 
 
TO: Anne-Marie Johnson 
Epidemiology 
545 Lakeside Dr. Statesville NC 28677 
 
FROM: Public Health-Nursing IRB 
 
_____________________________ 
Authorized signature on behalf of IRB 
 
APPROVAL DATE: 6/14/2007 
 
EXPIRATION DATE OF APPROVAL: 6/12/2008 
 
RE: Notice of IRB Approval by Expedited Review (under 45 CFR 46.110) 
Submission Type: Renewal 
Expedited Category: 5.Existing or non-research data 
Study #: 05-1140 Also (05-2661) 
 
Study Title: Association Between Exposure to Combat-Related Stress  
and Predicted Risk of CHD and Stroke in Aging Men: The  
Atherosclerosis Risk in Communities(ARIC) Study 
 
This submission has been approved by the above IRB for the period 
indicated. It has been determined that the risk involved in this 
research is no more than minimal.  
 
Federal regulations require that all research be reviewed at least 
annually. It is the Principal Investigator’s responsibility to submit 
for renewal and obtain approval before the expiration date. You may 
not continue any research activity beyond the expiration date without 
IRB approval. Failure to receive approval for continuation before the 
expiration date will result in automatic termination of the approval 
for this study on the expiration date. 
 
When applicable, enclosed are stamped copies of approved consent 
documents and other recruitment materials. You must copy the stamped 
consent forms for use with subjects unless you have approval to do 
otherwise. 
 
You are required to obtain IRB approval for any changes to any aspect 
of this study before they can be implemented (use the modification 
form at ohre.unc.edu/forms). Should any adverse event or  
unanticipated problem involving risks to subjects or others occur it 
must be reported immediately to the IRB using the adverse event form 
at the same website. 
 
 177 
 
 
Study Description: 
This student project uses the ARIC data to study the association 
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factors, sub clinical atherosclerosis, and the predicted risk of and 
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Details: 
Based on the information provided, the IRB has determined that HIPAA 
does not apply to this study. 
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according to 45 CFR 46.116(d). 
 
Call the IRB at 966-3113 if you have any questions. You can now access 
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This study was reviewed in accordance with federal regulations 
governing human subjects research, including those found at 45 CFR 46 
(Common Rule), 45 CFR 164 (HIPAA), and 21 CFR 50 & 56 (FDA), where 
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Data Use and Distribution Agreement of the ARIC data was entered into as of 5/31/2005; 
Data Use and Distribution Agreement of the LC-SES data was entered into as of 7/5/2005;  
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B. Annual Follow-up Interview Questions, 2001-2002 (Select Questions). 
 
   AFU RESIDENTIAL/OCCUPATIONAL HISTORY (SESB) 
 
   E. MILITARY SERVICE OR EXPOSURE TO WAR 
 
Y = Yes  
N = No  
U = Unsure 
 
37. Did you ever serve in the armed forces? ……………………………………… Y N U 
38. How old were you when you first entered? ……………………………………Y N U 
39. For how many years all together did you serve in active duty? ……………….Y N U 
40. While in the armed services, did you ever serve over-seas? …………………. Y N U 
41. Did you ever serve in a combat zone? ………………………………………... Y N U 
42. Were you ever under enemy fire or did you ever fire at the enemy? ………… Y N U 
43. Did you ever see anyone wounded or killed during the war? ………………… Y N U 
44. Were you ever wounded, or declared a prisoner of war or missing in action? .. Y N U 
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C. Supplemental Results, Manuscript 1.  
 
 
Table 22. Wald Tests for Interaction on the Multiplicative Scale (Risk Ratio Using 
Modified Poisson Regression). 
OUTCOME: Plaque 
Potential modifier Wald p-value (p > χ2) Interpretation 
NCV v. NV   
Race 0.5672 No interaction 
CV v. NV   
Race 0.2099 No interaction 
CV v. NCV   
Race 0.4741 No interaction 
Era of service 0.6207 No interaction 
OUTCOME: Binary CIMT 
Potential modifier Wald p-value (p > χ2) Interpretation 
NCV v. NV   
Race 0.9672 No interaction 
CV v. NV   
Race 0.9810 No interaction 
CV v. NCV   
Race 0.9543 No interaction 
Era of service 0.2743 No interaction 
H0: OR are equal across strata. If p<0.20 then reject H0. 
NOTE: Tests are underpowered; i.e., cannot conclude that no interaction is present. 
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Table 23. Distribution of Age in Years (Categorized) by Era of Service.  
 Age in years 
 
Era of Service N (%) 44-49 
(n=648)   
50-54    
(n=768) 
55-59    
(n=986) 
60-66 
(n=903)    
World War II (n=792) 0 0 48 (6.1) 744 (93.9) 
Korean war (n=1082)   0 207 (19.1) 777 (71.8) 98 (9.1) 
Vietnam conflict (n=704)   529 (75.1) 165 (23.4) 9 (1.3) 1 (0.1) 
Between periods of defined conflict (n=727)   119 (16.4) 396 (54.5) 152 (20.9) 60 (8.3) 
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Table 24. Mean Age at Induction into the Military, by Era of Service, Including Men  
Who Served Between Periods of Defined Conflict. 
 Non-Combat 
Veterans 
 
Combat  
Veterans 
Era of Service N (%) N Mean SD1 N Mean SD 
World War II (n=792) 314 17.86 0.92 478 17.98 1.03 
Korean war (n=1082)   675 19.70 1.88 407 19.35 1.86 
Vietnam conflict (n=704)   506 21.16 2.79 198 20.87 3.31 
Between periods of defined conflict (n=727)   621 19.93 2.31 92 19.50 2.42 
1 SD = Standard Deviation                          
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Table 25. Observed Carotid Plaque and Carotid Intima-Media Thickness through 2002, Stratified by Education and Field 
Center. 
 Non-Combat Veterans vs.  
Non-Veterans1 
Combat Veterans vs.  
Non-Veterans 
 OR2 Plaque OR CIMT RD CIMT OR Plaque OR CIMT RD CIMT 
Education  
 
      
< High school 1.645        
(1.082, 2.501) 
1.581        
(0.986, 2.536) 
0.0378 
(0.0118, 0.0637) 
  2.301        
(1.522, 3.480) 
2.550        
1.631, 3.987) 
0.0394 
(0.0251, 0.0536) 
High school or 
equivalent 
1.218        
(0.851, 1.744) 
0.921       
 (0.613, 1.383) 
0.0050 
(-0.0117, 0.0217) 
1.841        
(1.249, 2.713) 
1.838        
(1.212, 2.789) 
0.0274 
(0.0171, 0.0378) 
> High school 1.792        
(1.173, 2.737) 
1.732        
(1.065, 2.818) 
0.0324 
(0.0184, 0.0465) 
2.877        
(1.844, 4.487) 
3.145        
(1.910, 5.180) 
0.0322 
(0.0238, 0.0406) 
Field Center       
Forsyth County, NC           1.226        
(0.802, 1.876) 
0.830        
(0.537, 1.283) 
0.0056 
(-0.0139, 0.0250) 
1.635        
(0.986, 2.713) 
1.363        
(0.823, 2.257) 
0.0259 
(0.0123, 0.0395) 
Jackson, MS            0.792 
(0.405, 1.551) 
0.874        
(0.418, 1.830) 
0.0084 
(-0.0139, 0.0306) 
1.502        
(0.758, 2.978) 
2.394        
(1.222, 4.692) 
0.0168 
(0.0022, 0.0313) 
Minneapolis, MN 1.370        
(0.907, 2.069) 
1.451        
(0.897, 2.347) 
0.0257 
(0.0056, 0.0457) 
2.231        
(1.454, 3.423) 
2.726        
(1.679, 4.428) 
0.0349 
(0.0230, 0.0467) 
Washington County, 
MD 
1.176 
(0.777, 1.781) 
1.086        
(0.638, 1.848) 
0.0072 
(-0.0120, 0.0263) 
1.921        
(1.270, 2.905) 
2.348        
(1.422, 3.876) 
0.0297 
(0.0191, 0.0404) 
1
 Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the individual 
(1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during 
war; Non-Combat Veterans are defined as those who served in the military but did not report any combat exposures (1-4). 
2  OR = Odds ratio; RD = Risk Difference
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Table 26: Observed Carotid Plaque and Carotid Intima-Media Thickness 
through 2002, Stratified by Race, Adjusted for Age. 
 Non-Combat 
Veterans vs.  
Non-Veterans1 
Combat Veterans 
vs. Non-Veterans 
Combat Veterans 
vs. Non-Combat 
Veterans 
Plaque (OR (95% CI)) 2    
Unadjusted  1.15 (1.01, 1.30) 1.42 (1.22, 1.64) 1.24 (1.07, 1.43) 
Age Adjusted  0.98 (0.86, 1.11) 0.92 (0.78, 1.09) 1.00 (0.85, 1.16) 
Age-adjusted, by race    
African-Americans only 0.86 (0.63, 1.18) 0.74 (0.50, 1.11) 0.88 (0.57, 1.35) 
Caucasians only 0.98 (0.85, 1.14) 0.93 (0.77, 1.13) 1.02 (0.86, 1.20) 
Age-adjusted, by era of service    
World War II only N/A N/A 1.19 (0.87, 1.64) 
Korean War only N/A N/A 1.10 (0.85, 1.42) 
Vietnam conflict only N/A N/A 0.88 (0.61, 1.26) 
Between periods of defined  
conflict only 
N/A N/A 0.78 (0.50, 1.22) 
CIMT (µm) (RD (95% CI))    
Unadjusted  12.50 (2.6, 22.3) 28.6 (22.5, 34.6) 44.68 (32.47, 56.89) 
Age Adjusted  -10.3 (-19.9, -0.8) 0.3 (-0.6.1, 6.6) 12.79 (0.72, 24.86) 
Age-adjusted, by race    
African-Americans only -8.51 (-29.13, 12.11 ) -5.18 (-18.57, 8.21) -7.08 (-37.40, 23.24) 
Caucasians only -9.88 (-20.99, 1.23) 0.65 (-6.72, 8.02) 15.89 (2.74, 29.04) 
Age-adjusted, by era of service    
World War II only N/A N/A 16.66 (-12.86, 46.18) 
Korean War only N/A N/A 16.89 (-4.14, 37.92) 
Vietnam conflict only N/A N/A 4.22 (-15.56, 24.00) 
Between periods of defined  
conflict only 
N/A N/A 10.64 (7.11, 14.17) 
CIMT ≥ 1 mm (OR (95% CI))    
Unadjusted  1.115 (0.87, 1.43) 2.170 (1.685, 2.80) 1.95 (1.53, 2.48) 
Age Adjusted  0.836 (0.65, 1.08) 1.080 (0.811, 1.44) 1.27 (0.97, 1.65) 
Age-adjusted, by race    
African-Americans only 0.810 (0.41, 1.59) 1.273 (0.62, 2.61) 1.385 (0.62, 3.09) 
Caucasians only 0.792 (0.60, 1.06) 0.975 (0.71, 1.34) 1.250 (0.95, 1.65) 
Age-adjusted, by era of service    
World War II only N/A N/A 1.09 (0.72, 1.65) 
Korean War only N/A N/A 1.63 (1.08, 2.45) 
Vietnam conflict only N/A N/A 0.99 (0.30, 3.27) 
Between periods of defined  
conflict only 
N/A N/A 1.51 (0.67, 3.40) 
1
 Combat Veterans are identified by a summary variable based on whether or not the individual served in the military 
and, if so, whether the individual (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw 
wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans are defined as those 
who served in the military but did not report any combat exposures (1-4). 
2
 OR = Odds ratio; RD = Risk Difference 
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Table 27: Profile of Recalled Military Service and Combat History Reported During the LC-SES Interview, by War/Conflict 
Era (Including Men Who Served between Periods of Defined Conflict). 
 
Non-Combat Veterans * 
 
Combat Veterans * 
 
 Total World  
War II 
Korean 
War 
  Vietnam  
Conflict 
  Between 
   conflicts 
Total World  
War II 
Korean  
War 
Vietnam 
Conflict 
Between  
conflicts 
N  2127 314 675 506 632 1178 478 407 198 95 
Mean (SD) Age at induction into service 
(years) 
 
19.8  
(2.4) 
17.9  
(0.9) 
19.7  
(1.9) 
21.2  
(2.8) 
19.9 
(2.3) 
19.1  
(2.2) 
18.0  
(1.0) 
19.4  
(1.9) 
20.9  
(3.3) 
19.5 
(2.4) 
Mean (SD) Elapsed time since age at 
induction into service (years) 3 
 
34.3   
(5.9) 
43.6  
(1.3) 
36.6  
(2.0) 
27.0  
(3.0) 
32.9 
(3.5) 
38.2   
(6.8) 
44.5  
(1.3) 
37.3  
(2.0) 
26.7  
(3.7) 
34.5 
(4.5) 
Mean (SD) Duration of service (years) 3.1 
(3.2) 
2.5 
(2.2) 
3.5 
(3.7) 
4.0 
(4.4) 
2.1 
(1.1) 
4.9 
(5.6) 
4.2 
(4.5) 
5.2 
(6.1) 
7.2 
(7.2) 
2.5 
(1.1) 
n (%) Served overseas 1085  
(51.0) 
169  
(54.2) 
384  
(56.9) 
244  
(48.2) 
288 
(45.9) 
1108  
(94.1) 
460  
(96.4) 
392  
(96.3) 
182  
(91.9) 
74 
(77.9) 
n (%) Served in combat zone N/A N/A N/A N/A N/A 975  
(82.8)          
430  
(90.0) 
339  
(83.3) 
163  
(82.3) 
43  
(45.7) 
n (%) Under enemy fire or fired at enemy N/A N/A N/A N/A N/A 700  
(59.7)          
 
337  
(70.7) 
229  
(56.8) 
110  
(55.6) 
24  
(25.3) 
n (%) Saw wounded or killed during war N/A N/A N/A N/A N/A 853  
(72.7)         
357  
(74.8) 
294  
(73.0) 
139  
(70.2) 
63  
(66.3) 
n (%) Ever wounded or missing during war N/A N/A N/A N/A N/A 154  
(13.1)         
76  
(15.9) 
57  
(14.1) 
18  
(9.1) 
3  
(3.2) 
1
 Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the individual (1) 
served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; 
Non-Combat Veterans are defined as those who served in the military but did not report any combat exposures (1-4). 
2 OR = Odds ratio; RD = Risk Difference 
3 Age at Visit 1 – self-reported age at entry into the military 
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Table 28: Sociodemographic Profile at Entry into the ARIC Cohort, by Military Service and Combat History, by War/Conflict 
Era (Including Men Who Served between Periods of Defined Conflict). 
 NV Non-Combat Veterans 1 Combat Veterans  
 Total Total World  
War II 
Korean 
War 
Vietnam 
Conflict 
Between 
conflicts 
Total World  
War II 
Korean  
War 
Vietnam 
Conflict 
Between 
 conflicts 
N 2042 2127 314 675 506 632 1178 478 407 198 95 
Mean (SD) Age at Baseline  
ARIC Visit (years) 
51.8  
(5.2) 
54.12  
(5.1) 
61.5  
(1.6) 
56.3  
(2.4) 
48.2  
(2.5) 
52.9  
(3.6) 
57.3  
(5.8) 
62.5  
(1.5) 
56.7  
(2.2) 
47.6  
(2.6) 
54.3  
(4.7) 
n (%) African-American 643  
(31.5) 
278  
(13.1)  
37  
(11.8) 
88 
 (13.0) 
75  
(14.8) 
78  
(12.3) 
155  
(13.2)  
45  
(9.4) 
60  
(14.7) 
39  
(19.7) 
11  
(11.6) 
n (%) Education < High School 625  
(30.7) 
244  
(11.5)  
77  
(24.5) 
94  
(14.0) 
20  
(4.0) 
53  
(8.4) 
209  
(17.8)  
112  
(23.4) 
67  
(16.5) 
8  
(4.1) 
22  
(23.2) 
n (%) Natural Father’s  
Education < High School 2 
1010  
(61.0 ) 
1102  
(59.4)  
178  
(63.1) 
374  
(64.0) 
219  
(50.9) 
331  
(59.3) 
634  
(61.4) 
282  
(64.7) 
229  
(65.4) 
79  
(48.2) 
44  
(53.0) 
n (%) Combined Family  
Income < $25,000 
625  
(32.5) 
368  
(18.0) 
81  
(26.8) 
135  
(20.6) 
63  
(12.9) 
89  
(14.8) 
284  
(25.3) 
163  
(35.8) 
74  
(19.2) 
26  
(13.7) 
21  
(22.8) 
n (%) Occupation Non- 
Managerial/ Professional 
1446  
(70.9) 
1382  
(65.0) 
245  
(78.0) 
446  
(66.1) 
302  
(59.7) 
389  
(61.6) 
903  
(76.7) 
412  
(86.2) 
290  
(71.3) 
132  
(66.7) 
69  
(72.6) 
Note: columns may not sum to 100% due to rounding 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the 
individual (1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans (NCV) are defined as those who served in the military but did not report any combat exposures (1-4).  
2
 804 values missing information on natural father’s education 
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Table 29. Profile of Cardiovascular Risk Factors and Morbidity at Entry into the ARIC 
Cohort, by Military Service and Combat History, Means (Standard Deviations) or 
Frequencies (Percentages).  
Because of missing data, N differs in some variables. 
Some columns may not sum to 100% due to rounding. 
1  Current alcohol drinking is defined as self-report of drinking any alcohol at baseline; Current cigarette 
smoking is defined as self-report of smoking one or more cigarettes per year at baseline; Heavy cigarette 
years of smoking is calculated by multiplying the number of cigarettes smoked per year by the number of 
years the individual has been smoking and is defined as having smoked 660 or more cigarettes; Physical 
inactivity is defined as having a sports activity index score less than 2.0.  
 Non-Veterans 2 Non-Combat 
Veterans 
Combat 
Veterans 
N 2042 2127 1178 
Behavioral Risk Factors 1    
n (%) Current Alcoholic Drinking  1212 (59.73) 1492 (70.34) 824 (70.31) 
n (%) Current Cigarette smoking status  541 (26.51) 473 (22.25) 247 (20.99)  
n (%) Heavy Cigarette years of smoking  438 (21.85) 545 (25.93) 368 (31.72) 
n (%) Physically inactive  616 (30.36) 843 (39.75) 515 (43.90) 
Physical Risk Factors     
Mean (SD) BMI (m/kg2) 27.8 (4.4) 27.2 (3.8) 27.7 (4.0) 
Mean (SD) Waist circumference (cm)   99.1 (11.6) 98.4 (10.0)  99.6 (10.3) 
Mean (SD) Systolic BP (mmHg) 121.8 (17.6) 119.9 (16.3) 122.5 (16.7) 
Mean (SD) Diastolic BP (mmHg) 76.6 (11.6) 74.6 (10.3)  74.4 (10.2)  
Mean (SD) Total cholesterol (mg/dL) 209.7 (39.8) 210.7 (37.9) 213.5 (40.4) 
Mean (SD) LDL cholesterol (mg/dL) 138.3 (37.3) 139.6 (35.4) 141.9 (37.0) 
Mean (SD) HDL cholesterol (mg/dL) 44.8 (13.5) 44.2 (13.2) 43.7 (12.8) 
Mean (SD) Triglycerides (mg/dL) 137.0(84.8) 140.3 (96.9) 148.1 (110.7) 
n (%) Hypertension 671 (32.9) 617 (29.0) 377 (32.0) 
n (%) Prevalent Diabetes  213 (10.6) 167 (7.9) 123 (10.5) 
n (%) Prevalent CHD  107 (5.2) 117 (5.5) 94 (8.0) 
2
 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether he (1) served in a combat zone, (2) was under enemy fire or 
fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; Non-
Combat Veterans (NCV) are defined as those who served in the military but did not report any combat 
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Table 30. Frequencies and Percentages of Men Who Fall into the 85th and 90th 
Percentiles of Carotid Intima Media Thickness (CIMT) by Race and Age Category. 
85th percentile n (%) 
 
 
CIMT 85th 
percentile  
cutpoint by race  
and age category 
total > 85th 
percentile 
≤ 85th 
percentile 
By race/age category     
Black 45-54 0.8324 678 (100) 101 (14.9) 577 (85.1) 
Black 55-65 0.9402 398 (100) 59 (14.8) 339 (85.2) 
White 45-54 0.8289 2215 (100) 331 (14.9) 1884 (85.1) 
White 55-65 0.9805 2056 (100) 308 (15.0) 1748 (85.0) 
By combat exposure       
Non-veteran N/A 2042 (100) 302 (14.8) 1740 (85.2) 
Non-combat veteran N/A 2127 (100) 293 (13.8) 1834 (86.2) 
Combat veteran N/A 1178 (100) 204 (17.3) 974 (82.7) 
90th percentile n (%) 
 
 
CIMT 90th 
percentile 
cutpoint by race  
and age category 
total > 90th 
percentile 
≤ 90th 
percentile 
By race/age category     
Black 45-54 0.8883 678 (100) 64 (9.4) 614 (90.6) 
Black 55-65 0.9820 398 (100) 38 (9.6) 360 (90.4) 
White 45-54 0.8730 2215 (100) 219 (9.9) 1996 (90.1) 
White 55-65 1.0604 2056 (100) 204 (9.9) 1852  (90.1) 
By combat exposure       
Non-veteran N/A 2042 (100) 200 (9.8) 1842 (90.2) 
Non-combat veteran N/A 2127 (100) 193 (9.1) 1934 (90.9) 
Combat veteran N/A 1178 (100) 132 (11.2) 1046 (88.8) 
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Table 31: Observed Carotid Plaque and Carotid Intima-Media Thickness (CIMT) 
through 2002, by Military Service and Combat History, Means (Standard Deviations) 
or Frequencies (Percentages), LC-SES Men versus ARIC Men.  
 LCSES men 
 
ARIC 
men 
 Total Non- 
Veterans 2 
Non- 
Combat 
Veterans 
Combat 
Veterans 
Total 
N 5347 
 
2042 2127 1178  
n (%) Plaque 2423  
(48.4) 
 
858 
(45.09) 
970 
(48.48) 
595  
(53.75) 
3368  
(51.96) 
Mean (SD) 3-year average CIMT 
(µm)1 
762.9  
(167.3) 
 
745.2 
(157.7) 
757.7 
(164.1) 
802.4 
(182.2) 
784.6  
(186.1) 
n (%) 3-year average CIMT ≥ 1 
(µm)  
408  
(7.7) 
 
122 
(6.08) 
142 
(6.74) 
144  
(12.33) 
719  
(10.40) 
n (%) CIMT > 85th percentile 3-
year average CIMT (µm)  
661  
(12.4) 
255 
(12.49) 
242  
(11.38) 
164  
(13.92) 
1052  
(14.96) 
NOTE:  ARIC men have less favorable plaque and CIMT profiles, even after age and race-specific 
percentiles of CIMT are considered. 
1Average far wall imputed CIMT over ARIC Visits 1 and 2; 85th percentile of CIMT for all African-
American or Caucasian male ARIC participants; four separate age and race-specific 85th percentile 
cutpoints were used: Black men ages 45-54, Black men ages 55-65, White men ages 45-54 and 
White men ages 55-65. 
2
 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans (NCV) are defined as those who served in the military but did 
not report any combat exposures (1-4). 
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Table 32: Profile of Behavioral Cardiovascular Risk Factors and Morbidity at Baseline, 
by Race and Era of Combat, Means (Standard Deviations) or Frequencies 
(Percentages). 
 Non- 
Veterans 2 
Non- 
Combat 
Veterans 
Combat 
Veterans 
N 2042 2127 1178 
n (%) Current alcoholic drinking 1 
   
Total 1212 (59.7) 1492 (70.3) 824 (70.3) 
By race    
African-American 289 (45.7) 144 (52.2) 94 (61.4) 
Caucasian 923 (66.1) 1348 (73.1) 730 (71.6) 
By era of service    
World War II N/A 199 (63.6) 341 (71.8) 
Korean War N/A   455 (67.7) 272 (66.8) 
Vietnam conflict N/A 380 (75.1) 144 (73.5) 
n (%) Current cigarette smoking status     
Total 541 (26.5) 473 (22.3) 247 (21.0)  
By race    
African-American 233 (36.2) 82 (29.5)   46 (29.9) 
Caucasian 308 (22.0) 391 (21.2) 201 (19.7) 
By era of service    
World War II N/A 44 (14.0) 70 (14.6) 
Korean War N/A 139 (20.6) 108 (26.6) 
Vietnam conflict N/A 136 (26.9) 44 (22.2) 
n (%) Heavy cigarette years of smoking     
Total 438 (21.9) 545 (25.9) 368 (31.7) 
By race    
African-American 104 (16.8) 50 (18.5)   23 (15.7) 
Caucasian 334 (24.1) 495 (27.0) 345 (34.1) 
By era of service    
World War II N/A 94 (30.3) 163 (34.6) 
Korean War N/A 209 (31.2) 147 (36.8) 
Vietnam conflict N/A   94 (18.8) 32 (16.4) 
n (%) Physically inactive     
Total 616 (30.4) 843 (39.8) 515 (43.9) 
By race    
African-American 217 (34.2) 95 (34.3) 50 (32.7) 
Caucasian 299 (21.5) 307 (16.7) 163 (16.0) 
By era of service    
World War II N/A 59 (18.9) 73 (15.3) 
Korean War N/A 142 (21.1) 84 (20.7) 
Vietnam conflict N/A 90 (17.8) 38 (19.3) 
Because of missing data, N differs in some variables. 
Some columns may not sum to 100% due to rounding. 
1  Current alcohol drinking is defined as self-report of drinking any alcohol at baseline; Current cigarette 
smoking is defined as self-report of smoking one or more cigarettes per year at baseline; Heavy 
cigarette years of smoking is calculated by multiplying the number of cigarettes smoked per year by 
the number of years the individual has been smoking and is defined as having smoked 660 or more 
cigarettes; Physical inactivity is defined as having a sports activity index score less than 2.0.  
2
 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual served in 
the military and, if so, whether he (1) served in a combat zone, was under enemy fire or fired at enemy, (3) saw 
wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans (NCV) are 
defined as those who served in the military but did not report any combat exposures (1-4).
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Table 33. Profile of Physical Cardiovascular Risk Factors and Morbidity at Baseline, by 
Race and Era of Combat, Means (Standard Deviations) or Frequencies (Percentages).  
 Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat 
Veterans 
N 2042 2127 1178 
Mean (SD) BMI (m/kg2)    
Total 27.8 (4.4) 27.2 (3.8) 27.7 (4.0) 
By race    
African-American 27.9 (4.6) 27.9 (4.9) 27.8 (4.7) 
Caucasian 27.7 (4.3) 27.0 (3.6) 27.7 (3.8) 
By era of service    
World War II N/A 27.4 (3.9) 27.3 (3.6) 
Korean War N/A 27.1 (3.8) 27.9 (4.2) 
Vietnam conflict N/A 27.0 (3.9) 27.9 (4.1) 
Mean (SD) Waist circumference (cm)      
Total 99.1 (11.6) 98.4 (10.0)  99.6 (10.3) 
By race    
African-American 97.0 (12.3) 97.2 (12.2) 96.9 (12.1) 
Caucasian 100.0 (11.2) 98.6 (9.6) 100.0 (9.9) 
By era of service    
World War II N/A 99.7 (9.9) 99.3 (9.5) 
Korean War N/A 98.7 (9.9) 99.7 (10.6) 
Vietnam conflict N/A 97.1 (10.3)                                    99.4 (10.8)
Mean (SD) Systolic BP (mmHg)    
Total 121.8 (17.6) 119.9 (16.3) 122.5 (16.7) 
By race    
African-American 128.2 (20.2) 127.6 (19.5) 130.2 (19.2) 
Caucasian 118.8 (15.4) 118.8 (15.4) 121.4 (16.0) 
By era of service    
World War II N/A 125.7 (18.9) 125.6 (17.3) 
Korean War N/A 120.8 (16.3) 122.5 (16.0) 
Vietnam conflict N/A 116.1 (14.6) 116.6 (14.5) 
Mean (SD) Diastolic BP (mmHg)    
Total 76.6 (11.6) 74.6 (10.3)  74.4 (10.2)  
By race    
African-American 82.8 (12.3) 81.7 (11.8) 81.4 (12.2) 
Caucasian 73.8 (10.0) 73.6 (9.6) 73.3 (9.4) 
By era of service    
World War II N/A 74.1 (10.6) 73.6 (10.1) 
Korean War N/A 74.8 (10.3) 74.9 (10.1) 
Vietnam conflict N/A 74.2 (11.0) 75.2 (10.6) 
Mean (SD) Total cholesterol (mg/dL)    
Total 209.7 (39.8) 210.7 (37.9) 213.5 (40.4) 
By race    
African-American 211.9 (43.3) 213.6 (41.9) 214.6 (45.4) 
Caucasian 208.7 (38.1) 210.2 (37.2) 213.4 (39.6) 
By era of service    
World War II N/A 212.0 (37.9) 214.3 (38.0) 
Korean War N/A 212.5 (37.3) 214.6 (42.6) 
Vietnam conflict N/A 205.9 (39.0) 207.7 (41.0) 
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 Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat  
Veterans 
Mean (SD) LDL cholesterol (mg/dL)    
Total 138.3 (37.3) 139.6 (35.4) 141.9 (37.0) 
By race    
African-American 138.7 (41.3) 141.2 (41.0) 142.7 (41.9) 
Caucasian 138.0 (35.4) 139.4 (34.4) 141.7 (36.3) 
By era of service    
World War II N/A 139.8 (35.0) 142.0 (35.1) 
Korean War N/A 141.5 (35.3) 143.4 (38.8) 
Vietnam conflict N/A 134.9 (36.0) 136.5 (37.0) 
Mean (SD) HDL cholesterol (mg/dL)    
Total 44.8 (13.5) 44.2 (13.2) 43.7 (12.8) 
By race    
African-American 50.4 (15.9) 49.2 (14.9) 49.1 (15.2) 
Caucasian 42.4 (11.5) 43.4 (12.8) 42.9 (12.2) 
By era of service    
World War II N/A 44.7 (14.1) 44.1 (12.2) 
Korean War N/A 43.9 (12.8) 43.3 (13.2) 
Vietnam conflict N/A 43.9 (13.0) 43.6 (13.1) 
Mean (SD) Triglycerides (mg/dL)    
Total 137.0 (84.8) 140.3 (96.9) 148.1 (110.7) 
By race    
African-American 117.1 (73.2) 115.7 (61.0) 125.7 (102.1) 
Caucasian 145.8 (88.1) 143.9 (100.6) 151.4 (111.6) 
By era of service    
World War II N/A 142.5 (92.0) 142.3 (71.1) 
Korean War N/A 139.3 (88.8) 150.8 (110.1) 
Vietnam conflict N/A 141.7 (95.6) 160.2 (180.1) 
n (%) Hypertension    
Total 671 (32.9) 617 (29.0) 377 (32.0) 
By race    
African-American 314 (58.9) 138 (49.8) 81 (52.26) 
Caucasian 354 (25.4) 476 (25.9) 293 (28.90) 
By era of service    
World War II N/A 133 (42.6) 172 (36.3) 
Korean War N/A 212 (31.5) 132 (32.5) 
Vietnam conflict N/A 104 (20.7) 41 (21.1) 
n (%) Prevalent Diabetes     
Total 213 (10.6) 167 (7.9) 123 (10.5) 
By race    
African-American 99 (15.9) 31 (11.4) 19 (12.5) 
Caucasian 114 (8.2) 136 (7.4) 104 (10.2) 
By era of service    
World War II N/A 40 (12.7) 56 (11.8) 
Korean War N/A 55 (8.2) 36 (8.9) 
Vietnam conflict N/A 29 (5.8) 17 (8.6) 
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Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat  
Veterans 
n (%) Prevalent CHD     
Total 107 (5.2) 117 (5.5) 94 (8.0) 
By race    
African-American 20 (3.2) 9 (3.3) 8 (5.2) 
Caucasian 85 (6.2) 105 (5.8) 84 (8.4) 
By era of service    
World War II N/A 36 (11.6) 45 (9.6) 
Korean War N/A 42 (6.4) 37 (9.3) 
Vietnam conflict N/A 12 (2.4) 4 (2.0) 
1
 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual served 
in the military and, if so, whether he (1) served in a combat zone, was under enemy fire or fired at enemy, 
(3) saw wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans 
(NCV) are defined as those who served in the military but did not report any combat exposures (1-4). 
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E. Supplemental Results, Manuscript 2  
Table 34: Profile of Physical Cardiovascular Risk Factors and Morbidity at Baseline, 
by Race and Era of Combat, Means (Standard Deviations) or Frequencies 
(Percentages), LC-SES Men and ARIC Men. 
LCSES men ARIC men  
Total Non- 
Veterans 2 
Non- 
Combat 
Veterans 
Combat 
Veterans 
Total 
N 5347    7030 
n (%) Current drinking 1 
     
Total 3528 (66.0) 1212 (59.7) 1492 (70.3) 824 (70.3) 4526 (64.7) 
African-American 527 (49.6) 289 (45.7) 144 (52.2) 94 (61.4) 782 (49.5) 
Caucasian 3001 (70.5) 923 (66.1) 1348 (73.1) 730 (71.6) 3744 (69.2) 
World War II 540 (68.5) N/A 199 (63.6) 341 (71.8) 540 (68.5) 
Korean War 727 (67.4) N/A   455 (67.7) 272 (66.8) 727 (67.4) 
Vietnam conflict 524 (74.6) N/A 380 (75.1) 144 (73.5) 524 (74.6) 
n (%) Current smoking       
Total 1261 (23.6) 541 (26.5) 473 (22.3) 247 (21.0)  1952 (27.8) 
African-American 361 (33.6) 233 (36.2) 82 (29.5)   46 (29.9) 615 (38.4) 
Caucasian 900 (21.1) 308 (22.0) 391 (21.2) 201 (19.7) 1337 (24.6) 
World War II 114 (14.4) N/A 44 (14.0) 70 (14.6) 114 (14.4) 
Korean War 247 (22.9) N/A 139 (20.6) 108 (26.6) 247 (22.9) 
Vietnam conflict 180 (25.6) N/A 136 (26.9) 44 (22.2) 18 (25.6) 
n (%) Years of heavy smoking       
Total 1351 (25.3) 438 (21.9) 545 (25.9) 368 (31.7) 2111 (30.6) 
African-American 177 (17.07) 104 (16.8) 50 (18.5)   23 (15.7) 355 (23.1) 
Caucasian 1174 (27.8) 334 (24.1) 495 (27.0) 345 (34.1) 1756 (32.7) 
World War II 257 (32.9) N/A 94 (30.3) 163 (34.6) 257 (32.9) 
Korean War 356 (33.3) N/A 209 (31.2) 147 (36.8) 356 (33.3) 
Vietnam conflict 126 (18.1) N/A   94 (18.8) 32 (16.4) 126 (18.1) 
n (%) Physically inactive       
Total 1131 (21.3) 616 (30.4) 843 (39.8) 515 (43.9) 1645 (23.5) 
African-American 362 (34.0) 217 (34.2) 95 (34.3) 50 (32.7) 588 (37.1) 
Caucasian 769 (18.1) 299 (21.5) 307 (16.7) 163 (16.0) 1057 (19.5) 
World War II 132 (16.7) N/A 59 (18.9) 73 (15.3) 132 (16.7) 
Korean War 226 (21.0) N/A 142 (21.1) 84 (20.7) 226 (21.0) 
Vietnam conflict 128 (18.2) N/A 90 (17.8) 38 (19.3) 128 (18.2) 
n (%) Used blood pressure- 
lowering medications in  
past 2 weeks 
     
Total 1289 (24.1) 493 (24.1) 495 (23.3) 301 (25.6) 1921 (27.4) 
African-American 353 (32.8) 201 (31.3) 103 (37.2) 49 (31.6) 577 (36.1) 
Caucasian 936 (21.9) 292 (20.9) 392 (21.2) 252 (24.7) 1344 (24.8) 
World War II 257 (32.5) N/A 118 (37.6) 139 (29.1) 257 (32.5) 
Korean War 288 (26.7) N/A 175 (25.9) 113 (27.9) 288 (26.7) 
Vietnam conflict 106 (15.1) N/A 78 (15.4) 28 (14.1) 106 (15.1) 
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LCSES men ARIC men  
Total Non- 
Veterans 2 
Non- 
Combat 
Veterans 
Combat 
Veterans 
Total 
n (%) Used cholesterol- 
lowering medications in  
past 2 weeks 
     
Total 151 (2.9) 53 (2.6) 64 (3.0) 34 (2.9) 216 (3.1) 
African-American 15 (1.4) 7 (1.1) 7 (1.5) 4 (2.6) 22 (1.4) 
Caucasian 136 (3.2) 46 (3.3) 60 (3.3) 30 (3.0) 194 (3.6) 
World War II 25 (3.2) N/A 10 (3.2) 15 (3.2) 25 (3.2) 
Korean War 34 (3.2) N/A 25 (3.7) 9 (2.2) 34 (3.2) 
Vietnam conflict 19 (2.7) N/A 13 (2.6) 6 (3.1) 19 (2.7) 
n (%) Left ventricular  
hypertrophy present by  
Cornell definition 
     
Total 94 (1.8) 48 (2.4) 29 (1.4) 17 (1.5) 151 (2.2) 
African-American 55 (5.3) 33 (5.35) 15 (5.6) 7 (4.6) 92 (6.0) 
Caucasian 39 (0.9) 15 (1.1) 14 (0.8) 10 (1.0) 59 (1.1) 
World War II 17 (2.2) N/A 10 (3.3) 7 (1.5) 17 (2.2) 
Korean War 13 (1.2) N/A 5 (0.8) 8 (2.0) 13 (1.2) 
Vietnam conflict 5 (0.7) N/A 4 (0.8) 1 (0.5) 5 (0.7) 
n (%) Prevalent Diabetes       
Total 503 (9.4) 213 (10.6) 167 (7.9) 123 (10.5) 844 (12.1) 
African-American 149 (14.2) 99 (15.9) 31 (11.4) 19 (12.5) 291 (18.6) 
Caucasian 354 (8.3) 114 (8.2) 136 (7.4) 104 (10.2) 553 (10.2) 
World War II 96 (12.2) N/A 40 (12.7) 56 (11.8) 96 (12.2) 
Korean War 91 (8.4) N/A 55 (8.2) 36 (8.9) 91 (8.4) 
Vietnam conflict 46 (6.6) N/A 29 (5.8) 17 (8.6) 46 (6.6) 
n (%) Prevalent CHD       
Total 311 (5.9) 107 (5.2) 117 (5.5) 94 (8.0) 574 (8.3) 
African-American 37 (3.50) 20 (3.2) 9 (3.3) 8 (5.2) 93 (5.92) 
Caucasian 274 (6.54) 85 (6.2) 105 (5.8) 84 (8.4) 481 (9.05) 
World War II 81 (10.41) N/A 36 (11.6) 45 (9.6) 81 (10.41) 
Korean War 79 (7.47) N/A 42 (6.4) 37 (9.3) 79 (7.47) 
Vietnam conflict 16 (2.31) N/A 12 (2.4) 4 (2.0) 16 (2.31) 
1  Current alcohol drinking is defined as self-report of drinking any alcohol at baseline; Current cigarette 
smoking is defined as self-report of smoking one or more cigarettes per year at baseline; Heavy cigarette 
years of smoking is calculated by multiplying the number of cigarettes smoked per year by the number of 
years the individual has been smoking and is defined as having smoked 660 or more cigarettes; Physical 
inactivity is defined as having a sports activity index score less than 2.0.  
2
 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual served 
in the military and, if so, whether he (1) served in a combat zone, was under enemy fire or fired at enemy, 
(3) saw wounded or killed during war, and/or (4) was ever wounded during war; Non-Combat Veterans 
(NCV) are defined as those who served in the military but did not report any combat exposures (1-4). 
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Table 35: Profile of Recalled Military Service and Combat History Reported during the 
LC-SES Interview, Overall and by Race. 
 Non-Combat 
Veterans1 
Combat 
Veterans 
N    
Total 2 2127 1178 
Black  278 155 
White 1849 1023 
Mean (SD) Age at induction into service (years)   
Total  19.8 (2.4) 19.1 (2.2) 
Black  20.2 (2.3) 19.7 (2.5) 
White 19.8 (2.4) 19.0 (2.2) 
Mean (SD) Elapsed years since induction into service 3 
  
Total  34.3 (5.9) 38.2 (6.8) 
Black  34.0 (6.3) 36.5 (7.5) 
White 34.3 (5.9) 38.5 (6.6) 
Mean (SD) Duration of service (years)   
Total  3.1 (3.2) 4.9 (5.6) 
Black  3.8 (4.7) 6.3 (7.3) 
White 3.0 (3.0) 4.7 (5.3) 
n (%) Served overseas   
Total  1085 (51.0) 1108 (94.1) 
Black  164 (59.4) 151 (97.4) 
White 921 (50.0) 957 (93.6) 
n (%) Served in combat zone   
Total  N/A 975 (82.8)          
Black  N/A 141 (91.0) 
White N/A 834 (81.6) 
n (%) Under enemy fire or fired at enemy   
Total  N/A 700 (59.7)          
Black  N/A 95 (62.1) 
White N/A 605 (59.3) 
n (%) Saw wounded or killed during war   
Total  N/A 853 (72.7)         
Black  N/A 93 (60.8) 
White N/A 760 (74.5) 
n (%) Ever wounded or missing during war   
Total  N/A 154 (13.1)         
Black  N/A 23 (15.0) 
White N/A 131 (12.8) 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether he (1) served in a combat zone, (2) was under enemy fire or 
fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during war; 
Non-Combat Veterans (NCV) are defined as those who served in the military but did not report any 
combat exposures (1-4).  
2 The 632 NCV and 95 CV that served between periods of defined conflict are included in the totals 
but not as a distinct category in stratified results as shown in the primary results reported in the 
manuscript.  
3
 Age at Visit 1 – self-reported age at entry into the military
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Table 36: Profile of Risk Factors and Morbidity at Entry into the ARIC Cohort 
(Dichotomous Variables), Overall and by Race. 
LCSES men ARIC men  
Total Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat 
Veterans 
Total 
N 5347 2042 2127 1178 7030 
n (%) African-American       
Total 2 1076 (20.1) 643 (31.5) 278 (13.1) 155 (13.2) 1602 (22.8) 
n (%) Current cigarette 
smoking status 3 
     
Total  1261 (23.6) 541 (26.5) 473 (22.3) 247 (21.0)  1952 (27.8) 
Black  361 (33.6) 233 (36.2) 82 (29.5)   46 (29.9) 615 (38.4) 
White 900 (21.1) 308 (22.0) 391 (21.2) 201 (19.7) 1337 (24.6) 
n (%) Used blood pressure-
lowering medications in past 2 
weeks 
     
Total  1289 (24.1) 493 (24.1) 495 (23.3) 301 (25.6) 1921 (27.4) 
Black  353 (32.8) 201 (31.3) 103 (37.2) 49 (31.6) 577 (36.1) 
White 936 (21.9) 292 (20.9) 392 (21.2) 252 (24.7) 1344 (24.8) 
n (%) Prevalent left 
ventricular hypertrophy 4 
     
Total  94 (1.8) 48 (2.4) 29 (1.4) 17 (1.5) 151 (2.2) 
Black  55 (5.3) 33 (5.35) 15 (5.6) 7 (4.6) 92 (6.0) 
White 39 (0.9) 15 (1.1) 14 (0.8) 10 (1.0) 59 (1.1) 
n (%) Prevalent diabetes       
Total  503 (9.4) 213 (10.6) 167 (7.9) 123 (10.5) 844 (12.1) 
Black  149 (14.2) 99 (15.9) 31 (11.4) 19 (12.5) 291 (18.6) 
White 354 (8.3) 114 (8.2) 136 (7.4) 104 (10.2) 553 (10.2) 
n (%) Prevalent CHD       
Total  311 (5.9) 107 (5.2) 117 (5.5) 94 (8.0) 574 (8.3) 
Black  37 (3.50) 20 (3.2) 9 (3.3) 8 (5.2) 93 (5.92) 
White 274 (6.54) 85 (6.2) 105 (5.8) 84 (8.4) 481 (9.05) 
NOTE: Because of missing data, N differs for some variables; Some columns may not sum to 100% 
due to rounding. 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans (NCV) are defined as those who served in the military but did 
not report any combat exposures (1-4).  
2 The 632 NCV and 95 CV that served between periods of defined conflict are included in the totals 
but not as a distinct category in stratified results as shown in the primary results reported in the 
manuscript.  
3 Current cigarette smoking is defined as self-report of smoking one or more cigarettes per year at 
baseline; Heavy cigarette years of smoking is calculated by multiplying the number of cigarettes 
smoked per year by the number of years the individual has been smoking and is defined as having 
smoked 660 or more cigarettes; Physical inactivity is defined as having a sports activity index score 
less than 2.0.  
4 Presence of left ventricular hypertrophy was determined electrocardiographically using the Cornell 
criteria.
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Table 37: Profile of Cardiovascular Risk Factors and Morbidity at Entry into the 
ARIC Cohort (Continuous Variables), Overall and by Race.  
LCSES men ARIC men  
Total Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat 
Veterans 
Total 
N 5347 2042 2127 1178 7030 
Mean (SD) Age (years)      
Total 2 53.9 (5.7) 51.8 (5.2) 54.1 (5.1) 57.3 (5.8) 54.6 (5.8) 
Black  52.9 (5.7) 51.5 (5.2) 54.2 (5.5) 56.2 (6.3) 53.9 (6.0) 
White 54.2 (5.6) 51.9 (5.2) 54.1 (5.0) 57.5 (5.7) 54.8 (5.7) 
Mean (SD) Systolic blood 
pressure (mmHg) 
     
Total  121.2 (16.9) 121.8 (17.6) 119.9 (16.3) 122.5 (16.7) 122.6 (18.1) 
Black  128.3 (19.9) 128.2 (20.2) 127.6 (19.5) 130.2 (19.2) 130.5 (21.7) 
White 119.4 (15.6) 118.8 (15.4) 118.8 (15.4) 121.4 (16.0) 120.2 (16.2) 
Mean (SD) Total 
cholesterol (mg/dL) 
     
Total  210.9 (39.2) 209.7 (39.8) 210.7 (37.9) 213.5 (40.4) 211.1 (40.0) 
Black  212.7 (43.3) 211.9 (43.3) 213.6 (41.9) 214.6 (45.4) 210.9 (44.1) 
White 210.5 (38.2) 208.7 (38.1) 210.2 (37.2) 213.4 (39.6) 211.1 (38.7) 
Mean (SD) HDL 
cholesterol (mg/dL) 
     
Total  44.3 (13.2) 44.8 (13.5) 44.2 (13.2) 43.7 (12.8) 44.4 (13.9) 
Black  49.9 (15.5) 50.4 (15.9) 49.2 (14.9) 49.1 (15.2) 50.4 (16.9) 
White 43.0 (12.2) 42.4 (11.5) 43.4 (12.8) 42.9 (12.2) 42.6 (12.4) 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans (NCV) are defined as those who served in the military but did 
not report any combat exposures (1-4).  
2 The 632 NCV and 95 CV that served between periods of defined conflict are included in the totals 
but not as a distinct category in stratified results as shown in the primary results reported in the 
manuscript.  
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Table 38: Observed Cumulative Incidence of Coronary Heart Disease through 
2002 by Military Service and Combat History, Overall and by Race.   
 Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat Veterans 
N    
Total 2 2042 2127 1178 
Black  643 278 155 
White 1399 1849 1023 
CHD Events    
Total  330 382 235 
Black  74 30 20 
White 256 352 215 
Mean (SD) time to event or  
censored in years    
Total  9.85 (1.81) 9.83 (1.94) 9.85 (2.05) 
Black  10.00 (1.60) 9.78 (1.99) 9.98 (1.62) 
White 9.78 (1.89) 9.84 (1.93) 9.83 (2.10) 
Incidence rate (incident events 
per 10 person-years)    
Total  0.1627 0.1819 0.2000 
Black  0.1151 0.1103 0.1293 
White 0.1871 0.1935 0.2138 
Incidence rate ratio (95% CI)    
Total  REF 1.11 (0.96, 1.29) 1.23 (1.05, 1.46) 
Black  REF 0.96 (0.63, 1.46) 1.12 (0.69, 1.84) 
White REF 1.03 (0.88, 1.21) 1.14 (0.95, 1.37) 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the individual 
served in the military and, if so, whether the individual (1) served in a combat zone, (2) was under 
enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded 
during war; Non-Combat Veterans (NCV) are defined as those who served in the military but did 
not report any combat exposures (1-4).  
2 The 632 NCV and 95 CV that served between periods of defined conflict are included in the totals 
but not as a distinct category in stratified results as shown in the primary results reported in the 
manuscript.  
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Table 39: Observed Cumulative Incidence of Ischemic Stroke through 2002 by Military 
Service and Combat History, Overall and by Race.  
 Non- 
Veterans 1 
Non- 
Combat 
Veterans 
Combat 
Veterans 
N    
Total 2 2042 2127 1178 
Black  643 278 155 
White 1399 1849 1023 
Ischemic stroke events    
Total  71 64 53 
Black  47 11 12 
White 24 53 41 
Mean (SD) time to event or  
censored in years    
Total  14.11 (1.49) 14.22 (1.30) 14.18 (1.65) 
Black  13.87 (1.99) 14.08 (1.56) 13.91 (1.79) 
White 14.22 (1.18) 14.24 (1.26) 14.22 (1.63) 
Incidence rate (incident 
events per 10 person-years)    
Total  0.0246 0.0212 0.0317 
Black  0.0527 0.0281 0.0557 
White 0.0121 0.0201 0.0282 
Incidence rate ratio (95% CI)    
Total  REF 0.86 (0.61, 1.20) 1.29 (0.90, 1.83) 
Black  REF 0.53 (0.28, 1.02) 1.06 (0.56, 1.98) 
White REF 1.67 (1.03, 2.70) 2.34 (1.42, 3.86) 
1 Combat Veterans (CV) are identified by a summary variable based on whether or not the 
individual served in the military and, if so, whether the individual (1) served in a combat 
zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, 
and/or (4) was ever wounded during war; Non-Combat Veterans (NCV) are defined as 
those who served in the military but did not report any combat exposures (1-4).  
2 The 632 NCV and 95 CV that served between periods of defined conflict are included in 
the totals but not as a distinct category in stratified results as shown in the primary results 
reported in the manuscript. 
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